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Cell-cell interactions in a microenvironment under stress conditions play a critical 
role in pathogenesis and pre-malignant progression. Hypoxia is a central factor in 
carcinogenesis, which induces selective pressure in this process. Understanding the role 
of intercellular communications and cellular adaptation to hypoxia can help discover new 
cancer biosignatures and more effective diagnostic and therapeutic strategies.  
This dissertation presents a study on transcriptomic and metabolic profiling of 
pre-malignant progression of Barrett’s esophagus. It encompasses two methodology 
developments and experimental findings of two related studies.  
To integrate phenotype and genotype measurements, a minimally invasive method 
was developed for selectively retrieving single adherent cells from cell cultures. Selected 
single cells can be harvested by a combination of mechanical force and biochemical 
treatment after phenotype measurements and used for end-point assays. Furthermore, a 
method was developed for analyzing expression levels of ten genes in individual 
mammalian cells with high sensitivity and reproducibility without the need of pre-
amplifying cDNA. It is inexpensive and compatible with most of commercially available 
RT-qPCR systems, which warrants a wide applicability of the method to gene expression 
analysis in single cells. 
In the first study, the effect of intercellular interactions was investigated between 
normal esophageal epithelial and dysplastic Barrett’s esophagus cells on gene expression 
levels and cellular functions. As a result, gene expression levels in dysplastic cells were 
found to be affected to a significantly larger extent than in the normal esophageal 
epithelial cells. These differentially expressed genes are enriched in cellular movement, 
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TGFβ and EGF signaling networks. Heterotypic interactions between normal and 
dysplastic cells can change cellular motility and inhibit proliferation in both normal and 
dysplastic cells. In the second study, alterations in gene transcription levels and metabolic 
phenotypes between hypoxia-adapted cells and age-matched normoxic controls 
representing four different stages of pre-malignant progression in Barrett’s esophagus 
were investigated. Through differential gene expression analysis and mitochondrial 
membrane potential measurements, evidence of clonal evolution induced by hypoxia 
selection pressure in metaplastic and high-grade dysplastic cells was found. These 
discoveries on cell-cell interactions and hypoxia adaptations provide a deeper insight into 
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CHAPTER 1  
OBJECTIVES AND CONTRIBUTION 
1.1 Significance and objectives 
Cell-cell interactions and metabolism are essential for growth and function of 
multicellular organisms. Aberrant intercellular communication plays a key role in 
carcinogenesis and tumor progression (Hanahan and Weinberg 2011, Hanahan and 
Coussens 2012). Metabolic reprogramming is one of the emerging hallmarks of cancer 
(Hanahan and Weinberg 2011). Understanding the role of intercellular communications 
and hypoxia-adapted metabolic reprogramming in pre-malignant progression could aid in 
early diagnosis and help discover more effective prognostic, diagnostic and management 
strategies of cancer.  
Barrett’s esophagus is a precancerous condition which predisposes to esophageal 
adenocarcinoma, a cancer type with high mortality rates (Shaheen and Ransohoff 2002). 
Barrett’s esophagus is one of the best characterized models for studying pre-malignant 
progression due to its relative easy access to biopsies that can be taken at multiple time 
points from the same patient, following current standard-of-care procedures (Barrett, 
Yeung et al. 2002). Two important factors in the clonal evolution of Barrett’s esophagus 
neoplastic progression are intercellular communications and hypoxia-selection pressure. 
Gene expression profiling (Helm, Enkemann et al. 2005) and metabolic phenotype 
measurements (Suchorolski, Paulson et al. 2013) indicate that Barrett’s esophagus cells 
undergo a series of transcriptional and metabolic changes in the context of cell-cell 
interactions or hypoxia. However, the mechanisms underlying these changes remain little 
known. In this thesis, one hypothesis is that intercellular communications between 
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normal and dysplastic cells affects cellular proliferation and motility. Barrett’s esophagus 
cells can reprogram their metabolisms to adapt to hypoxia selection pressure. 
Understanding the mechanisms and molecular signatures of cell-cell interactions and 
hypoxia adaptation in Barrett’s esophagus will open new ways for designing diagnosis 
and treatment strategies for Barrett’s esophagus and adenocarcinoma. The biosignatures 
discovered in this study can be used for early diagnosis, treatment and risk stratification 
for Barrett’s esophagus. As cell-cell interactions and hypoxia -adaptations widely exist in 
other cancers, the pre-malignant evolutionary process characterized in this study will be 
transferrable to other cancer types and can help advance the field of cancer research. 
 The goal of this doctoral dissertation project is to study gene transcription and 
metabolic profiles of pre-malignant progression in Barrett’s esophagus. The objectives of 
the project are: 
i) Conceive, develop and optimize a minimally invasive method for 
retrieving single adherent cells of different types from cultures. This method will be used 
for harvesting single adherent cells from a glass substrate after metabolic phenotype 
measurement.  
ii) Develop and optimize a reverse transcriptase quantitative polymerase 
chain reaction (RT-qPCR) method for measuring expressions that does not require a pre-
amplification step of more than five genes within a single cell. This single cell RT-qPCR 
method will detect heterogeneity in gene expression levels in a cell population and 
provide information on hypoxia response. 
iii) Characterize differential gene expression profiles as a result of heterotypic 
cell-cell interactions in Barrett’s esophagus using whole transcriptome RNA-Seq. 
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Identify functional relevance of gene expression changes and correlate with cellular 
functional phenotypes. This will allow unprecedented inquiries into pre-malignant 
progression in Barrett’s esophagus. 
iv) Study whole-transcriptome profiles and mitochondrial functions in pre-
malignant Barrett’s esophagus cell lines adapted to hypoxia and compare them with age-
matched normoxic control cells. The result will lead to a better understanding of the 
pathways that regulate cell metabolism in pre-malignant stages, and potentially warrant 
deeper insight into cancer cell development and progression.  
An overall study schematic goal is depicted in Figure 1-1. Single cell harvesting 
and RT-qPCR methods will be developed and optimized for implementing a multi-
Figure 1-1 Overview of experimental process. 
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parameter single-cell analysis pipeline. Whole transcriptome analysis of cell-cell 
interactions and hypoxia responses in Barrett’s esophagus cells will identify differentially 
expressed genes in the neoplastic progression. The findings will provide a set of gene 
candidates for gene expression profiling using RT-qPCR and be correlated with 
functional level alterations in this process.  
1.2 Scientific contributions 
Based on the results of this doctoral dissertation project, all objectives have been 
successfully achieved. The scientific contributions of the research are the following:  
(i) A new method was developed for retrieving individual adherent cells with 
minimal perturbation using a combination of mechanical forces and biochemical 
treatment. A method to selectively harvest individual cells of different types from 
microwells with co-cultured cells was demonstrated using a fluorescence-assisted single-
cell harvesting platform.  Stress gene responses to varying levels of mechanical forces 
and biochemical treatment were measured. The findings of this part of work are useful 
for studies focused on single-cell analysis that involve any mechanical manipulation of 
live cells. 
(ii) A SYBR green-based RT-qPCR method was developed for detecting 
expression levels of up to ten different genes without pre-amplification of cDNA. Gene 
expression heterogeneity can be detected in single cells with good reproducibility and 
specificity. This method is inexpensive and compatible with most commercially available 
RT-qPCR instrumentation. It can be easily integrated in many applications focused on 
gene expression analysis in single cells, which will provide further insights into the 
cellular mechanisms involved in physiological and pathological processes at the single-
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cell level and has the potential of becoming a tool for future point-of-care medical 
applications. 
(iii) In the transcriptome-wide study of effects of cell-cell interactions in pre-
malignant progression of Barrett’s esophagus a set of genes was found whose expression 
is down-regulated in dysplastic cells when they are co-cultured with normal esophageal 
epithelial cells. Upstream regulators, TGFβ and EGF, that act as “first responders” of 
cell-cell interactions are also identified.  Normal cells are found to inhibit the growth of 
dysplastic cells which is mediated by growth factor signaling pathways. This study 
indicated that the fraction of normal to dysplastic cells can be used as risk stratification 
markers for Barrett’s esophagus and esophageal adenocarcinoma. TGFβ, EGF and their 
downstream genes have great potential to become biosignatures for esophageal 
adenocarcinoma diagnosis and disease management.  
(iv) Whole transcriptome analysis and metabolic phenotypic measurements of 
hypoxia response in Barrett’s esophagus cells representing different stages of pre-
malignant progression revealed a series of transcriptional alterations and changes in 
mitochondrial function. It was found that the mitochondrial functions as measured by 
mitochondrial membrane potentials are suppressed in hypoxia-selected Barrett’s 
esophagus cells as compared to their age-matched normoxic controls. Hypoxia-adapted 
cells reprogrammed their metabolism and retained functional plasticity to survive and 
thrive under hypoxia stress. Adaptation to hypoxia can be used as a risk prediction 
marker for progression towards esophageal adenocarcinoma. Functional plasticity in 
hypoxia-adapted cells also suggested that physicians need to design multiple targets such 
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as oxidative phosphorylation and glycolysis to treat pre-malignant conditions in Barrett’s 
esophagus.  
With these results, one paper was published, one manuscript was submitted and 
two more manuscripts are in preparation for publication. All of them are listed below. 
1. Zeng, J.*, Wang, J.*, Gao, W., Mohammadreza, A., Kelbauskas, L., 
Zhang, W., Johnson, R. H., and Meldrum, D. R. (2011). Quantitative single-cell gene 
expression measurements of multiple genes in response to hypoxia treatment. Analytical 
and Bioanalytical Chemistry 401, 3-13. (*Co-first authorship) PMID:21614642. 
Published in a special, accelerated section, “Paper in Forefront.” 
2. Zeng, J., Mohammadreza, A., Gao, W., Merza, S., Smith D., Kelbauskas, 
L., and Meldrum, D. R. A minimally invasive method for retrieving single adherent cells 
of different types from cultures. Under review. 
3. Whole transcriptome and metabolic profiling of intercellular interactions 
between normal and pre-malignant esophageal cells. In preparation. 
4. Alterations in gene expression levels and metabolic phenotype in response 
to hypoxic selection in pre-malignant Barrett’s esophagus cells. In preparation. 
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CHAPTER 2  
INTRODUCTION 
2.1 Cancer 
2.1.1 Hallmarks of cancer 
Cancer is a major cause of death in the United States and many other parts of the 
world (Siegel, Ma et al. 2014). Although a great amount of effort has been devoted to 
cancer research and clinical practice, we still cannot eradicate or control the advanced 
disease of cancer. The complexity and diversity of cancer lay both roadblocks to, and 
stepping stones for successful treatment (Greaves and Maley 2012).  
In 2000 and 2011, Hanahan and Weinberg proposed and updated cancer 
hallmarks: sustaining proliferative signaling, evading growth suppressors, resisting cell 
death, enabling replicative immortality, inducing angiogenesis, activating invasion and 
metastasis, reprogramming of energy metabolism and evading immune destruction 
(Hanahan and Weinberg 2000, Hanahan and Weinberg 2011).Genome instability and 
mutation and tumor-promoting inflammation are two characteristics enabling cancer cells 
to acquire hallmark functional capabilities (Hanahan and Weinberg 2011). Tumor 
microenvironment – the signaling interactions between cancer cells and their supporting 
normal cells—also contribute to the acquisition of hallmark traits, further diversifying the 
mechanisms of cancer pathogenesis (Hanahan and Weinberg 2011). 
2.1.2 Neoplasia 
Neoplasia is unregulated growth of cells. Neoplastic cells can proliferate without 
the influence of any external stimuli while ignoring growth-controlling signals. Neoplasia 
usually results in an abnormal mass of tissue, known as neoplasm. 
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Before cells become neoplastic, they often first become metaplastic or dysplastic. 
Metaplasia is a transformation of one differentiated cell type into another. One typical 
example is Barrett’s esophagus, in which the esophageal squamous epithelium transforms 
into intestinal-like columnar cells. Dysplasia is the fractional increase of immature cells 
compared to matured and differentiated cells in a sample. It is mainly due to genetic 
alterations, changes in gene expression, and dysregulation of cell maturation. Metaplastic 
or dysplastic cells may progress to cancer or regress to normal cells (Schlecht, Platt et al. 
2003).  
Neoplasms are usually caused by genetic mutations. They can be benign, pre-
malignant or malignant (cancer). Recognized as an evolutionary process (Nowell 1976), 
neoplastic progression is characterized by genomic instability and clonal expansion. 
Neoplastic cells accumulate genetic and epigenetic alterations--which contribute to clonal 
heterogeneity--and undergo evolution by natural selection. Acquiring the hallmark traits 
of cancer provides an evolutionary advantage to neoplastic cells (Hanahan and Weinberg 
2000). Based on the scope of this dissertation work, microenvironment and metabolic 
reprogramming in cancer are the primary areas of discussion. 
2.1.3 Microenvironment 
2.1.3.1 Intercellular interactions within the tumor microenvironment 
Over the past several decades, the prevailing view towards neoplastic progression 
and carcinogenesis is that cancer cells act autonomously in isolation. Yet, more and more 
evidence has shown that a tumor is not merely a collection of homogenous cancer cells 
transforming autonomously. Its genesis and progression is rather an ecological process 
involving a dynamic interplay between malignant and non-malignant cells (Barcellos-
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Hoff, Lyden et al. 2013). Tumors are recognized as complex organs consisting of various 
types of cells: cells at different stages of tumor progression, cancer-associated fibroblasts, 
angiogenic vascular cells and infiltrating immune cells (Hanahan and Weinberg 2011). 
Tumor cells are affected by reciprocal interaction between the parenchymal and stromal 
cells either through direct contact or through signaling molecules. Therefore, the tumor 
microenvironment is an integral part of cancer initiation, growth and progression. 
Intercellular communications between tumor cells and their microenvironment create a 
context that promotes tumor growth and evasion from immune attack. This new 
perspective will reveal more underlying organizing principles of tumorigenesis and 
progression. The functions of the tumor microenvironment that contribute to sustained 
growth and survival of neoplastic cells during neoplastic progression is illustrated here. 
2.1.3.2 Sustaining proliferative signaling 
An indispensable feature of the tumor microenvironment is the ability to support 
and promote the proliferation of cancer cells (Hanahan and Weinberg 2011, Hanahan and 
Coussens 2012). Normal epithelial cells are connected with each other to form cellular 
apical and basal surfaces and maintain the differentiated state. The basement membrane, 
a specialized form of extracellular matrix, provides both structural support and a variety 
of polarization cues to the epithelium. Genetic alterations can cause the loss of polarity in 
dysplastic or metaplastic cells (Alison, Hunt et al. 2002). Aberrant interactions between 
epithelial cells and the basement membrane can support genomic instability within the 
epithelium. Alterations in communications between tumor cells and their environment 
have been proposed to account for increased proliferation (Hanahan and Coussens 2012).  
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2.1.3.3 Evading Growth Suppressors 
Tumor cells circumvent growth suppression in various ways, by inactivating or 
down-regulating tumor suppressor genes, or by evading cell-to-cell contact inhibition. 
Physical contacts among dense populations of normal cells can suppress further cell 
proliferation. This contact inhibition is an intrinsic mechanism for maintaining normal 
tissue homeostasis (Gatenby and Gillies 2008). Tumor cells, which carry mutations 
enabling neoplastic growth, can be suppressed when introduced into a context of normal 
connective tissue fibroblasts. The malignant phenotype of epithelial tumor cells could be 
reversed by the normal tissue microenvironment; normal fibroblasts hence act as an 
extrinsic epithelial growth suppressor at the early stage of cancer (Bissell and Hines 2011, 
Flaberg, Markasz et al. 2011). When the fibroblasts convert from normal tissue to cancer 
associated fibroblasts, the contact inhibition is abrogated (Bissell and Hines 2011, 
Flaberg, Markasz et al. 2011). The conversion might be driven by reprogramming of 
fibroblasts by dysplastic or metaplastic cells, or extrinsic conditions such as infection or 
fibrosis. The interplays between aberrant epithelial cells and their supporting fibroblasts 
might eventually relieve the inhibition of epithelial cell growth. As a result, neoplastic 
development takes place (Hanahan and Coussens 2012).  
2.1.3.4 Resisting cell death 
One barrier to tumorigenesis is programmed cell death, or apoptosis, which can be 
induced by various physiological stresses during tumorigenesis or anticancer therapy. 
Two machineries can trigger apoptosis: the extrinsic program, by which cells detect, 
receive and process extracellular death signals, and the intrinsic program, by which cells 
sense intracellular signals and initiate the apoptosis pathway.  
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When normal cells surrounding neoplastic cells sense the “invasion” or presence 
of foreign cell types, they will convey apoptotic signals to the neoplastic cells. Neoplastic 
cells have evolved diverse extrinsic and intrinsic strategies to avoid apoptosis and survive. 
In the microenvironment, cancer-associated fibroblasts synthesize molecules to form a 
neoplastic extracellular matrix for tumor cell survival (Lu, Weaver et al. 2012). 
Traditionally, normal immune cells combat pathogens and clean up the apoptotic cells. 
On the contrary, tumor-associated macrophages can bind to tumor cells, activate 
PI3K/AKT signaling, and suppress apoptosis (Chen, Zhang et al. 2011).  Tumor-
associated macrophages also guard tumor cells against chemotherapy-induced cell death 
in breast cancer (Shree, Olson et al. 2011). The interactions between cancer-associated 
fibroblasts and neoplastic cells facilitate evasion of apoptosis in the latter thus helping 
them evade the surveillance processes taking place in normal tissue. The resulting 
selective pressure for apoptosis-resistant tumor cells can lead to a significantly lower 
efficacy of cytotoxic and targeted therapy. Reprogramming energy metabolism 
Metabolic reprogramming in tumor cells was proposed more than eighty years 
ago (Warburg, Wind et al. 1927) and is recognized as an emerging hallmark of cancer 
(Hanahan and Weinberg 2011). Neoplastic cells need to adjust their energy metabolism 
to support rapid growth and proliferation. They can use a variety of fuel sources to 
generate energy, synthesize biomaterials such as nucleotides, amino acids, and organelles 
for assembling new cells.  The most prominent change is that cancer cells mainly rely on 
glycolysis rather than oxidative phosphorylation for their energy even in the presence of 
oxygen (Warburg, Wind et al. 1927). Metabolic reprogramming has been considered as 
the consequence of intrinsic mechanisms. However, more and more evidence is 
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substantiating the roles of reciprocal interactions between tumor cells and tumor 
microenvironment in metabolic reprogramming (Rattigan, Patel et al. 2012, Sotgia, 
Martinez-Outschoorn et al. 2012). 
Cancer-associated fibroblasts can switch to glycolytic pathway once they are 
induced by reactive oxygen species released by breast cancer cells (Rattigan, Patel et al. 
2012, Sotgia, Martinez-Outschoorn et al. 2012). Tumor cells can then uptake the lactate 
and pyruvate secreted by cancer-associated fibroblasts, to match their proliferation needs 
(Rattigan, Patel et al. 2012, Sotgia, Martinez-Outschoorn et al. 2012). In other cases, 
tumor cells utilize glucose and export lactate. Cancer-associated fibroblasts consume 
lactate, which acts as a paracrine modulator in driving tumor progression.  Lactate 
shuffling suggests a symbiotic relationship between tumor cells and tumor 
microenvironment (Rattigan, Patel et al. 2012), which promotes the tumor growth. 
2.1.3.6 Summary 
The contributions from the tumor microenvironment to neoplastic progression 
have recently attracted substantial attention in the field. Understanding how multiple types 
of cells are co-opted to support different stages of carcinogenesis and progression is 
fundamental in studying the cross-talk between tumors and their microenvironment. One of 
the central challenges in tumor microenvironment studies is the delineation of 
intercellular communication signaling networks in greater detail and clarity. Cells at 
different stages of progression may activate different molecular pathways to recruit, adapt 
to and interact with their microenvironment. Subpopulations of cells might become more 
malignant or resistant in the shelter of their microenvironment. New discoveries in the 
tumor environment field will help physicians design innovative multi-target strategies for 
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both primary tumors and metastatic stages and revolutionize the treatment and 
management of cancer. 
2.1.4 Metabolic reprogramming 
One of the emerging hallmarks of cancer is metabolic transformation, which 
supports cell growth and proliferation (Hanahan and Weinberg 2011). In 1927, Otto 
Warburg discovered that, in contrast to normal cells, cancer cells under normoxic 
conditions rely primarily on glycolysis instead of oxidative phosphorylation to support 
their energy needs (Warburg, Wind et al. 1927). This metabolic phenomenon is known as 
the “Warburg effect”. The Warburg effect has been both supported and refuted during the 
past century. In normal cells, the primary role of mitochondria is to produce energy in the 
form of ATP through oxidative phosphorylation. The hypothesis that tumor mitochondria 
are damaged was challenged because tumor mitochondria do respire and produce ATP 
through oxidative phosphorylation (Weinhouse 1976). In certain cancer types, the 
reprogramming of energy metabolism does not correlate with mitochondrial defects 
(Gogvadze, Orrenius et al. 2008), although some aggressive tumors do display 
mitochondrial deterioration (Gogvadze, Zhivotovsky et al. 2010).  
2.1.4.1 Hypoxia 
Hypoxia is a condition when the oxygen level in tissue is reduced to lower than 
80-100 Hg (Barer, Howard et al. 1970). It is implicated as a factor in a variety of diseases, 
including cancer. Hypoxic conditions are known to arise in intermediate stages of tumor 
growth. As tumor cells proliferate rapidly and massively, the distance between cells and 
the vasculature increases, which eventually creates a local microenvironment deficient in 
oxygen supply. Such hypoxic conditions become a selection pressure for tumor growth. 
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Tumor cells undergo genetic, transcriptional or metabolic level reprogramming in order 
to survive and proliferate under hypoxia (Harris 2002). Therefore, hypoxia is closely 
related to malignant phenotype and aggressive tumor behavior. 
Even though hypoxia is recognized as instrumental in tumor progression, its role 
in earlier premalignant progression is poorly understood. Hypoxia can also occur in 
chronic inflammation, a risk factor for cancer, in several forms such as ulceration, 
scarring or burns. Acute tissue oxygen level changes between hypoxia and 
reoxygeneration can generate reactive oxygen species. Deep ulceration in Barrett’s 
esophagus creates a periodic hypoxic environment for the esophageal epithelial cells 
(Suchorolski, Paulson et al. 2013). Barrett’s esophagus develops as a protective 
mechanism to the acid-bile reflex, which can result in hypoxic conditions. It is poorly 
understood how cells alter their genotypes and phenotypes under selective pressure of 
hypoxia during premalignant progression. 
In eukaryotic cells, the hypoxia-inducible factor (HIF) is a key molecular 
mediator under hypoxic conditions. HIF is a heterodimeric transcription factor, whose 
transcriptional activation function is inhibited under normoxic conditions. The inhibition 
is exerted via post-translational hydroxylation by oxygen-dependent oxygenases, prolyl 
hydroxylase domain proteins (PHD) (Masson, Willam et al. 2001) and factor inhibiting 
HIF (FIH) (Semenza 2002). Under hypoxia, HIF1-α translocates into the nucleus and 
interacts with co-activators p300/CBP to regulate a broad range of genes participating in 
adaptation to hypoxia (Semenza 2002). These proteins are involved in angiogenesis, 
metabolism, cell proliferation, apoptosis, immortalization and migration. The interplay 
between oncogenic pathways and hypoxia responses are discussed below. 
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2.1.4.2 Angiogenesis 
HIF1-α triggers the expression of genes involved in blood-vessel formation, such 
as vascular endothelial growth factor-A (VEGF-A) and angiopoietin (Ang-2) (Oh, Takagi 
et al. 1999). VEGF can be secreted by cancer cells and normal cells in response to 
hypoxia. Consequently, new vasculatures can be formed to provide oxygen and nutrition 
to the cells. Nonetheless, the newly generated vessels are usually distorted, irregular, and 
leaky, which results in oxygen supply deficiencies. 
2.1.4.3 Metabolism 
Hypoxic cells usually switch from mitochondrial oxidative phosphorylation to 
glycolysis to meet their energy needs. This is promoted by HIF-mediated expression of 
both glucose transporters and enzymes in the glycolytic pathway. Glucose transporters 
GLUT1 and GLUT3 facilitate cellular glucose uptake (Vannucci, Seaman et al. 1996). 
Two enzymes in the pyruvate metabolism pathway are known to be mediated by HIF1-α. 
Lactate dehydrogenase A (LDH-A) is responsible for converting pyruvate to lactate. 
Pyruvate dehydrogenase kinase 1 (PDK1) is enzyme that phosphorylates and inactivates 
pyruvate dehydrogenase (PDH), thereby feeding pyruvate into the glycolysis rather than 
oxidative phosphorylation (Kim, Tchernyshyov et al. 2006). 
The mammalian target of rapamycin (mTOR) pathway is inhibited by HIF 
downstream of O2-sensing. Under normoxic conditions, diverse signals converge to the 
mTOR kinase and the latter transmits the signal to regulate cell survival and growth 
through mRNA translation, ribosomal biogenesis and metabolism. Hypoxia can inhibit 
mTOR pathway and thereby control protein synthesis, energy metabolism and cell 
survival under the selection pressure (Brugarolas, Lei et al. 2004). 
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2.1.4.4 Proliferation 
Hypoxia affects cell proliferation by inducing the production of growth factors, 
such as transforming growth factor-β and platelet-derived growth factor (Lal, Peters et al. 
2001). Some factors upstream of HIF-1α expression or function also regulate cell 
proliferation. Proteins in oncogene signaling pathways, such as p42/p44 mitogen-
activated protein kinases (Berra 2000) and phosphatidylinositol 3-OH kinase (PI3K) 
(Zundel, Schindler et al. 2000) regulate HIF-1α either transcriptionally or post-
transcriptionally and synergistically promote cell growth. 
2.1.4.5 Apoptosis or Necrosis 
Hypoxia can induce apoptotic and necrotic cell death. HIF-1α increases the 
expression of NIX (Sowter, Ratcliffe et al. 2001) and NIP3 (Bruick 2000, Velde, Cizeau 
et al. 2000). Activated NIP3 can cause early plasma-membrane permeability, cytoplasmic 
vacuolation, mitochondrial damage and mitochondrial autophagy, which can eventually 
lead to necrosis.  
The way HIF-1α interacts with p53-dependent apoptosis is determined by HIF-1α 
phosphorylation status (Suzuki, Tomida et al. 2001). When HIF-1α is dephosphorylated, 
there are two possible scenarios: HIF-1α stabilizes p53 and activates apoptosis, or p53 
blocks HIF-1α and inhibits the transcriptional activation of anti-apoptotic genes. When 
HIF-1α is phosphorylated, it binds to ARNT (Bacon and Harris 2004) and regulates 
cytochrome c-independent apoptosis via NIX and NIP3. 
Tumor cells have developed strategies to evade the apoptosis induced by HIF-1α. 
In the early stages of tumor progression, the activation of pro-apoptotic genes can be 
induced by hypoxia. Circumventing apoptosis due to hypoxia becomes a selective factor 
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for tumor cells. Cells that survive hypoxia would gain advantage in the clonal evolution 
of cancer and exhibit aggressive phenotypes that is associated with hypoxia. 
2.1.4.6 Genomic instability 
Hypoxia can alter cell cycle checkpoint control as well as sensing and repair of 
DNA damage. Acute hypoxia usually generates reactive oxygen species during the 
anoxia and re-oxygenation cycle. Acute hypoxia can activate cellular ataxia telangiectasia 
mutated (ATM) – ataxia telangiectasia- and Rad3-related kinase (ATR)-mediated cell 
cycle check points to arrest the cell cycle and repair DNA damage caused by reactive 
oxygen species (Bristow and Hill 2008). Failure in repairing DNA breaks will contribute 
to a markedly increased genomic instability.  
Chronic hypoxia can cause genomic instability because translation of DNA repair 
proteins is slowed down. This will result in defective DNA repair, chromosomal 
aberrations, fragility, and aneuploidy in proliferating cells. 
2.1.4.7 Migration 
HIF-1α activation enhances esophageal adenocarcinoma migration and invasion 
(Jing, Wang et al. 2013). HIF-1α activation attenuates the expression of E-cadherin, a 
component of adherens junctions which bind cells within tissues together (Imai, Horiuchi 
et al. 2003).  HIF-1α also enhances the expression matrix metalloproteinase-2 (MMP-2), 
which disrupts cell-cell and cell-matrix interactions) (Semenza 2003), twist family bHLH 
transcription factor 1 (TWIST1), which regulates epithelial-mesenchymal transition) 
(Yang 2008), and c-met, which promotes invasive growth (Pennacchietti, Michieli et al. 
2003). 
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2.2 Barrett’s esophagus 
2.2.1 Overview 
Barrett’s esophagus (BE) is a pre-malignant condition of esophageal 
adenocarcinoma. Barrett’s esophagus develops when esophageal squamous epithelium is 
damaged by chronic acid-bile reflux and replaced by columnar epithelium. Barrett’s 
esophagus is the strongest risk factor for esophageal adenocarcinoma (EAC). Patients 
with Barrett’s esophagus have 30- to 60-fold greater risk of developing esophageal 
adenocarcinoma than the general population (Cameron, Ott et al. 1985, Drewitz, 
Sampliner et al. 1997, Kim, Weissfeld et al. 1997). Recent studies suggest that an 
approximate yearly rate of 0.5% of Barrett’s esophagus patients who progress to 
adenocarcinoma (Shaheen, Crosby et al. 2000). The incidence of EAC has increased 7-
fold from 1973 (3.6 cases per million) to 2006 (25.6 per million) in the United States 
(Spechler 2013). The increasing trend of esophageal adenocarcinoma is greater than that 
reported in melanoma, breast cancer and prostate cancer. The prognosis of esophageal 
adenocarcinoma is poor, with a five-year survival rate of only about 10% in most 
Western countries (Portale, Hagen et al. 2006). Introduction of screening and surveillance 
programs for early BE and EAC detection have resulted in greater survival rates. 
Other than early identification and stratification purposes, Barrett’s esophagus is 
considered as a valuable model for studying premalignant progression of cancer. Most 
premalignant conditions are difficult to follow, either because they are removed upon 
detection (colonic polyps) or hard to biopsy (pancreatic cancer) (Paulson and Reid 2004). 
In contrast, periodic biopsies of Barrett’s esophagus patients can be taken from the same 
patient to test for dysplasia as a part of standard-of-care. This allows researchers to study 
 19 
premalignant progression longitudinally and evaluate genetic alteration during clonal 
evolution in cancer. By studying the different steps during pre-malignant progression in 
Barrett’s esophagus, researchers can gain insights into molecular mechanisms and 
potentially expand the findings to other types of cancers. 
Pathological examination of tissue architecture has been the standard detection 
and classification method for Barrett’s esophagus diagnosis and treatment. Dysplasia in 
Barrett’s esophagus is the neoplastic epithelium which is still confined within the 
basement membrane and has not formed a mass. Dysplasia has been used as a marker for 
patient’s stratification for the risk of developing adenocarcinoma (Reid, Levine et al. 
2000, Weston, Sharma et al. 2000, Schnell, Sontag et al. 2001, Overholt, Lightdale et al. 
2005). Barrett’s esophagus ranges from metaplasia, low-grade dysplasia, high-grade 
dysplasia and invasive carcinoma. Challenges with using histology-based clinical care 
involve variation among pathologists’ interpretations, high biological heterogeneity 
within the same grade of dysplasia and so forth (Ong, Lao-Sirieix et al. 2010). Therefore, 
identifying molecular and/or imaging markers for Barrett’s esophagus neoplastic 
progression and esophageal adenocarcinoma risk prediction is urgent and necessary. 
Besides tissue architecture, promising biomarkers for surveillance of Barrett’s 
esophagus patients include DNA content abnormalities and loss of heterozygosity 
(9pLOH , 17pLOH) (Galipeau, Li et al. 2007), and markers of proliferation 
(minichromosome maintenance protein (Mcm) 2, 5 and Ki67 (Sirieix, O’Donovan et al. 
2003), p53 positivity by immunohistochemistry (Weston, Banerjee et al. 2001, Murray, 
Sedo et al. 2006), cell cycle marker (CDKN2A, cyclin A and cyclin D) (Lao-Sirieix, Lovat 
et al. 2007), epigenetic changes (methylation markers) (Schulmann, Sterian et al. 2005, 
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Jin, Cheng et al. 2009). These markers have gone through the third or fourth stage of 
biomarkers development as defined by the Early Detection Research Network (EDRN) 
(Pepe, Etzioni et al. 2001, Ong, Lao-Sirieix et al. 2010). These markers, representing 
genomic instability, disruption of regulatory pathways and genetic divergence, also 
feature fundamental properties of neoplastic progression. However, most of these 
biomarkers are not clinically available because the biomarker lacks sufficient sensitivity 
and specificity (Pepe, Etzioni et al. 2001, Ong, Lao-Sirieix et al. 2010). This calls for 
large scale translational research to advance the field of biomarker discovery and clinical 
implementation. 
2.2.2 Hallmarks of pre-malignant progression in Barrett’s esophagus 
Neoplastic progression in Barrett’s esophagus arises from a series of genetic and 
epigenetic changes. These changes can be categorized according to the cancer hallmark 
traits that they affect. The hallmarks contribute to the evolution and progression from 
Barrett’s metaplastic cells to esophageal adenocarcinoma (Morales, Souza et al. 2002).  
2.2.2.1 Sustaining proliferative signaling 
Genetic alterations in cell-cycle control genes usually can affect cell proliferation. 
Growth factors, hormones, and cytokines can activate transmembrane receptors and 
downstream signaling pathways that include pro-growth cyclin protein family. In 
Barrett’s esophagus, cyclin D1 and cyclin E (Bani-Hani, Martin et al. 2000) are 
overexpressed. They form complexes with cyclin-dependent kinases and drive cell-cycle 
progression. Tumor cells can also promote their own growth via autocrine signaling with 
growth factors or by modifying the growth-factor receptors to achieve growth self-
sufficiency. The pre-malignant progression in Barrett’s esophagus is also associated with 
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upregulation of epidermal growth factor (Pande, Iyer et al. 2008), Erb family of tyrosine-
kinase ligands and receptors (Miller, Moy et al. 2003), transforming growth factor (Rees, 
Onwuegbusi et al. 2006), and fibroblast growth factor (Lord, Park et al. 2003). 
2.2.2.2 Evading growth suppressors 
Mutations of TP53 (Gonzalez, Artimez et al. 1997) and CDKN2A (Klump, Hsieh 
et al. 1998, Wang, Guo et al. 2009), promoter hypermethylation of CDKN2A and APC 
(Wang, Guo et al. 2009), and non-random losses of heterozygosity (Barrett, Sanchez et al. 
1999) are common inactivation mechanisms of tumor suppressor genes. Abnormalities in 
these genes block anti-growth signals. Hypermethylation of p16 and APC is a frequent 
and early event during the progression from normal esophagus through Barrett’s 
esophagus to esophageal adenocarcinoma. It is a strong predictor of progression to high-
grade dysplasia or esophageal adenocarcinoma in Barrett’s esophagus patients (Wang, 
Guo et al. 2009). Loss of p53 function also occurs at an early stage of progression, which 
inactivates cell cycle check point mechanisms and increases the fraction of 4N cells with 
4N DNA amount (Galipeau, Cowan et al. 1996). 
2.2.2.3 Resisting cell death 
Inhibition of apoptosis occurs early in the dysplasia-carcinoma sequence of 
Barrett’s esophagus (Katada, Hinder et al. 1997, Halm, Tannapfel et al. 1999). In both 
Barrett’s metaplasia and esophageal adenocarcinoma, the overexpression of 
cyclooxygenase-2 (COX-2) (Wilson, Fu et al. 1998, Morris, Armstrong et al. 2001, Souza, 
Shewmake et al. 2004) and Bcl-2 (Shimizu, Vallböhmer et al. 2006) inhibits the apoptotic 
pathways.  
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In normal cells, severe DNA damage causes an accumulation of p53 and 
apoptosis.  But in Barrett’s esophagus cells, loss of heterozygosity of p53 occur in 57% 
of patients with high-grade dysplasia. The loss of heterozygosity of p53 helps the cells 
with DNA damage evade apoptosis and thereby increases the genomic instability. These 
patients are at increased risk for neoplastic progression to esophageal adenocarcinoma 
(Reid, Prevo et al. 2001). 
2.2.2.4 Enabling replicative immortality 
To overcome the replicative limit and gain replicative potential, neoplastic cells 
need to stabilize their telomeres by reactivating telomerase (Shay and Bacchetti 1997). In 
the Barrett’s metaplasia, dysplasia, and esophageal adenocarcinoma sequence, the 
expression of telomerase progressively increases (Morales, Lee et al. 1998, Lord, Salonga 
et al. 2000). Telomerase activation may be the main reason why Barrett’s esophagus cells 
become immortal. 
2.2.2.5 Inducing angiogenesis 
Any neoplasm larger than a few milligrams requires sustained angiogenesis to 
survive (Ausprunk and Folkman 1977). Vascular endothelial growth factors (VEGFs) 
family stimulate endothelial cells of blood vessels to grow and migrate, thus inducing 
angiogenesis. Different members of VEGF family are expressed in epithelial and 
endothelial cells during the neoplastic progression of Barrett’s esophagus, correlating 
with angiogenesis in the same process (Couvelard, Paraf et al. 2000). Expression levels of 
VEGF and fibroblast growth factor (FGF) were significantly increased in 
adenocarcinoma compared with in normal squamous mucosa or intestinal metaplasia 
(Lord, Park et al. 2003). Microvessel intensity and the percentage of immature blood 
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vessels also increase in this progression (Sihvo, Ruohtula et al. 2003). Therefore, 
angiogenesis and neovascularization may emerge early in Barrett’s esophagus and 
develop progressively in the metaplasia-dysplasia-adenocarcinoma sequence. 
2.2.2.6 Activating invasion and metastasis 
Esophageal adenocarcinoma is prone to early metastasis (Dulak, Stojanov et al. 
2013). Alterations in cell-cell adhesion as well as motility signals may contribute to 
invasion and metastasis. The expression of E-cadherin, which bridges two cells, is 
significantly down-regulated as the Barrett's metaplasia-dysplasia-adenocarcinoma 
sequence progresses (Bailey, Biddlestone et al. 1998). Recurrent mutations in RAC1 cell 
motility signaling pathway are identified in esophageal adenocarcinoma (Dulak, Stojanov 
et al. 2013). Activated RAC1 signaling can enhance cell invasiveness and motility. These 
genetic changes may alter cytoskeletal structure, increase invasive properties, induce 
mitosis, and thereby increasing tumor fitness (Dulak, Stojanov et al. 2013). 
2.2.2.7 Reprogramming of energy metabolism 
In esophageal adenocarcinoma, cells mainly rely on glycolysis rather than 
oxidative phosphorylation to produce ATP with damaged mitochondria, known as the 
Warburg effect (Warburg, Wind et al. 1927, Taylor, Smith et al. 2009). A panel of 
metabolic related or hypoxia response genes, such as Glut-1 (Younes, Ertan et al. 1997), 
pyruvate kinase isoform M2 (PKM2) (Koss, Harrison et al. 2004), VEGF and 
erythropoietin (EPO) (Griffiths, Pritchard et al. 2007) have been reported in Barrett’s 
esophagus tissue. 
Barrett's metaplastic cells generate energy through normal mitochondrial 
phosphorylation. In the intermediate stages of Barrett’s dysplasia, cells retained 
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functional mitochondria, employ oxidative phosphorylation to produce energy and 
increase glycolysis in response to substrate (Suchorolski, Paulson et al. 2013).  
2.2.2.8 Evading immune destruction 
FasL (death-promoting ligand) is a surface protein usually expressed by activated 
lymphocytes and binds to Fas (death receptor) on lymphocytes and gut-epithelial cells. 
The lymphocytes received the death signal and attack neoplastic cells. In Barrett’s 
metaplastic tissue, neoplastic cells express an excess amount of FasL, which occupies 
Fas on the surface of lymphocytes and kills them (Younes, Schwartz et al. 1999, Younes, 
Lechago et al. 2000). This is mechanism how Barrett’s esophagus cells evades immune 
surveillance.  
2.2.2.9 Genomic instability 
Chromosomal and genomic instability predicts the progression of Barrett’s 
esophagus (Rabinovitch, Reid et al. 1989, Galipeau, Cowan et al. 1996, Barrett, Sanchez 
et al. 1999, Paulson, Maley et al. 2009). 17p (p53) allelic losses, methylation of 
CDKN2A/p16, loss of heterozygpsity at 5q, 9p, 13q, 17p and 18q, DNA-content 
aneuploidy or increased 4N (G2/tetraploid) populations are all associated with Barrett’s 
esophagus neoplastic progression (Barrett, Sanchez et al. 1999). Genome-wide analysis 
shows the number of copy number alterations predicts the progression as well (Paulson, 
Maley et al. 2009).    
2.2.2.10 Tumor-promoting inflammation 
Tumor tissues are often infiltrated by immune cells that enable or promote tumor 
growth. Acid and bile reflux causes inflammation in esophagus, which potentially causes 
Barrett’s metaplastic cells to progress (Fitzgerald, Abdalla et al. 2002). The inflammatory 
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cell infiltrate generates reactive oxygen species (Naya, Pereboom et al. 1997), which 
might contribute to DNA damage. Reactive oxygen species may also induce growth 
factors, survival factors or Fas ligand secretions (Younes, Schwartz et al. 1999). 
Inflammatory cell infiltrate themselves produce many cytokines, such as transforming 
growth factor β (TGFβ), interleukin one β (IL-1β), interferon γ (IFNγ), interleukin six 
(IL-6) (Zhang, Zhang et al. 2011) and TNFα (Tselepis, Perry et al. 2002). Persistence of 
Barrett’s metaplasia and the development of dysplasia and adenocarcinoma are closely 
associated with IL-1β and TNFα (Jankowski, Harrison et al. 2000). 
2.2.2.11 Tumor microenvironment 
Barrett’s esophagus cells evolve under the influence of their surrounding cells and 
other factors in the environment. Acid and bile in Barrett’s luminal refluxate can induce 
double-stranded DNA breaks or promote oxidative DNA damage (Clemons, McColl et al. 
2007).  
In the stromal compartment of Barrett’s esophagus, the gene expression profiles 
are different between different stages of progression (Lao-Sirieix and Fitzgerald 2010). 
Thrombospondin-1 (TSP1) is overexpressed in stroma from Barrett’s esophagus biopsy 
samples. TSP1 can activate TGFβ, which either controls proliferation or promotes 
epithelial-mesenchymal transition in Barrett’s esophagus and esophageal adenocarcinoma 
(Rees, Onwuegbusi et al. 2006, Onwuegbusi, Rees et al. 2007). Furthermore, co-culture 
of squamous carcinoma and Barrett’s carcinoma cells produces more pro-inflammatory 
cytokines compared with cells cultured individually (Fitzgerald, Abdalla et al. 2002). 
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2.2.3 Models of Barrett’s esophagus neoplastic progression 
Pre-clinical models of Barrett’s esophagus neoplastic progression exist in both 
tissue culture and animal models. Tissue culture models include (1) squamous cell culture: 
EPC2 cells (Harada, Nakagawa et al. 2003), an esophageal epithelial cell line 
transformed with hTERT; (2) Barrett’s esophagus cell culture: CP-A, derived from a 
patient with metaplastic BE, immortalized with hTERT transfection, with inactivated 
CDKN2A and wildtype TP53; CP-B, CP-C and CP-D derived from patients with high-
grade dysplasia and display CDKN2A and TP53 abnormalities (Palanca-Wessels, Barrett 
et al. 1998); BAR-T, immortalized with hTERT, initially show both functioning CDKN2A 
and TP53, and lost CDKN2A during adaptation to culture conditions (Jaiswal, Morales et 
al. 2007) (3) esophageal adenocarcinoma cell culture, 10 cell lines have been verified to 
be derived from human esophageal adenocarcinoma, including FLO-1, KYAE-1, SK-GT-
4, OE19, OE33, JH-EsoAd1, OACP4C, OACM5.1, ESO26, and ESO51 (Boonstra, van 
Marion et al. 2010). Recently, Okawa T et al. (Okawa, Michaylira et al. 2007), Koskoff et 
al. (Kosoff, Gardiner et al. 2012) and Stairs et al. (Stairs, Nakagawa et al. 2008) created 
organotypic models of Barrett’s esophagus and esophageal adenocarcinoma to mimic the 
tumor microenvironment in vivo. Rat, mouse and dog models exist for Barrett’s 
esophagus study. Surgical models are created by inducing reflux of gastrodeudenal acid-
bile reflex into the esophagus, or removing the mucosa of the distal esophagus and 
generating a hiatal hernia thus inducing columnar epithelium. Surgical models are 
difficult to implement and have not been popular. Genetic models for Barrett’s esophagus 
are up-and-coming. One of the latest developments of genetic models include rat models 
expressing intestinal transcription factor Cdx2 ectopically in esophageal squamous tissues, 
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which demonstrate a progression from squamous epithelium to Barrett’s esophagus 
(Kong, Crissey et al. 2011). In 2011, Wang and Ouyang et al. reported that p63-deficient 
mice develop intestine-like metaplasia similar to Barrett’s esophagus in a process that 
p63-null embryonic cells migrate towards epithelium and facilitate the proliferation of 
columnar epithelial cells (Wang, Ouyang et al. 2011). 
In this study, cell lines representing normal squamous (EPC-2), early (CP-A) and 
late (CP-B, CP-C, and CP-D) in Barrett’s esophagus neoplastic progression are used to 
characterize intracellular interactions and energy metabolism changes in pre-malignant 
progression that have persisted in culture. 
2.2.4 Genome and transcriptome study of Barrett’s esophagus 
Genome-wide study of neoplastic progression in Barrett’s esophagus started more 
than 10 years ago. In 2001, Riegman et al. reported an inventory of genetic aberration 
during the malignant transformation in Barrett’s esophagus, using comparative genomic 
hybridization method to evaluate esophageal adenocarcinomas, as well as metaplasia, 
low-grade dysplasia and high-grade dysplasia in Barrett’s esophagus (Riegman, Vissers 
et al. 2001). They identified losses of 5q21-q23, 9p21, 17p12–13.1, 18q21, and Y in low-
grade dysplasia, loss of 7q33-q35 and gains of 7p12-p15, 7q21-q22, and 17q21 in high-
grade dysplasia, and a variety of known and novel aberrations in adenocarcinoma as well. 
This study also revealed potential discriminators between different stages of neoplastic 
progression and adenocarcinoma.  
Furthermore, Barrett et al. performed transcriptional profiling on biopsies 
obtained from Barrett’s metaplasia and normal upper gastrointestinal mucosae, including 
gastric, duodenal, and esophageal squamous epithelium using oligonucleotide microarray 
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in 2002 (Barrett, Yeung et al. 2002). They identified tissue-specific cluster of genes 
whose expression was elevated in each of the four tissues. The Barrett’s esophagus 
cluster showed genes are associated with a panel of different functional categories 
including cell cycle alteration, apoptosis, cellular movement, and stress responses, which 
are all associated with neoplasia. With the advancement of technology, researchers have 
performed differential gene expression profiling on normal, Barrett’s esophagus and 
adenocarcinoma tissues, and found out genes involved in epidermal differentiation are 
suppressed during the progression to adenocarcinoma (Kimchi, Posner et al. 2005, Luthra, 
Wu et al. 2006). In 2009, Wang et al. analyzed three publically available microarray 
datasets and one public serial analysis of gene expression (SAGE) dataset using Gene Set 
Enrichment Analysis and immunohistochemistry methods. The results suggested that 
transcription factors such as CDX1 and CDX2, as well as BMP/TGFβ pathways might be 
involved in the development of Barrett’s esophagus (Wang, Qin et al. 2009). 
Genome-wide single nucleotide polymorphisms (SNPs) studies provide a 
powerful tool to discover genetic cause and premalignant neoplastic progression of 
Barrett’s esophagus. A study using high resolution array-comparative genomic 
hybridization by Lai et al. showed that copy number and allelic changes, corresponding 
to genomic instability, increase during the course of neoplastic progression (Lai, Paulson 
et al. 2007). Notably, the first genome-wide association study of Barrett’s esophagus also 
employed a SNP test to analyze samples from more than 10,000 cases and controls (Su, 
Gay et al. 2012). The paper reported two SNPs on chromosomes 6p21 and 16q24 
predispose to the development of Barrett’s esophagus. The lead SNP 6p21 is close to the 
major histocompatability complex (MHC) region, where immune system, inflammation 
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and olfactory related genes are located. The other region 16q24 is close to FOXF1, which 
is involved in gastrointestinal tract development. 
2.3 Single cell transcription analysis 
2.3.1 Single cell analysis 
Many traditional biochemical approaches rely on the presumption that cells within 
a population appear similar and behave like each other. Most assays are based on the lysis 
of hundreds or thousands of cells and the discernment of their component parts. However, 
cell-to-cell differences widely exist in multiple cell and tissue types, ranging from uni-
cellular organisms to complex tissues (Lidstrom and Meldrum 2003, Raj and van 
Oudenaarden 2008). Cellular heterogeneity within genetically similar or identical cell 
populations usually arises from stochastic expression of genes, proteins and metabolites 
(Wang and Bodovitz 2010). The sources of such variability can be ascribed to extrinsic 
factors, such as subtle differences in the microenvironment (growth factors, oxygen and 
other environmental components), or intrinsic factors which are due to the inherently 
probabilistic and discrete nature (Snijder and Pelkmans 2011). Therefore, biochemical 
research at the bulk-cell level is prone to average out the cellular heterogeneity and mask 
the presence of functionally important subpopulation of cells.  
Single cell analysis is a new frontier for gaining insights into cancer (Dalerba, 
Kalisky et al. 2011). A tumor is not merely a collection of malignant cells with identical 
behavior. Solid tumors are usually composed of molecularly distinct clones that differ in 
growth rates, metastatic potential and responses to drug treatment. Tumor heterogeneity 
adds complexity and difficulty in discovering diagnostic and prognostic cancer 
biomarkers, as well as finding effective target therapies of disease. Single cell analysis 
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can not only measure intratumor heterogeneity, but detect rare tumor cells at early stages 
(Russnes, Navin et al. 2011) and monitor circulating tumor cells. Investigating cancer at 
single-cell resolution has the potential to resolve fundamental biological questions and 
improve disease management. 
Currently, single cell analysis has been challenging for several reasons: (1) the 
scarcity of the components, such as DNA, RNA and proteins, inside a single cell and (2) 
the lack of integrative analysis tools for “omics” data at the single-cell level. Over the 
past decade, significant efforts have been made towards developing tools to overcome the 
limitations and uncover the biology inside a single cell (Van Gelder, von Zastrow et al. 
1990, Chiu and Lorenz 2009, Tang, Barbacioru et al. 2009, Zhu, Holl et al. 2009, Anis, 
Holl et al. 2010, Taniguchi, Choi et al. 2010, Tay, Hughey et al. 2010, Anis, Houkal et al. 
2011, Bendall, Simonds et al. 2011, Fan, Wang et al. 2011, Flatz, Roychoudhuri et al. 
2011, Gao, Zhang et al. 2011, Navin, Kendall et al. 2011, Schubert 2011, Zeng, Wang et 
al. 2011, Bartfai, Buckley et al. 2012, Kelbauskas, Ashili et al. 2012, Xu, Hou et al. 2012, 
Zong, Lu et al. 2012, Shi, Gao et al. 2013, Wang, Shi et al. 2013). Specifically, the ability 
of dissecting the transcriptome at the single-cell level, using next-generation sequencing 
(Tang, Barbacioru et al. 2009, Navin, Kendall et al. 2011, Xu, Hou et al. 2012, Zong, Lu 
et al. 2012, Lasken 2013), quantitative polymerase chain reaction (qPCR) (Flatz, 
Roychoudhuri et al. 2011, Zeng, Wang et al. 2011) and microscopy (Taniguchi, Choi et 
al. 2010), has greatly advanced our knowledge in understanding complex systems such as 
cancer and development. 
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2.3.2 Methods for transcript profiling at the single-cell level 
Three major categories of transcript profiling methods exist for single-cell 
analysis: (1) whole-genome RNA-Seq, (2) real-time qPCR (RT-qPCR), and (3) image-
based single molecule RNA fluorescence in situ hybridization (FISH). Both RNA-Seq 
and RT-qPCR take cell lysate as the input, while RNA FISH examines fixed and 
permeabilized cells. The former two approaches share common steps: single cell 
harvesting, cDNA synthesis and detection.  
2.3.2.1 Harvesting 
Prior to end-point analysis of transcripts, single cells need to be isolated from 
culture or tissue, or retrieved from experimental platforms. Single cells should be 
harvested with minimal perturbation to their original state.  
2.3.2.1.1 Micromanipulation 
Micromanipulation has been the gold standard method for handling single cells. 
There are two types of micromanipulation: mechanical and optical manipulations. A 
mechanical micromanipulation system usually has an inverted microscope, a motorized 
platform operated by a joy-stick, and a microcapillary pipette connected to a pump for 
aspirating and dispensing single cells. Using a mechanical micromanipulator, single cells 
can be individually captured from a cell population and transferred to other culture 
conditions or end-point experimental vials. A more advanced system with vision-based 
feedback control can help users verify the successful transfer of single cells into a new 
experimental condition or vial, adding a straight-forward quality control step (Anis, Holl 
et al. 2010, Anis, Houkal et al. 2011, Zeng, Wang et al. 2011, Kelbauskas, Ashili et al. 
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2012). Current mechanical micromanipulation platforms largely rely on the expertise of a 
well-trained experimentalist, have low throughput and are difficult to automate. 
Optical tweezers are another micromanipulation method. Single cells can be 
trapped and manipulated by highly focused, near-infrared laser beams (Arai, Ng et al. 
2005, Zhang and Liu 2008). Two forces applied by the light, the scattering force and the 
gradient force, can move the trapped cell and transfer it to another compartment for later 
analysis. The optical manipulation is sterile because it does not need physical contact. 
Fortunately, visual evaluation of single cells is an inherent advantage of optical tweezer 
manipulation. However, the throughput of optical micromanipulation is also limited and 
automation is hard to achieve. At present, micromanipulation is probably the most precise 
method for single-cell isolation and transfer. Nonetheless, implementation of high-
throughput and automated platforms, with minimal damage to the cells, is needed 
urgently for single-cell analysis (Yun, Kim et al. 2013). 
2.3.2.1.2 Laser capture microdissection 
Laser capture microdissection is a method to obtain single cells from a fixed 
tissue or live cell culture under the guidance of microscopic visualization. A typical laser 
capture microdissection process includes the following steps: (1) visualizing cells via 
light microscopy, (2) transferring infrared laser energy to melt a thermolabile polymer 
and form a polymer-cell composite (capture method), or transferring ultraviolet laser 
energy via an ultraviolet laser to photovolatize a region of tissue (cutting method), and (3) 
removing single cells from the tissue or live culture (Emmert-Buck, Bonner et al. 1996, 
Suarez-Quian, Goldstein et al. 1999). One outstanding advantage of laser capture 
microdissection is that samples can be preserved in the condition closest to its original 
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one, without physical contact or contamination. However, even though laser capture 
microdissection has visual-feedback control during cell collection, it does not have this 
control when it places single cells into tubes or other vials. The throughput is also limited 
because it could only capture one cell at a time. Laser capture microdissection is a precise 
single cell sampling technique that could be used in DNA, RNA (Tietjen, Rihel et al. 
2003), protein and metabolite level analysis (Suarez-Quian, Goldstein et al. 1999, 
Golubeva, Salcedo et al. 2013). 
2.3.2.1.3 Fluorescent-activated cell sorting 
Fluorescent-activated cell sorting (FACS) is an automated, high-throughput 
method for harvesting single cells. In FACS, cells from tissue or culture are dissociated, 
suspended and then mixed with a carrier fluid. A stream of cells is generated by 
hydrodynamic focusing. Only single cells could pass through an illumination zone where 
forward and side light scatter and several fluorescence parameters can be measured. An 
intense vibrator underneath the illumination zone creates droplets from the stream. Each 
droplet contains only one single cell. Droplets carrying individual cells are charged and 
deflected into a micro-titer plate. FACS can sort single cells with a rate up to 40 cells per 
second (El-Ali, Sorger et al. 2006). Nonetheless, because cells should be dissociated from 
the tissue or culture, the transcriptome changes due to microenvironment alteration may 
cover up the original subtle RNA profiles of the cell of interest. Moreover, FACS 
requires a relatively large volume of sample and reagent for analysis, which limits the full 
utilization of the FACS system in precious biological samples. 
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2.3.2.1.4 Microfluidics 
The microfluidic lab-on-a-chip platform has emerged as a powerful technology to 
analyze microscale to nanoscale biological systems (Zare and Kim 2010). It can handle 
rare cells and streamline multiple procedures on a single chip with high-throughput (Chiu 
and Lorenz 2009). A plethora of microfluidic single cell sorting/isolation techniques have 
been developed based on various forces, including optical (Krishnan and Erickson 2012), 
magnetic (Liu, Lien et al. 2009), electrical (Prinz, Tegenfeldt et al. 2002, Peitz and van 
Leeuwen 2010) and mechanical force (Di Carlo, Wu et al. 2006).  
In optical manipulation, target cells in a microfluidic channel can be 
simultaneously measured and sorted based on their physical properties, such as size, light 
absorption and refractive index (Zhang and Liu 2008). Optical trapping can be combined 
with a microfluidic system, which helps investigators manipulate the microenvironment 
and study cell behavior and response under physical and chemical stimulation.  
Magnetic-activated cell sorting techniques sort single cells based on their 
membrane-conjugated magnetic nanoparticles or internalized magnetic nanoparticles 
(Schmitz, Radbruch et al. 1994, Tseng, Judy et al. 2012). Microfluidic channels or 
microwells can be integrated with magnets to generate a magnetic field and trap single 
cells attached to magnetic beads (Tseng, Judy et al. 2012). 
Dielectrophoresis is a noncontact, noninvasive method to trap and isolate cells 
from a heterogeneous culture (Pohl and Pohl 1978). A microfluidic cytometer utilizing 
dielectrophoresis was developed to trap cells against fluid flows (Hu, Bessette et al. 2005, 
Hunt and Westervelt 2006). Dielectrophoresis operates on the motion of dielectric cells, 
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focuses on cells within the fluid stream and then traps single cells into the center of the 
microchannel.  
Hydrodynamic manipulation is the most common mechanical approach for 
isolating cells (Yang, Li et al. 2002, Wheeler, Throndset et al. 2003, Lee, Hung et al. 
2005). Cells can be hydrodynamically focused into a narrow stream inside a 
microchannel. This is then followed with accurate positioning of cells by balanced flows.  
Microfluidic single-cell isolation techniques hold great potential for engineering 
and biotechnological studies because they are handy, inexpensive and high throughput. 
When combined with other upstream (microenvironment monitoring, drug treatment, 
imaging and so on) or downstream biochemical assays, microfluidics can become more 
versatile in the blooming field of single-cell analysis.  
2.3.2.1.5 Summary of harvesting methods 
Each of the current single cell harvesting techniques has its own advantages and 
drawbacks. The micropipette manipulation method has almost the highest precision but 
its throughput is low. Laser capture microdissection does not perturb the original states of 
the cell but the cost is expensive. Fluorescent-activated cell sorting is a traditional method 
for sorting cells. However, non-cellular particles or multiple cells can be collected as a 
single cell in the process. The achievements of microfluidic single-cell isolation 
techniques are encouraging in mimicking tissue or organ-like network environments in 
vitro. The above-mentioned techniques will become more useful when combined with 
other phenotype measurement techniques to explore various aspects of single cells. 
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2.3.2.2 Next-generation sequencing 
Next-generation sequencing has become a revolutionary approach for acquiring 
genome-scale data since 2005 (Margulies, Egholm et al. 2005). It allows for more 
qualitative and quantitative DNA to be acquired than the automated Sanger sequencing 
method (Sanger, Nicklen et al. 1977) which is considered “first-generation” technology. 
Next-generation sequencing brought paradigm shifts in many perspectives including 
template preparation, sequencing, and data analysis (Reis-Filho 2009). 
2.3.2.2.1 Template Preparation 
Next-generation sequencing does not require a cloning step as needed in the 
Sanger sequencing approach (Metzker 2010, Mardis 2011, Mardis 2013). DNA are 
randomly broken into smaller sizes and covalently linked with adapters. The DNA library 
fragments are clonally amplified by emulsion PCR or on a solid-phase, either on a bead 
or a flat glass microfluidic channel instead of microplate wells used in Sanger sequencing 
(Mardis 2013). The digital nature of clonal amplification results in a population of 
identical templates, each of which originates from a single fragment and undergoes the 
sequencing reaction.  
2.3.2.2.2 Sequencing 
The process of next-generation sequencing is massively parallel (Mardis 2013). 
After fragment amplification, the nucleotide addition reaction and imaging detection 
happen simultaneously. Repeated cycles of nucleotide synthesis and sequence extensions 
can yield hundreds of megabases to gigabases of output in one single instrument run. 
Four major platforms based on different sequencing mechanisms are reviewed below. 
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2.3.2.2.2.1 Pyrosequencing 
The first commercially available next-generation sequencing platform is based on 
pyrosequencing technology developed by Roche/454 in 2005. It relies on detecting 
pyrophosphate released during nucleotide incorporation. Each cycle of pyrosequencing 
consists of (a) the addition of a single nucleotide, (b) the introduction of substrate and 
enzymes (adenosine 5’-phosphosulphate, sulphurylase, luciferase, and luciferin), (c) the 
generation of ATP from PPi and the emission of light during the luciferin reaction driven 
by ATP, (d) a wash step by apyrase to remove unincorporated nucleotide (Shendure and 
Ji 2008). Two of the most outstanding characteristics of pyrosequencing by Roche/454 
are reading length and speed (Liu, Li et al. 2012). The 454 GS FLX sequencer can read 
up to 1,000 bp in length and the run time is 23 hours. 
2.3.2.2.2.2 Sequencing by synthesis 
The cyclic reversible termination sequencing method, developed by Solexa 
(acquired by Illumina in 2007), dominates the current next generation sequencing market. 
After the adaptor-flanked fragment is PCR amplified, a dense array of sequences will 
form on the solid platform. A typical sequencing cycle usually consists of the following 
steps: (a) the addition of a mixture of four dideoxynucleotides, each labeled with a 
different dye, (b) a wash step of unincorporated nucleotides, (c) four-color imaging 
detection of the incorporated nucleotide, (d) cleavage of both the fluorescent labels and 
terminating groups (Mardis 2013).  
2.3.2.2.2.3 Sequencing by ligation 
Sequencing by Oligo Ligation Detection (SOLiD) is a sequencing platform based 
on two-base-encoded probes in the sequencing by ligation process. It is also a cyclic 
 38 
method with the following steps: (a) the hybridization of a fluorescent probe to the target 
sequence and the ligation between the probe and the sequence primer, (b) a wash step to 
remove non-ligated probes, (c) four-color imaging and (d) the cleavage of the fluorescent 
probe. SOLiD sequencing has extraordinary sequencing accuracy. The SOLiD 5500xl has 
the accuracy of 99.99% when it came to the market in 2010 (Barba, Czosnek et al. 2014).  
2.3.2.2.2.4 pH change monitoring 
In 2010, Ion Torrent commercialized a semiconductor-based sequencing 
instrument. It detects the pH change upon the incorporation of a new nucleotide during 
the synthesis process (Rothberg, Hinz et al. 2011). During sequencing, different types of 
nucleotides flow across the chip in a systematic order. When a nucleotide is incorporated, 
a proton is released. The pH change can be detected by the hydrogen ion detector and the 
signal can be translated into a quantitated readout of nucleotide bases. In Ion Torrent 
sequencing, incorporating nucleotides are not modified with fluorescence dyes or 
blocking groups. A semiconductor sensor replaced a camera in recording signals. Both 
factors speed up the sequencing process and lower the cost (Mardis 2013). Ion Torrent 
has the potential of becoming a fast sequencer in detecting new pathogens. 
2.3.2.2.2.5 Single-molecule real-time sequencing 
Single-molecule real-time sequencing is one of emerging third-generation DNA 
sequencing technologies (Eid, Fehr et al. 2009, Schadt, Turner et al. 2010). It is distinct 
from aforementioned next-generation sequencing methods because it detects single 
molecules without washing steps during DNA synthesis. It directly observes kinetics of 
DNA polymerase as it incorporates nucleotides. The DNA polymerase is modified to 
lower the rate of polymerization and can incorporate fluorescently-tagged nucleotides. 
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This approach requires neither PCR amplification nor synchronized synthesis and 
detection, thereby reducing amplification biases and dephasing errors. Since no scanning 
and washing steps are needed, the rate of sequencing could be accelerated from days to 
minutes. The read lengths of single-molecule real-time sequencing are 1,000 bp on 
average, reaching 10,000 bp at maximum. It is an unmatched capability so far, enabling 
de novo assembly (Schadt, Turner et al. 2010). 
2.3.2.2.3 Sequencing alignment and assembly 
The first step to understand the sequence reads is to align them to a reference or to 
assemble them de novo (Flicek and Birney 2009).  
Alignment programs for Sanger sequencing, such as BLAST (Altschul, Gish et al. 
1990), were designed to search for homologous sequences in large databases. In contrast, 
short-read alignment algorithms for next-generation sequencing tend to assume the 
sources of expected mismatches are species polymorphisms and the technology error rate 
(Flicek and Birney 2009, Li and Homer 2010). Two major categories of alignment 
algorithms are (a) hash table-based implementations, which build a hash table of either 
the input reads or the reference genome assembly, and (b) alignment based on 
suffix/prefix tries, such as Burrows Wheeler Transform, which enables fast string 
matching (Li and Durbin 2009, Li and Homer 2010). 
The framework for assembly is based on the notion of a k-mer in a de Bruijn 
graph data structure. In this graph, k-mers are collected into nodes and the nodes are 
adjacently combined to form continuous linear stretches and combined further into larger 
nodes. Finally, the sequencing errors will be corrected to create a final graph structure 
representing the original genome sequence (Miller, Koren et al. 2010).  
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2.3.2.3 RNA-Seq 
The advent of next-generation sequencing technologies brought unprecedented 
changes in characterizing and quantifying transcriptome by introducing RNA (cDNA) 
sequencing at massive scale (Wang, Gerstein et al. 2009). A population of RNA can be 
reverse-transcribed into cDNA and fragmented, followed with library construction which 
adds adaptors to both ends of the cDNA for sequencing. The sequence reads are aligned 
with the reference genome or transcriptome. The aligned reads are classified as rRNA, 
snRNA, exon, intron, junction and intergenic reads. Exonic reads and junction reads are 
used to generate a base-resolution expression profile for each gene. The applications of 
RNA-Seq are versatile: mapping transcriptional structure, splicing patterns and other 
post-transcriptional modifications, cataloguing mRNAs, non-coding RNAs and small 
RNAs, and identifying differentially expressed genes between different conditions 
(Pareek, Smoczynski et al. 2011). 
One of the advantages of RNA-Seq is its accuracy in quantifying RNA expression 
levels. Compared with hybridization-based approaches such as microarrays, RNA-Seq 
can detect novel transcripts that do not exist in current genome databases. The sequences 
throughout the exon are uniformly covered. The gene expression levels can be quantified 
by normalizing the total number of reads that fall into the exons of a gene against the 
length of the exons that can be uniquely mapped (RPKM). In principle, by increasing 
coverage, depth and amplification capability, RNA-Seq can capture the presence of every 
RNA molecule from a cell (Wang, Gerstein et al. 2009). It also does not have an upper 
limit of quantification, either. RNA-Seq greatly expands the dynamic range of 
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quantifying gene expression level--more than 8,000-fold (Nagalakshmi, Wang et al. 
2008). 
2.3.2.4 Single cell RNA-Seq  
The total RNA from one single cell is about 1-10 picograms (Iscove, Barbara et al. 
2002). Many researchers are working on lowering RNA input requirements for next-
generation sequencing. Particularly, real-time single-molecule sequencing holds promise 
in analyzing RNA at the single cell level. Nevertheless, the amount of RNA from a single 
cell does not meet the microgram level input on any current platforms. Therefore, 
amplification is an indispensable and the most critical step for RNA-Seq at the single-cell 
resolution. So far, four main amplification approaches have been reported for amplifying 
RNA from single cells for RNA-Seq (Hebenstreit 2012).  
The initial mRNA-Seq method was reported in 2009. (Tang, Barbacioru et al. 
2009). Tang et al. described an amplification method to generate as long as 3 kilobases of 
cDNA without bias. The mRNAs obtained from a single cell are reverse-transcribed into 
cDNA, using a poly-T primer anchoring on its 3’ end. Excess primers are digested with 
exonuclease. Poly-A sequence is added to the 3’ end of the first-strand cDNAs and then 
second-strand cDNAs are synthesized using another poly-T primer with another anchor 
sequence. The cDNA is amplified using two anchor sequence primers by PCR. After that, 
the cDNAs are fragmented, ligated with adaptors and further amplified (Tang, Barbacioru 
et al. 2010). However, the strand information is not preserved since PCR amplification 
occurs before fragmentation. 
Another major category of amplification uses the “template-switching” method 
(Cocquet, Chong et al. 2006). This method is recently commercialized by Clontech as the 
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SMARTer (Switching mechanism at the 5’ end of the RNA transcript) Ultra Low RNA 
Kit for Illumina sequencing. The SMART-Seq method starts with lysing individual cells 
in a hypotonic solution containing a high concentration of RNase inhibitors. It also uses 
poly-T primer to synthesize the first strand from the poly-A RNA. It employs Moloney 
murine leukemia virus (MMLV) reverse transcriptase to add a few nontemplated C 
nucleotides to the 3’ end of the cDNA. The oligonucleotide with ribonucleotide G forms 
base-pairs with the additional C nucleotides and become an extended template for the 
second strand synthesis. The MMLV reverse transcriptase switches templates and 
synthesizes DNA until the end of the sequence. The oligonucleotide with ribonucleotide 
G and poly-T serve as the priming sites for PCR amplification. This ensures only the 
cDNAs with ribonucleotide G priming site can be amplified and sequenced, improving 
the read coverage across full-length transcripts (Goetz and Trimarchi 2012, Ramsköld, 
Luo et al. 2012, Picelli, Björklund et al. 2013). RNA-Seq data generated using SMART-
Seq showed a substantial increase in the number of alternative transcript isoforms and 
identification of single-nucleotide polymorphisms. 
In 2012, Tamar Hashimshony et al. presented Cell Expression by Linear 
amplification and Sequencing (CEL-Seq) method using linear in vitro transcription (IVT) 
(Hashimshony, Wagner et al. 2012). This strategy begins with reverse transcription of 
RNA from individual cells. The primer is designed with an anchoring poly-T, a 
sequencing adaptor, a unique barcode for individual cells, and a T7 promoter. After the 
second-strand synthesis, the cDNA is pooled from multiple cells with unique barcodes 
for RNA synthesis. RNA is then fragmented and ligated with another adapter. Finally, 
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RNA is reverse transcribed to DNA. The linear amplification method is claimed to 
outperform single cell RNA-Seq with PCR amplification in sensitivity and accuracy. 
Recently, Xinghua Pan et al. developed two methods for amplifying cDNA for 
single cell RNA-Seq (Pan, Durrett et al. 2013). One approach uses Phi29 DNA 
polymerase, an active player in multiple displacement amplification. After full-length 
cDNAs are synthesized from RNA, cDNAs are circularized at the intramolecular level 
for efficient amplification by Phi29 DNA polymerase. Another approach is called semi-
random primed PCR-based mRNA transcriptome amplification. RNAs are also reverse-
transcribed into cDNA first. Semi-random primers are then used to generate a library of 
overlapping cDNA fragments. Both methods can cover RNA (cDNA) in the full-length, 
as long as 23 kb. The Phi29-based method uses an isothermal reaction and produces 
longer products; while the semi-random primed PCR method detects more genes when 
the transcript level is low. 
Amplification for single-cell RNA-Seq faces several challenges including 
deepening transcript coverage, reducing amplification bias and increasing reproducibility. 
Besides amplification, single-cell RNA-Seq technology also needs to meet several 
requirements (Hebenstreit 2012). Quantification of transcripts at the single cell level 
lacks controls. Spike-in controls or endogenous RNA controls can help calibrate the 
original number of transcripts given the information on sequencing reads. Another issue 
is parameter estimation for mathematical models of transcript regulation. At least a few 
hundred cells in each experimental condition should be analyzed for modeling purposes. 
Amplification methods with multiplexing of different cells, such as SMART-Seq and 
CEL-Seq, will help accelerate the process. 
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2.3.2.5 Single-cell real-time quantitative polymerase chain reaction 
Real-time quantitative polymerase chain reaction (RT-qPCR) is a classical 
method for analyzing transcript levels. It is characterized by a large dynamic range, 
excellent reproducibility and sufficient sensitivity to detect a single transcript. Single-cell 
RT-qPCR includes several sequential experimental steps: cell collection, cell lysis and 
RNA extraction, reverse transcription, pre-amplification (if needed), real-time PCR and 
data analysis (Stahlberg and Bengtsson 2010).  
Current RT-qPCR systems depend on the detection and quantification of 
fluorescent reporters. Two of the commonly used reporters are SYBR Green and Taqman 
Probe (Kubista, Andrade et al. 2006). SYBR Green dye binds to all double-stranded 
DNA. As the double-stranded DNA is synthesized throughout the cycle, the fluorescent 
signal increase can be measured and is proportional to the amount of PCR products. The 
SYBR Green probe is inexpensive and easy to use. However, it could bind to primer-
dimers and other non-specific amplification products, which become background signals. 
Taqman probes are oligonucleotides with a fluorescent dye on the 5’ base and a 
quenching dye on the 3’ base. Once a Taqman probe hybridizes to an internal region of a 
PCR product, its fluorescent and quenching dyes are separated and the former one emits 
light. Fluorescence signals increases each cycle, proportional to the rate of cleaving 
fluorescent and quenching dyes (Parashar, Chauhan et al. 2006). Taqman probe-based 
qPCR has significantly higher specificity, because its probe is targeting specific 
amplicons. It also provides feasible multiplexing strategy, because multiple primers with 
different fluorescent probes could be designed to target different genes from a single cell.  
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Since transcript variability is intrinsic to different cells, special consideration is 
required in both experimental and data analysis processes. Theoretically, no gene could 
be used as a reference gene for normalization in single cells (Bustin, Benes et al. 2009). 
In this scenario, an RNA spike-in control can be used to separate experimental variability 
from biological variability at the single-cell level (Shi, Gao et al. 2013). The spike-in 
RNA can be a RNA sequence that does not exist in the species being studied. One 
challenge with spike-in RNA is that it should be injected into the cell so that it will go 
through the same lysis process as the endogeneous RNAs do.  
High-content microfluidic RT-qPCR platforms have made great strides in 
analyzing transcripts at the single-cell level (Marcus, Anderson et al. 2006, White, 
VanInsberghe et al. 2011). Microfluidic platforms can limit the loss of the picogram 
amounts of RNA present in single cells (Marcus, Anderson et al. 2006). They also get rid 
of variances brought by manual handling. Most importantly, they increase the reaction 
throughput and minimize batch-to-batch variations. Commercially available high-
throughput systems, such as Fluidigm’s BioMark™ and Applied Biosystems’ 
OpenArray® can measure transcript levels of up to 96 genes in 96 samples and 48 genes 
for 48 samples, respectively. 
2.3.2.6 Single-molecule RNA fluorescence in situ hybridization 
Single-molecule RNA fluorescence in situ hybridization (FISH) is based on the 
use of fluorescence labeled oligonucleotides, each targeting RNA of interest (Taniguchi, 
Choi et al. 2010). Hybridization of fluorescent probes to fixed single cells enables direct 
counting of mRNA abundance at the single-cell level. 
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Standard RNA FISH can quantify up to three genes simultaneously within single 
cells (Tischler and Surani 2013). Using spectral barcoding, an approach dividing 
individual probe sets into subsets and coupling each subset with a different fluorescent 
probe, researchers can simultaneously detect up to seven RNAs in individual cells 
(Femino, Fay et al. 1998, Levsky, Shenoy et al. 2002). For RNA FISH, researchers do not 
need to lyse individual cells and extract RNA. RNA FISH acts directly on mRNA within 
a fixed cell, thereby preserving the spatial information of the transcripts (Tischler and 
Surani 2013). Because RNA FISH directly counts the number of transcripts, it does not 
need internal references for quantification. It holds the potential to be combined with 
genomic (DNA FISH) or proteomic (protein labeling) approaches for studying “omics” 
within single cells.  One limitation of RNA FISH is that it only measures the copy 
number of known transcripts (Tischler and Surani 2013). 
2.3.2.7 Summary 
The approaches mentioned above can provide gene transcription information at the 
single-cell level. The information will be revolutionary in revealing discrete molecular 
states within heterogeneous cell populations and identifying aberrant subpopulations. In 
this study, RNA-Seq and RT-qPCR were integrated to explore a little-known area in 
tumor neoplastic progression. The transcriptomes of cell-cell interactions and hypoxia-
adaptations using RNA-Seq were analyzed. After statistical filtering and gene ontology 
study, changes were correlated with metabolic phenotype measurements and transcript 
states were analyzed using RT-qPCR. The lower cost of RT-qPCR allows analysis of a 
larger number of individual cells, providing higher statistical power. By combining 
different approaches, insights were gained into previously unknown cellular decision-
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making processes in normal and aberrant states. It is expected that the progress of single-
cell transcription profiling will advance personalized medicine.
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CHAPTER 3  
A MINIMALLY INVASIVE METHOD FOR RETRIEVING SINGLE 
ADHERENT CELLS OF DIFFERENT TYPES FROM CULTURES 
3.1 Abstract 
The field of single-cell analysis has gained significant momentum over the last 
decade. Separation and isolation of individual cells is an indispensable step in almost all 
currently available single-cell analysis technologies. However, stress levels introduced by 
such manipulations remain largely unstudied. In this thesis a method is presented for 
minimally invasive retrieval of selected individual adherent cells of different types from 
cell cultures. The method is based on a combination of mechanical (shear flow) force and 
biochemical (trypsin digestion) treatment. Alterations in the transcription levels of stress 
response genes in individual cells exposed to varying levels of shear flow and 
trypsinization were quantified. Optimal temperature, RNA preservation reagents, shear 
flow rate and trypsinization conditions necessary to minimize changes in the stress-
related gene expression levels are reported. The method and experimental findings are 
broadly applicable and can be used by a broad research community working in the field 
of single cell analysis.  
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3.2 Introduction 
The field of single cell analysis has experienced a tremendous growth over the 
last decade owing to the intense interest in intercellular heterogeneity and its functional 
role at the tissue level and disease states in vivo (Eberwine, Yeh et al. 1992, Elowitz, 
Levine et al. 2002, Lidstrom and Meldrum 2003, Irish, Hovland et al. 2004). New 
technological advancements have enabled the exploration of biological phenomena with 
single-cell resolution (Arai, Ng et al. 2005, Anis, Holl et al. 2010, Wang and Bodovitz 
2010, Kelbauskas, Ashili et al. 2012). Almost all existing methods for single-cell analysis 
that require isolation of (Arai, Ng et al. 2005) individual cells involve some type of 
mechanical transportation or manipulation of single cells for sample preparation and/or 
analysis purposes. One of the current technological challenges is the minimization of 
perturbation to the cells as a result of such transportation to make biologically relevant 
inferences about cell function possible. If the resulting stress to the cell is significant it 
can alter cellular profiles at the physiological, gene transcription and/or expression levels 
and confound experimental results. Although widely used, stress levels introduced to 
cells by manipulation and, more importantly, their potential effects on cell function 
remain largely unknown. Mechanical cues and mechanical stress have been found to 
strongly affect most cellular functions and critically influence gene transcription during 
embryogenesis, organogenesis (Mammoto, Mammoto et al. 2012) and embryonic 
vasculature development (Roman and Pekkan 2012). Mechanical stress also exhibits a 
direct effect on the nuclear architecture-mediated gene transcription regulation (Martins, 
Finan et al. 2012), oncogenesis (Jean, Gravelle et al. 2011), stem cell differentiation, 
cancer metastasis and the immune response (Hynes 2009) among others. It is thus likely 
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that mechanical stress introduced during cell manipulation can significantly alter gene 
expression profile in cells resulting in atypical both gene expression profile and cellular 
function. Therefore, characterization of stress levels that can significantly perturb cell 
function is necessary for studies that utilize single-cell analysis techniques. 
In the context of single-cell analysis methods, perturbations can be divided into 
two major categories with regard to time scales. One category is perturbations that cause 
reversible alterations that occur on a timescale that is much shorter than the time between 
the perturbation and analysis. By definition, perturbations of this type do not result in 
significant changes in the cell at the time of analysis and thus can be considered 
negligible. The second category is perturbations that induce a long-lasting (on timescales 
comparable or longer than the time between stress administration and analysis) response 
in the form of a modified gene expression profile. These perturbations can introduce 
modifications to the cell function, mRNA or protein expression levels or all of them 
simultaneously and thus need to be properly assessed before reaching any conclusions 
about experimental findings. It is likely that adherent cell types should be affected by 
manipulation more than non-adherent cells simply due to the fact that the former need to 
be detached from the growth substrate or dissociated from tissue before any kind of 
manipulation can be performed. Owing to changes in cellular tension, the detachment 
step itself could cause the cell to respond with an altered gene expression profile 
mediated by mechanosensing through e.g. integrin-actin linkages and 
mechanostransduction via downstream signaling cascades such as receptor-type tyrosine-
protein phosphatase alpha (RPTP-α), Src family kinases (SFKs) (von Wichert, Jiang et al. 
2003, Jiang, Huang et al. 2006, Yu, Law et al. 2011), focal adhesion kinase (FAK) (Wang, 
 51 
Dembo et al. 2001, Schober, Raghavan et al. 2007) and others. In addition, any type of 
manipulation can induce additional cellular responses at biomolecular and/or organelle 
levels. Epithelial cells adhere to the extracellular matrix through transmembrane adhesion 
protein complexes. At the basal membrane, the adhesion of epithelial cells to the 
extracellular matrix is built upon different types of cell-ECM adhesions, including focal 
adhesions and hemidesmosomes, both of which are mediated by integrin connections 
(Balda and Matter 2003), nascent adhesions, focal complexes, focal adhesions, 
podosomes and others (Dubash, Menold et al. 2009). These protein complexes, including 
integrin-actin networks and integrin-intermediate filament networks, regulate the 
adhesion but also mediate mechanosensing and signal mechanotransduction into the cell 
(Roca-Cusachs, Iskratsch et al. 2012). To remove cells from a given culture substrate, 
various mechanical and chemical methods have been employed. For instance, proteolytic 
enzymes, such as trypsin, or chelators, can break the integrin-ligand bonds that mediate 
cell attachment to the substrate (Phelan 2007). However, enzymatic dissociation can 
damage cells, especially the cell surface. Moreover, alterations of gene expression levels 
in cells treated with trypsin were discovered using global gene expression profiling on the 
microarray platform (Chaudhry 2008). Therefore, trypsinization should be performed 
with caution, by optimizing both the duration of trypsinization and the concentration of 
trypsin. 
Mechanical means such as scraping or shear flow were employed to remove cells 
from substrates (Zhang, Jones et al. 2008). However, mechanical methods are usually 
disruptive to the cells and potentially result in a loss of cellular contents. When combined 
with chemical force, shear flow can remove cells from the surface and transfer them 
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without causing damage to the plasma membrane. Still, even under relatively mild 
conditions, shear stress can affect signal transduction pathways, especially in endothelial 
cells (Chen, Li et al. 1999). Because epithelial cells experience much less shear stress in 
the body, gene expression alterations within those cells in response to shear stress could 
be significant and need to be explored. So far, expression levels of chemokine (C-C motif) 
ligand 2 (CCL2) have been shown to be upregulated in epithelial cells in response to 
shear flow stress (Flores, Battini et al. 2010).  
In this study a new method is developed for retrieval of individual adherent cells 
from cell cultures that is based on a combination of mechanical forces and biochemical 
treatment. Stress response induced by the method in terms of gene expression levels in 
individual cells is investigated. Alterations in expression levels of stress response-related 
genes in single cells are quantified as a function of varying mechanical stress while 
employing both shear flow and trypsin digestion to detach single cells from glass 
substrates. Treatment conditions were optimized in a highly controllable manner to 
minimize the effects of gene expression changes that could be induced by stresses. An 
optimal range for mechanical force needed to efficiently detach single cells with no 
detectable change in expression levels of the studied stress-response genes is reported. 
The utility of this technique is expanded to distinguish and harvest co-cultured cells from 
microwells using a fluorescence-assisted single-cell harvesting method. These findings 
can be useful for studies focused on single-cell analysis that involve any mechanical 




3.3.1 Microwell design 
Arrays of 3 × 3 microwells were used for culturing single-cells. Each microwell 
has an inner diameter of 50 µm and is 20 µm deep (Figure 3-1) (Zhu, Holl et al. 2009). 
The microwells were fabricated in fused silica substrates using wet-etch lithography. The 
dimensions of these microwells were optimized for cell-cell interaction studies to monitor 
cellular gene expressions in a controlled microenvironment.  
3.3.2 Cell culture  
The normal cell line, EPC-2 (Harada, Nakagawa et al. 2003), the metaplastic cell 
line, CP-A, and the pre-malignant cell line, CP-D, were derived from a healthy, 
Figure 3-1 Microwell array design 
3 × 3 arrays of wells with 300-μm center-to-center spacing were fabricated on 
fused silica wafers using hydrofluoric acid (HF) deep wet etch lithography. Each 
well is 20-µm deep and has a diameter of 50 µm.  
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metaplastic and dysplastic human esophageal region in Barrett’s esophagus (Palanca-
Wessels, Barrett et al. 1998), respectively. Cells were cultured using Gibco keratinocyte 
serum-free cell growth medium (Invitrogen, Carlsbad, CA, USA), supplemented with 
hEGF (Peprotech, Rocky Hill, NJ, USA) at 2.5 μg/500 mL, BPE (bovine pituitary extract) 
at 25 mg/500 mL and penicillin–streptomycin solution (Invitrogen) at 100 units/100 
μg/mL. Cells were grown at 37 °C under 5% CO2. Prior to experimentation, cells were 
cultured in a 75 cm2 flask to approximately 80% confluency.  
3.3.3 Cell loading into microwells 
Individual cells were loaded into microwells using a single-cell manipulation 
platform as previously described (Anis, Holl et al. 2010, Kelbauskas, Ashili et al. 2012). 
Briefly, the platform is built around a diaphragm micropump that can aspirate and 
dispense sub-nanoliter volumes of liquid. Single cells in suspension were aspirated and 
dispensed into microwells using a 40-μm diameter glass capillary micropipette utilizing 
closed-loop microscopic vision-based feedback. Cells can be aspirated from a Petri dish 
by a drag force generated through a negative pressure applied to the micropipette 
capillary. Cells can be dispensed through the micropipette capillary into the microwell by 
applying a positive pressure to the capillary, generating an ejection force on the cell 
(Kelbauskas, Ashili et al. 2012). Glass substrates containing 3 × 3 arrays of microwells 
were glued to the bottom of a Petri dish with a pre-cut hole using medical-grade epoxy 
glue (K45-S-14ML, Chemical Concepts, Huntingdon Valley, PA). Loading 9 single-cells 
in a 3x3 array of microwells with one cell per well takes approximately 5-8 minutes, 
while loading two cells per well requires 20-25 minutes. After loading into the 
microwells, the cells were incubated in Keratinocyte SFM, at 37 °C under 5% CO2 for 
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16-24 hours to allow for cell adhesion and recuperation from potential stress caused by 
manipulation.  
3.3.4 Direct lysis of single cells in microwells 
The microwell substrate was placed on the stage of a pick-and-place single-cell 
manipulation platform. The micropipette was filled with Cell Lysis Buffer (Zymo 
Research, Orange, CA, USA) and lowered until it touched the substrate.  The 
micropipette orifice was aligned with a selected cell inside a microwell and encapsulated 
by the micropipette tip. The Cell Lysis Buffer was dispensed for 1 minute with enough 
volume to thoroughly coat the cell. After this, the lysate was immediately aspirated into 
the micropipette for 1 minute to minimize the diffusion of the lysate from the microwell. 
The lysate was then dispensed through the micropipette into the cap of a 1.5 mL 
microcentrifuge tube for 1 minute. 
3.3.5 Single-cell collection 
The pick-and-place single-cell manipulation platform (Anis, Holl et al. 2010, 
Kelbauskas, Ashili et al. 2012) (Figure 3-2) was used to collect single-cells from 
microwells. The microwell substrate containing individual cells was washed three times 
with 1 mL of warmed 1× PBS, and exposed to 1 mL of 0.05% v/v trypsin-EDTA for 8-12 
minutes at 37 °C. Subsequently, 1 mL of trypsin inhibitor (DTI) was added to the 
trypsinized cells to deactivate trypsin, which was followed by adding 1 mL of 
Keratinocyte SFM medium. The selected cell was first aligned with the micropipette 
orifice and then aspirated into the micropipette capillary. The aspirated cell was 
dispensed from the microcapillary tip into the cap of a 1.5-mL microcentrifuge tube 
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(VWR, West Chester, PA, USA) containing 200 μL of Keratinocyte SFM, Cell Lysis 
Buffer, or RNALater (Life Technologies, Austin, TX, USA). 
3.3.6 Preservation of RNA at low temperatures 
After trypsin deactivation, the substrate containing the 3 × 3 array of microwells 
with cells was placed inside a 4 °C refrigerator for 15 minutes. Simultaneously, the pick-
and-place manipulation platform was cooled using four ice-packs for 15 minutes. The 
substrate was placed on the cooled stage, and the temperature was monitored with a 
thermometer, ranging from 2 °C to 10 °C on the station. The pick-and-place cell 
manipulation system was used to aspirate the harvested cells and dispense them into caps 
Figure 3-2 The single cell manipulation platform used in this study 
(A) A side view of the platform built on a microscope. (B) Micropipette 
controlled by a piezoelectric pump is used for aspirating cells from and 
dispensing them into microwells located in the petri-dish. 
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of 1.5-mL microcentrifuge tubes as described in the Single-cell Collection Section above. 
A control group of cells was kept at room temperature during the harvesting process.  
3.3.7 Flow rate and trypsinization time 
The two major determinants of successful cell detachment are the trypsinization time and 
the applied shear flow rate. Each trypsinization time point and flow rate was selected 
Figure 3-3 Flow rate conversion 
Flow rate values of 1, 5, and 10 V/s were converted to units of nL/s. The inner 
diameter (i.d.) of the tip orifice is 40 µm. They were based on the assumption 
that the diaphragm of the piezoelectric pump is a fixed-fixed bending beam and 
that the piezoelectric actuator acts on the center of the beam. 
 58 
based on preliminary experiments that showed a range of possible values that 
demonstrated noticeable changes in detachment, from no detachment, partial detachment 
to full detachment. Flow rate was converted from the voltage change rate of the 
piezoelectric pump to volume change rate (Table 1, Figure 3-3).  
Table 1 Voltage-to-flow rate conversion 
 
To measure the success of each combination of flow rate and trypsinization time 
(Table 2), the micropipette tip was positioned vertically at a 90 degree angle with the 
substrate surface so that it enclosed the cell without making direct contact with the cell. A 
selected flow rate was then applied to aspirate the cell from the substrate. A successfully 
harvested cell is considered one that detaches without visible tearing of the plasma 
membrane and leaving remnants on the substrate. After a visual inspection and 
confirmation, the harvested cells were dispensed through the micropipette capillary into 
the caps of 1.5-mL microcentrifuge tubes as described in the Single-cell Collection 
Section above. The success rate of each combination of parameters is summarized in 
Table 2.  
V/s Flow rate (um3/s) Flow rate (nL/s) 
1 2513.27 0.002513 
5 12566.35 0.012566 
10 25132.7 0.025133 
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Success rate of 
cell harvesting 
2.5 5 6.7% 
2.5 8 13.3% 
2.5 10 40.0% 
12.5 5 20.0% 
12.5 8 46.7% 
12.5 10 66.7% 
25 5 80.0% 
25 8 73.3% 
25 10 93.3% 
 
3.3.8 Primer design for the shear flow stress response gene CCL2 
The chemokine (C-C motif) ligand 2 (CCL2) gene is upregulated in epithelial 
cells under shear flow stress (Flores, Battini et al. 2010). The qPCR primer was designed 
using the Primer-BLAST tool (www.ncbi.nlm.nih.gov/tools/primer-blast/ ). Multiple 
primer pairs were designed with a length range of 100-400 bp and appropriate GC 
content to provide a sufficient thermal window for efficient annealing. The selected 
primers were first evaluated at the bulk sample level. Optimized primer oligos for single-
cell analysis of the target genes were obtained from Fisher Scientific (Pittsburgh, PA, 




Table 3 Primer sequences used in the study 
Gene Description Sequence GenBank Access No. 
28S 
Homo sapiens RNA, 
28S ribosomal 1 
(RN28S1) 
F: CCGCTGCGGTGAGCCTTGAA  
R:  TCTCCGGGATCGGTCGCGTT  NR_003287.2 
ACTB Homo sapiens actin, beta mRNA (ACTB) 
F:  CATGTACGTTGCTATCCAGGC  







F: TGTTGCCATCAATGACCCCTT  
R: CTCCACGACGTACTCAGCG  NM_002046.3 
Hsp70 
Homo sapiens heat 
shock 70kDa protein 
1A (HSPA1A), 1B 
(HSPA1B), 2 
(HSPA2) 
F: CGACCTGAACAAGAGCATCA  







motif) ligand 2 
F: CATCTGGCTGAGCGAGCCCT 







R: CTTGAAGTGCATGTGGCTGT N/A 
 
3.3.9 On-chip lysis of single cells in microwells 
For on-chip lysis of single cells, individual cells were loaded into microwells 
using the pick-and-place single-cell manipulation platform (Anis, Holl et al. 2010, 
Kelbauskas, Ashili et al. 2012). Glass substrates containing 3 × 3 arrays of microwells 
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were simply placed in a Petri dish, rather than glued to the bottom of the dish. A total of 9 
cells were loaded into the 3 × 3 array of microwells (1 cell/well). The cells were 
incubated in Keratinocyte SFM, at 37 °C under 5% CO2 for 16-24 hours. The cells in the 
microwells were visually inspected under the microscope prior to the experiment for 
occupancy and/or morphological abnormalities. It was observed that after incubation, an 
average of 7 out of 9 cells were in the microwells due to cell motility, with the remaining 
2 cells usually located in the interstitial area just outside of the microwells. The 
microwell chips were picked up and placed into a 1.5-mL Eppendorf tube containing 200 
μL of RNA Lysis Buffer (Zymo Research, Orange, CA, USA) using tweezers. The cells 
on the chip were lysed in the tube for 30 seconds. After that, the microwell chip was 
taken out of the tube, and RNA isolation from the lysis buffer was immediately 
performed. 
3.3.10 RNA isolation, reverse transcription, and qPCR 
Single cell RNA isolation, reverse transcription, and qPCR were performed as 
previously described (Gao, Zhang et al. 2011, Zeng, Wang et al. 2011). The 1.5-mL 
microcentrifuge tubes, each containing an individual cell in the cap, were spun down at 
4 °C and 17,000 g for 10 minutes. After 160 µL of medium was taken out, 320 µL of 
RNA Lysis Buffer from the ZR RNA MicroPrep Kit (Zymo Research, Orange, CA, USA) 
was added into the tube. The RNA from each cell was extracted using the ZR RNA 
MicroPrep Kit according to the manufacturer’s instructions. A total volume of 6 µL of 
extracted RNA solution was obtained from the isolation steps and immediately used for 
the reverse transcription step. A total volume of 10 μL of the cDNA synthesis mixture 
contained the following reagents: 2 μL of 5 × VILO Reaction Mix (Invitrogen, Carlsbad, 
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CA, USA), 1 μL of 10 × SuperScript Enzyme Mix (Invitrogen, Carlsbad, CA, USA), 
including SuperScript III RT, RNaseOUT Recombinant Ribonuclease Inhibitor, and a 
proprietary “helper” protein (Invitrogen, Carlsbad, CA, USA), 6 μL of total RNA from a 
single cell, and 1 μL of DEPC-treated water (Ambion, Austin, TX, USA). The contents in 
each tube were gently mixed and spun down, and the cDNA synthesis was performed in 
the following thermal steps: a) 25 °C for 10 min, b) 42 °C for 60 min, and c) 85 °C for 5 
min to inactivate the reverse-transcriptase. The cDNA obtained from these reactions was 
stored at -20 °C until further use.  
Prior to qPCR, 10 µL of cDNA obtained from each single cell was diluted by 
adding 20 µL of DEPC-treated water (Ambion, Austin, TX, USA) for detecting multiple 
genes from a single cell with technical replicates. The qPCR runs were conducted using 
the following reagent mixtures: 5 µL of EXPRESS SYBR GreenER qPCR SuperMix 
Universal (Invitrogen, Carlsbad, CA, USA), 1 µL of each primer (4 µM), 0.1 µL of ROX 
Reference Dye (25 µM) (Invitrogen, Carlsbad, CA, USA), 2 µL of diluted cDNA (1/15th 
of the cDNA in 30 µL obtained from each single cell) and 0.9 µL of DEPC-treated water 
(Ambion, Austin, TX, USA). For negative controls, 2 µL of DEPC-treated water was 
used instead of cDNA. The thermal cycling profile was set up as follows: one cycle at 
95 °C for 10 min; 40 cycles consisting of 95 °C for 15 s; 60 °C for 1 min; and 80 °C for 
10 s with signal detection; melt-curve analysis at 60 °C for 1 min and the temperature 
increased in 0.3 °C increments to 95 °C, then at 95 °C for 15 s. The experiments were run 
on a StepOne Real Time PCR System (Applied Biosystems, Carlsbad, CA, USA). Data 
analysis was carried out using the StepOne software (Applied Biosystems, Carlsbad, CA, 
USA). 
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3.3.11 Lentiviral transfection of cells  
The CP-D and EPC-2 cell lines were tagged with TurboGFP and TagFP635, 
respectively, to distinguish different cell types in one microwell using the single-cell 
manipulation platform equipped with an epi-fluorescence imaging mode. CP-D cells 
were transfected with Lentiviral MISSION® pLKO.1-puro-UbC-TurboGFP™ Positive 
Control Transduction Particles (Sigma-Aldrich, St Louis, MO, USA), which contained a 
gene encoding TurboGFP under the control of the UbC promoter at a multiplicity of 
infection (MOI) of 2 following manufacturer’s instructions. Similarly, EPC-2 cells were 
transfected with lentiviral MISSION® pLKO.1-puro-UbC-TagFP635™ Positive Control 
Transduction Particles (Sigma-Aldrich, St Louis, MO, USA), which contained a gene 
encoding TagFP635 under the control of the UbC promoter at a MOI of 2. 96 hours post-
infection, the cells were imaged using a Nikon C1si (Nikon Inc., Melville, NY, USA) 
confocal microscope to inspect the expression of cytosolic TurboGFP in CP-D cells and 
TagFP635 in EPC-2 cells. After the culture was expanded into 75 cm2 flasks, a 
puromycin kill curve experiment was performed to determine the minimum concentration 
of puromycin to cause 0% viability of treated cells. 1.0 μg/mL and 0.5 μg/mL of 
puromycin were found to effectively kill the CP-D and EPC-2 cells, respectively, in 
which the TurboGFP or TagFP635 was not successfully expressed after 96 hours. CP-D 
and EPC-2 cells were grown in Keratinocyte serum-free medium containing puromycin 
(1.0 μg/mL for CP-D cells, 0.5 μg/mL for EPC-2 cells) for five passages, and then grown 
in normal Keratinocyte SFM. The expression of cytosolic TurboGFP or TagFP635 was 
retained in CP-D and EPC-2 cells, respectively, when checked under a Nikon C1si 
confocal microscope.  
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3.3.12 Fluorescence-assisted single cell harvesting  
To distinguish and harvest different types of cells (CP-D/TurboGFP and EPC-
2/FP635) from the co-culture in microwells, a fluorescence-assisted single cell harvesting 
platform was developed. To this end, a mercury arc epi-fluorescence illumination lamp 
and a cooled CCD camera were installed onto the pick-and-place single-cell manipulation 
platform equipped with appropriate excitation/emission filters. A LabVIEW program 
(National Instruments, Austin, TX, USA) was written for adjusting exposure time and 
gain settings of the fluorescent microscope. After cells were trypsinized as described in 
the Single-cell Collection Section, they were visualized under transmitted light 
illumination. Co-cultured cells were then imaged with the camera in epi-fluorescence 
mode using the different filter cubes. CP-D/TurboGFP and EPC-2/FP635 cells can be 
easily distinguished in green and red channels, respectively. The two types of cells were 
then collected separately into 1.5-mL Eppendorf tubes as described in Section 3.3.5 
Single-cell Collection.  
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3.4 Results and discussion 
3.4.1 Comparison between in-situ direct lysis and “pick-and-place” harvesting of 
single cells in microwells 
In order to perform end-point gene transcription analysis of single cells, the total 
RNA from individual cells needs to be harvested with minimal loss. First, the ability of 
different single-cell harvesting methods to preserve and recover the maximum amount of 
total RNA using several different buffers was tested. The in-situ direct lysis of single 
cells in microwells (Figure 3-1) contained three steps: (1) lysing single cells in 
microwells; (2) aspirating the lysate using a micropipette and a custom high-precision 
pump; (3) dispensing the lysate into the cap of a microcentrifuge tube for RT-qPCR 








Figure 3-4 Schematic view of the single cell manipulation platform 
The single-cell manipulation platform uses a micropipette controlled by a 
piezoelectric pump. Single cells can grow in microwells which are glued to the 
bottom of the Petri dish. The micropipette is used for aspirating and dispensing 
single cells. 
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detaching and transferring from microwells to analysis vials and avoid potential stress 
during the cell detachment process. As a comparison to the first method, a “pick-and-
place” cell harvesting method (Zeng, Wang et al. 2011, Kelbauskas, Ashili et al. 2012) 
using the single-cell manipulation platform (Anis, Holl et al. 2010) developed in the 
Center for Biosignatures Discovery Automation (D. Meldrum, Director) was tested 
(Figure 3-2, Figure 3-4). The method combines trypsinization and shear flow to detach 
single cells from the bottom of the microwells and collect them for downstream analysis, 
e.g. RT-qPCR (Figure 3-5). Esophageal epithelial cells (CP-A cell line) in microwells 
were treated with 0.05% Trypsin for 6 minutes until they were partially detached as 
judged from the change in the cellular morphology from fully stretched to a more 
spherical shape. Single cells were then collected from the microwells using the 
micropipette in the single-cell manipulation platform using 12.5 pL/s flow rate.  
Using the in-situ direct lysis method, the single cells were immediately lysed in 
microwells by adding the RNA lysis buffer into the microwell. The addition of the lysis 
Figure 3-5 Single-cell harvesting steps 
The single-cell harvesting procedure contains three major steps: (A) 
trypsinization to partially detach the cell from the substrate; (B) trypsin 
deactivation with trypsin inhibitor (DTI) and cell aspiration into the micropipette 
tip; (C) transfer of the cell into the cap of a PCR tube for downstream analysis. 
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buffer resulted in substantial morphological changes. It was observed that the lysate 
diffused out of the microwell prior to being collected rendering this method inappropriate 
for collecting total RNA from single cells. Compared with in-situ direct lysis, single-cells 
can be harvested without physical tearing or morphological changes to the cell using the 
pick-and-place harvesting method. Therefore, the pick-and-place harvesting was further 
developed and optimized in later experiments. 
3.4.2 Usage of cellular RNA preservation solution for single-cell harvesting 
Stabilization of the total RNA is an important aspect of gene transcription assays. 
To preserve the RNA quality, RNA degradation by RNase should be minimized during 
cell harvesting and until RNA extraction. Three different solutions - RNA Later®, RNA 
Lysis Buffer and Keratinocyte serum-free medium - were tested for their ability to 
preserve RNA in single cells harvested at room temperature. The RNA Later® solution 
(Ambion, Austin, TX, USA) is a concentrated salt solution (25 mM Sodium Citrate, 10 
mM EDTA, 70 g ammonium sulfate/100 ml solution, pH 5.2) that rapidly permeates 
tissues to stabilize and protect cellular RNA (Lader 2001). RNA Later® was mixed with 
Keratinocyte serum-free medium at a 5:1 v/v ratio in my experiments. RNA Lysis Buffer 
(Zymo Research, Orange, CA, USA) is composed of guanidinium thiocyanate, which can 
both lyse cells and deactivate RNases by denaturing them (Forman and Jia 2012). 
Keratinocyte serum-free medium was used as a control for RNA preservation 
experiments. In the harvesting experiments, 200 μL of the corresponding solution was 
added into the cap of a microcentrifuge tube. After the single cell was aspirated into the 
micropipette tip, it was directed into the cap and dispensed into the liquid solution in the 
cap. The tube was immediately closed and placed on dry ice.  
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First, the total RNA was extracted from single cells using ZR RNA MicroPrep Kit 
(Zymo Research) and expression levels of the 28S and actin β (ACTB) housekeeping 
genes were measured. Both genes are highly expressed in human cells and show low cell-
to-cell copy number variability. They can easily be detected using qPCR and used as 
references for total RNA extraction efficiency in comparison studies. The amount of 28S 
rRNA and ACTB mRNA was measured with reverse transcription quantitative PCR (RT-
qPCR) using the Superscript VILO cDNA synthesis kit and EXPRESS SYBR GreenER 
qPCR SuperMix Kit (both kits are from Invitrogen, Carlsbad, CA, USA). Compared with 
the quantification cycle (Cq) values of the two genes in the group where only cell medium 
was used for storing the harvested cells, the Cq values of the two genes in both the RNA 
Later® and the Lysis buffer groups are higher. The differences in Cq values of 28S and 
ACTB genes are shown in Figure 3-6. The Cq of both genes in the lysis buffer groups are 
significantly different from that of the medium group (p = 0.02 for 28S, p = 0.04 for 
ACTB, calculated using the non-parametric Mann-Whitney statistical significance test, α 
= 0.05, two-tailed). Higher amounts of 28S and ACTB mRNA in the medium group 
indicate that the medium outperforms RNA Later® and lysis buffer in preserving RNA. 
RNA Later® contains ammonium sulfate which can permeate the cellular membrane and 
lead to a leakage of cellular components including RNA (Park, Yu et al. 2006). In 
addition, it was not possible to spin down picogram levels of single cell RNA from RNA 
Later® solution, which may have further reduced the RNA extraction efficiency. RNA 
lysis buffer, on the other hand, lyses cells almost instantaneously, potentially exposing 
the picogram levels of single cell RNA to environmental RNases. Another RNA-
preserving agent, RNAstable (Biomatrica, San Diego, CA, USA), was tested by adding 
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200 µL of RNAstable LD into the cap prior to harvesting. Results (data not shown) 
indicated that RNAstable LD is inferior in preserving cellular RNA as compared with the 
medium. Based on these results it was found that the Keratinocyte cell growth medium 
Figure 3-6 Comparison of RNA preservation levels between medium, RNALater 
and RNA Lysis Buffer 
The quantification cycle (Cq) values are higher in the lysis buffer group for the 
28S (Panel A) and higher in the RNALater group for the ACTB gene (Panel B) 
as compared with the medium group. The corresponding Cq mean values are 
shown on top of the bars to compare the three conditions. Errors and error bars 
are corresponding standard deviations. The number of cells analyzed (n) for 
each harvesting condition is shown at the bottom of the graphs. Each qPCR 
reaction was run with three technical replicates. The difference between the lysis 
buffer and medium preservation group is statistically significant for the 28S 
gene and between the RNALater and medium group for the ACTB gene (both 
tested with the two-tailed Mann-Whitney test, α = 0.05). Therefore, dispensing 
cells in cell culture medium can better preserve mRNA. 
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exhibits the highest level of protection against RNA degradation/loss among the four 
solutions. Single-cell collection method was optimized by using 200 µL of Keratinocyte 
SFM in the 1.5-mL microcentrifuge tubes. 
3.4.3 Low temperature harvesting for preserving cellular RNA 
Low temperatures are known to inhibit enzymatic activity of cellular proteins, 
including RNase. To determine whether lowering the temperature can facilitate RNA 
preservation due to RNase inactivation, two ice packs were placed on the stage of the 
single-cell manipulation platform for 15 min before the harvesting experiment to pre-cool 





















Figure 3-7 Comparison between low temperature and room temperature 
harvesting conditions for preserving cellular RNA 
Three individual cells were harvested for each condition and each qPCR 
reaction was run with three technical replicates. The differences between the Cq 
mean values (shown above each box with S.D. as error) between the two groups 
in the 28S, ACTB and HSP70 genes are not statistically significant (Mann-
Whitney test, α = 0.05, two-tailed).  Error bars represent the standard deviations. 
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the platform. During the entire harvesting procedure, the Petri dish containing cells in the 
microwells was surrounded by the ice packs. Room temperature harvesting without ice 
pack cooling was used as the control. RT-qPCR analysis was performed on three genes-
28S, ACTB, and HSP70 from the harvested cells to assess the preservation efficiency. The 
HSP70 gene was chosen due to its role in cold response (Fujita 1999) and cellular stress 
response in general (Guzhova and Margulis 2006, Murphy 2013). Gene transcription 
levels of all three genes in the ice cooled harvesting group do not exhibit statistically 
significant changes compared with room temperature harvesting control (Figure 3-7). 
This indicates that the mRNA of the studied genes is stable under both cool and room 
temperature conditions, while other genes, such as ACTB, may be more sensitive to 
degradation at room temperature. Furthermore, the unchanged level of HSP70 mRNA 
indicated that the low temperature condition did not introduce an additional stress factor 
to the cells. Even though no statistically significant differences were observed between 
the room temperature and the ice-cooled conditions for the studied genes, the ice-cooled 
condition was used throughout the study to avoid potential degradation of the total RNA 
at room temperature.  
3.4.4 The effects of flow-rate and trypsinization time on harvesting success rate 
and RNA preservation 
In order to detach adherent cells from the microwell glass surface with minimal 
perturbation, a combination of mechanical force and enzymatic digestion was used. Shear 
flow through the micropipette tip can aspirate single cells out of the microwell; however, 
applying shear flow can result in damages to the plasma membrane and loss of the 
cellular RNA. Trypsin is a traditional protease which can cleave membrane adhesion 
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proteins, primarily integrins, and detach the cells from the substrate. Excessive 
trypsinization, however, especially with regard to trypsinization time, can alter the gene 
expression profile and affect cell viability (Wassarman and Keller 2003, Rasmussen, 
Frøbert et al. 2011). To minimize potential perturbations to the gene transcription profile 
and the loss of total RNA during harvesting, a combination of both methods was 
employed. First, trypsinization followed by applying a shear flow was performed to 
harvest single cells. Because either step can damage the cell integrity and/or mRNA 
profile, the approach was optimized by testing different combinations of mechanical, 
chemical, and temporal parameters. The purpose was to examine how the trypsinization 
time, trypsin concentration, and flow rate affect the harvesting success rate (HSR) and 
gene transcription levels. The main goal was to identify the lowest flow-rate and shortest 
trypsinization time needed to achieve reliable detachment of cells with the highest HSR 
while causing minimal changes in gene transcription levels. 
A total of nine different conditions (Table 2) were tested, including three rates of 
the shear flow (2.5 pL/s, 12.5 pL/s, 25 pL/s) and three trypsinization times (5 min, 8 min, 
10 min).  
Fifteen cells were treated under each condition and the successfully harvested 
cells were used for RT-qPCR analysis (Table 4). The success rate of cells harvested 
under each condition without taking into account cell stress levels demonstrates that 
trypsinizing cells for 10 minutes and harvesting at a flow rate of 25 pL/s has the highest 
success rate of 93.3% (Table 2).  
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Table 4 Two-way multivariate ANOVA of the effects of flow rate and trypsinization time 
on gene transcription analysis 
(* Significant at p = 0.05 level) 
Gene Flow rate (FR) Trypsinization time (TT) 
FR and TT 
combined 
HSP70 p = 0.367 p = 0.000* p = 0.493 
ACTB p = 0.014* p = 0.082 p = 0.048* 
28S p = 0.000* p = 0.000* p = 0.000* 
CCL2 p = 0.022* p = 0.000* p = 0.018* 
 
To assess the stress levels resulting from the different harvesting conditions, the 
mRNA levels of 28S, ACTB, HSP70 and CCL2 genes were analyzed in harvested cells 
using RT-qPCR. The cDNA extracted from single cells obtained for each harvesting 
condition was pooled and qPCR was performed on them. The results show that the 
transcription levels of the HSP70, 28S and CCL2 genes are generally higher in cells 
harvested after 5 min trypsinization as compared to cells harvested after 8 or 10 min of 
trypsinization. The difference in their expression levels in cells between 5 min, 8 min and 
10 min trypsinization groups is statistically significant (Table 4, Table 5). Moreover, the 
transcription levels of the ACTB, 28S and CCL2 genes are markedly affected by the flow 
rate. In general, the flow-rate of 12.5 pL/s yields the lowest Cq values for these genes. 
Different combinations of the flow rate and trypsinization time also significantly affect 
the gene transcription levels of the ACTB, 28S and CCL2 genes. The two-way 
multivariate ANOVA test (α = 0.05) performed on the Cq values as a function of 
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trypsinization time (TT) or flow rate (FR) shows (Table 4) that both the trypsinization 
time and flow rate have a statistically significant impact on the transcription levels of 
these genes. If the cells are trypsinized for a shorter time, a higher flow rate needs to be 
applied to retrieve the cells and vice versa. Interestingly, the p-values of the two factors 
(Table 4, combined FR and TT p-values) indicate that enzymatic cleavage and 
mechanical shear flow have a collective effect on the transcription of the ACTB, 28S and 
CCL2 genes. Since shorter trypsinization times and low flow rates are desired for 
preserving cellular RNA, the trypsinization time was limited to 5-7 minutes and a flow 
rate of 12.5 pL/s was utilized for single cell harvesting. 

















Cq ± S.D. Cq ± S.D. Cq ± S.D. Cq ± S.D. 
2.5 5 32.27 ± 0.19 13.52 ± 0.27 29.64 ± 0.38 30.16 ± 0.37 
2.5 8 34.97 ± 3.04 15.01 ± 0.05 36.05 ± 2.03 36.69 ± 2.51 
2.5 10 35.33 ± 2.10 13.60 ± 0.90 31.00 ± 1.79 33.90 ± 0.56 
12.5 5 33.60 ± 1.05 18.23 ± 0.62 29.30 ± 0.88 31.43 ± 1.13 
12.5 8 33.22 ± 3.13 19.45 ± 0.03 33.52 ± 0.40 36.50 ± 0.80 
12.5 10 not detected 18.94 ± 0.59 31.45 ± 1.45 34.38 ± 0.00 
25 5 26.69 ± 0.74 13.81 ± 0.14 29.30 ± 0.62 32.79 ± 0.83 
25 8 34.87 ± 0.31 29.10 ± 1.20 34.21 ± 1.77 36.49 ± 0.62 
25 10 27.93 ± 0.39 14.81 ± 0.13 30.03 ± 1.80 37.07 ± 0.15 
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3.4.5 Comparison between on-chip lysis of cells in microwells and harvesting cells 
from microwells 
With the preservation medium, temperature, trypsinization time and flow-rate 
conditions optimized, it was important to determine whether the harvesting procedure 
itself under those conditions causes any observable RNA loss or changes in gene 
transcription. To this end a comparison was made between the amounts of mRNA 
extracted from cells that were harvested with those that did not undergo harvesting. 
Individual cells were directly lysed in microwells on the chip and this condition was used 
as the untreated control group. If no significant differences in gene transcription levels of 
the selected genes can be detected between the control group and the harvested group, the 
harvesting procedure can be considered suitable to collect cells for gene transcription 
analysis. 
In the on-chip lysis experiment, 9 single cells were loaded into a 3 × 3 array of 
microwells made in fused silica chips, and the chips were placed in a Petri dish. The cells 
on the chip were incubated overnight. After being visually inspected under the 
microscope for cell occupancy in the microwells, the glass chips with cells adhered to the 
well bottom were placed into a 1.5-mL microcentrifuge tube containing 200 μL of RNA 
Lysis Buffer. In the harvesting experiment, single-cells were harvested from the 
microwells on the cooled stage, using 12.5 pL/s flow-rate and 6 min trypsinization time, 
and placed into the cap of a microcentrifuge tube containing 200 μL of cell growth 
medium. The mRNA levels of the 28S, ACTB, GAPDH and HSP70 genes in cells lysed 
on the chip or harvested were analyzed using RT-qPCR. 
 76 
Cq values of the four genes were compared between the on-chip lysis and 
harvesting groups to assess the capability of the two methods to preserve cellular RNA. 
The Cq values of 28S, ACTB, GAPDH and HSP70 genes in harvested cells were found to 
be very close to those measured in on-chip lysed cells (Figure 3-8). The Cq values of the 
28S, ACTB and GAPDH genes in harvested cells are slightly lower (ΔCq = -0.79 for 28S, 
-1.10 for ACTB and -0.57 for GAPDH), indicating a larger amount of mRNA in the 
harvested group; while the Cq values of the HSP70 gene in harvested cells are slightly 
higher than in on-chip lysed cells (ΔCq = 0.65), indicating a smaller amount of RNA in 
harvested cells. However, the Mann-Whitney test showed that the Cq differences between 
the two groups in all of the genes are not statistically significant. This suggests that the 
parameters used for harvesting preserve cellular RNA efficiently and do not induce 













Figure 3-8 Comparison of gene transcription levels between the on-chip lysis of 
cells in microwells and harvesting cells from microwells 
(A) Cq values of the 28S, ACTB, GAPDH and HSP70 genes. The corresponding 
Cq mean values are shown on top of the bars. Error bars show the standard 
deviations. ΔCq between the two groups in all of the genes (Panel B-E) are not 
statistically significant (Mann-Whitney test, n=6, α = 0.05, two-tailed). 
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3.4.6 Fluorescence-assisted single cell harvesting 
Cell-cell communications are critical to regulating various core cellular responses, 
such as metabolism and homeostasis. Understanding gene transcription changes as a 
result of intercellular interactions in cells at different stages of pre-malignant progression 
may help discover new cancer biosignatures.  
To enable harvesting of individual cells of different types from co-cultured cell 
populations, a fluorescence-assisted single-cell harvesting modality was added to the 
method. To perform cell harvesting with minimal effect on gene transcription levels, the 
harvesting parameters optimized in the cell stress as presented above were used. Using 
this approach, one can distinguish co-cultured cells of different types utilizing cell-type 
specific fluorescent markers and separately collect individual cells from a single 
microwell. 
To this end, two cell lines were produced, each expressing a different fluorescent 
protein. Normal epithelial EPC-2 cells were transfected with Lentiviral vectors 
expressing cytosolic FP635 to establish the EPC-2/FP635 cell line. Dysplastic Barrett’s 
esophagus CP-D cells were transfected with Lentiviral vectors expressing cytosolic 
TurboGFP to establish the CP-D/TurboGFP cell line. Co-cultured EPC-2/FP635 and CP-
D/TurboGFP cells could easily be distinguished under the fluorescence microscope 
(Figure 3-9).  
The single-cell manipulation platform (Anis, Holl et al. 2010, Kelbauskas, Ashili 
et al. 2012) was equipped with an epi-fluorescence illumination source and 
excitation/emission filter sets for TurboGFP and FP635. With the help of a custom-
written program (LabVIEW) for fluorescence-assisted cell harvesting, EPC-2/FP635 cells 
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and CP-D/TurboGFP cells can be identified within the co-culture in the microwells. They 
can be detached and collected separately using the optimized harvesting conditions.  
 In order to demonstrate the ability of the technique to distinguish specific 
signatures of single cells, the presence of TurboGFP transcripts in harvested cells was 
measured using RT-qPCR. It was expected that the Cq values of the Turbo-GFP gene in 
CP-D/TurboGFP cells would be significantly lower compared with those in EPC-
2/FP635 cells. 
Figure 3-9 Harvesting single cells from a co-culture 
One CP-D/TurboGFP cell and One EPC-2/FP635 cell were co-incubated in 
microwells. Micrographs of: (A) bright field; (B) overlay of green and red 
channel with bright field channel; (C) CP-D/TurboGFP cell in green spectral 
channel, (D) EPC-2/FP635 in red spectral channel. Co-cultured EPC-2/FP635 
and CP-D/TurboGFP cells can be distinguished and harvested using the 
fluorescence-assisted single cell harvesting platform. 
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The amplification plots of RT-qPCR showed the presence of TurboGFP in CP-
D/TurboGFP cells and marked differences in Cq in EPC-2/FP635 cells (Figure 3-10A). 
Normalized Cq values using CP-D/TurboGFP cells as the reference demonstrated a 
significant difference in signal between two types of cells as determined by the Wilcoxon 
test (α = 0.05, two-tailed) with p = 0.0009 (Figure 3-10B). 
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Figure 3-10 RT-qPCR analysis of TurboGFP genes in CPD/TurboGFP and 
EPC2/FP635 cells 
Different cell types can be reliably distinguished using the fluorescent assisted 
harvesting method as proven by the RT-qPCR results. Quantitative cycle values 
on the amplification plots (A) and ΔCq analysis using CPD/TurboGFP cells as 
the control (B) both demonstrate the presence of TurboGFP in harvested 
CPD/TurboGFP cells but not in EPC2/FP635 cells.   
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3.5 Conclusion 
In this study, a method was developed for retrieving adherent cells from 
substrates with minimal disruption and perturbation. The method features combined 
enzymatic cleavage and mechanical force applied by a piezo-pump on a single cell 
manipulation station. Reagents for RNA preservation, temperature settings, flow rate, and 
trypsinization time were also optimized to minimize gene transcription profile changes 
brought by harvesting. Using this method, gene transcription levels were analyzed in both 
harvested and on-chip directly-lysed single cells. The results showed conclusively that 
the harvesting method that was developed and optimized can preserve the RNA profiles 
in the cells retrieved from microwells. The application was expanded to fluorescence-
assisted single cell harvesting from a co-culture of different cell types. This method 
provides an approach to transfer adherent single cells from cell culture to any 
downstream end-point analysis or re-culture. It enables researchers to retrieve adherent 
single cells without perturbation and thus has the potential to become a broadly 
applicable tool in the growing field of single-cell analysis. 
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CHAPTER 4  
QUANTITATIVE SINGLE-CELL GENE EXPRESSION MEASUREMENTS OF 
MULTIPLE GENES IN RESPONSE TO HYPOXIA TREATMENT 
4.1 Abstract 
Cell-to-cell heterogeneity in gene transcription plays a central role in a variety of 
vital cell processes. To quantify gene expression heterogeneity patterns among cells and 
to determine their biological significance, methods to measure gene expression levels at 
the single-cell level are highly needed. Reported here is an experimental technique based 
on the DNA-intercalating fluorescent dye SYBR green for quantitative expression level 
analysis of up to ten selected genes in single mammalian cells. The method features a 
two-step procedure consisting of a step to isolate RNA from a single mammalian cell, 
synthesize cDNA from it, and a qPCR step. The method was applied to cell populations 
exposed to hypoxia, quantifying expression levels of seven different genes spanning a 
wide dynamic range of expression in randomly picked single cells. In the experiment, 72 
single Barrett’s esophageal epithelial (CP-A) cells, 36 grown under normal physiological 
conditions (controls) and 36 exposed to hypoxia for 30 min, were randomly collected and 
used for measuring the expression levels of 28S rRNA, PRKAA1, GAPDH, Angptl4, MT3, 
PTGES, and VEGFA genes. The results demonstrate that the method is sensitive enough 
to measure alterations in gene expression at the single-cell level, clearly showing 
heterogeneity within a cell population. Presented are technical details of the method 
development and implementation, and experimental results obtained by use of the 
procedure. The advantages of this technique are expected to facilitate further 
developments and advances in the field of single-cell gene expression profiling on a 
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Cell-to-cell heterogeneity in gene transcription plays a central role in a variety of 
vital cell processes, including differentiation (Losick and Desplan 2008, Furusawa and 
Kaneko 2009), stimulus response (Levsky, Shenoy et al. 2002), survival (Cohen, Geva-
Zatorsky et al. 2008, Fraser and Kaern 2009), and carcinogenesis (Elowitz, Levine et al. 
2002). Therefore, studies of the molecular mechanisms responsible for intercellular 
variability in gene expression levels at the single-cell level are expected not only to 
provide critical insights into core cellular processes but also to pave the way for new, 
more effective disease prevention and treatment strategies. The vast majority of currently 
existing experimental techniques for gene expression profiling are based on analysis of 
bulk samples containing 105–107 or more cells. Inherent to samples of that size is the 
ensemble-averaging of the results over a large number of cells, hiding key information 
emanating from individual cells. Thus, bulk techniques are rendered unsuitable for 
intercellular heterogeneity studies. The emerging importance of cell population 
heterogeneity imposes a demand for reliable gene transcription profiling techniques 
specifically tailored for individual cells. Measuring gene expression at the single-cell 
level is challenging because of the small amounts of total available mRNA (~1 pg). The 
large dynamic range of expression levels among genes is another hurdle that must be 
overcome by developing highly sensitive, specific, and reproducible detection strategies. 
The most reliable quantitative approach suitable for single-cell studies is based on reverse 
transcription (RT) without pre-amplification followed by quantitative polymerase chain 
reaction (qPCR). Besides enabling highly quantitative measurement of mRNA copy 
numbers, RT-qPCR theoretically allows detection of a single copy of mRNA. Several 
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experimental techniques based on RT-qPCR and specialized for quantitative gene 
expression profiling in individual cells have been reported in the literature (Hartshorn, 
Anshelevich et al. 2005, Hartshorn, Eckert et al. 2007, Bengtsson, Hemberg et al. 2008, 
Diercks, Kostner et al. 2009, Taniguchi, Kajiyama et al. 2009, Stahlberg and Bengtsson 
2010). Several of these techniques use a single-tube RT-qPCR approach (Bengtsson, 
Hemberg et al. 2008, Diercks, Kostner et al. 2009, Gong, Ogunniyi et al. 2010), in which 
all steps, including cell lysis, cDNA synthesis by reverse transcription, and quantitative 
PCR, are performed in one tube. This reduces the probability of mRNA loss and possible 
contamination during the sample-handling process. Although advantageous in terms of 
sample conservation, these single-tube methods can generate only one measurement for 
each cell, making it impossible to distinguish biological variation from measurement 
variation. In addition, the single-tube operation limits the number of genes that can be 
detected per single cell to less than five (Taniguchi, Kajiyama et al. 2009, Gong, 
Ogunniyi et al. 2010). To overcome these hurdles, multiple-step RT-qPCR procedures 
were recently developed (Taniguchi, Kajiyama et al. 2009, Joglekar, Wei et al. 2010). 
One of these protocols is based on a reusable single-cell cDNA library immobilized on 
beads for measuring the expression of multiple cDNA targets (from several copies to 
several hundred thousand copies) in a single mammalian cell. The results showed that the 
measurement error of this method is less than 15.9% among replicates (Bengtsson, 
Hemberg et al. 2008). Another procedure has been successful in assessing ten mRNA 
transcripts from a single cell, and each with one technical replicate (Hartshorn, 
Anshelevich et al. 2005). The procedure could potentially be extended to analyze twenty 
different mRNAs from a single cell by use of duplex PCR (Joglekar, Wei et al. 2010). 
 88 
Despite some initial successes (Bengtsson, Hemberg et al. 2008, Taniguchi, Kajiyama et 
al. 2009, Joglekar, Wei et al. 2010, Stahlberg and Bengtsson 2010), analyzing multiple 
genes from one single cell by RT-qPCR remains challenging because the total amount of 
cDNA must be divided into multiple portions, limiting the sensitivity of RT-qPCR 
product detection. 
Molecular oxygen is required for energy production in aerobic organisms. A 
shortage of oxygen (hypoxia) creates significant stress in cells, to which they respond by 
several different molecular mechanisms, including reduction in energy demand, cell cycle 
arrest, production and secretion of survival and angiogenic factors, and so forth. Hypoxia 
plays a pivotal role in cancer, causing alterations in cellular metabolism, increased 
resistance to radiation and chemotherapy (Bertout, Patel et al. 2008), and possibly 
increasing cells’ metastatic potential (Lopez-Lazaro 2007). Oxygen deprivation has been 
shown to cause alterations in stem cell proliferation, differentiation, and pluripotency 
(Mazumdar, Dondeti et al. 2009). Despite recent advances in understanding cells’ 
responses to hypoxia, the underlying molecular mechanisms remain unclear. More 
specifically, there is a lack of studies at the single-cell level that could provide deeper 
insights into hypoxia-driven selection and survival among different cell populations. 
To gain better understanding of the molecular mechanisms contributing to the 
hypoxia response pathways, an experimental technique based on the DNA-intercalating 
fluorescent dye SYBR green was developed and evaluated. The method enables 
quantitative expression level analysis of up to ten genes of interest in single mammalian 
cells. 
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The technique is a modification of one initially developed for gene expression 
analysis in single bacterial cells (Gao, Zhang et al. 2011) and has so far not been tested in 
mammalian cells. The choice of SYBR green for qPCR is based on its relative ease of use, 
low cost, and suitability for development of high throughput, lab-on-chip procedures for 
RT-qPCR in single mammalian cells. The procedure presented here enables detection of 
up to ten genes, each with three technical replicates, from a single cell, with high 
repeatability (i.e. low standard deviations of quantification cycle, Cq). In addition, the 
SYBR-based chemistry used in the protocol provides greater flexibility to measure more 
genes in the future than Taqman-based technology. 
The method features a two-step procedure consisting of RNA isolation from a 
single mammalian cell followed by cDNA synthesis and a qPCR step. The expression 
levels of multiple genes of interest can be quantified simultaneously in single mammalian 
cells. The primers were designed for selected gene targets known, on the basis of bulk-
cell studies, to be involved in hypoxia response (Arany, Huang et al. 1996, Yoshiji, 
Gomez et al. 1996, Zhong, Agani et al. 1998, Mu, Brozinick et al. 2001, Wang, Wood et 
al. 2008, Murata, Yudo et al. 2009, Lee, Natsuizaka et al. 2010). The primers were 
evaluated at both bulk-cell and single-cell levels. The method was applied to cell 
populations exposed to hypoxia and the expression levels of ten genes spanning a wide 
dynamic range of expression in randomly picked, single cells was quantitatively 
measured. The technical details of method development and implementation are 
presented along with experimental results obtained by use of the procedure. The results 
showed significant gene expression level heterogeneity among the analyzed cells for each 
of the target genes. Detailed interpretation of the observed heterogeneity among cells 
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from an isogenic cell population and its biological significance requires more 
experimental data. However, the results presented here demonstrate that the method is 
sensitive enough to quantify cellular responses at the single-cell level and to reveal gene 
expression heterogeneity in a cell population. The advantages of this technique will 




4.3.1 Cell culture 
The Barrett’s esophageal epithelial cell line CP-A was cultured using Gibco 
keratinocyte serum-free medium (SFM) cell growth medium (Invitrogen, Carlsbad, CA, 
USA), supplemented with hEGF (Peprotech, Rocky Hill, NJ, USA) at 2.5 μg/500 mL, 
BPE (bovine pituitary extract) at 25 mg/500 mL and penicillin–streptomycin solution 
(Invitrogen) at 100 units/100 μg/mL. Cells were grown at 37 °C under 5% CO2. Before 
experimentation, cells were cultured in a 75-mL flask to approximately 80% confluency. 
Cells were washed with 1× PBS (Cellgro, Manassas, VA, USA) and detached from the 
flask with 0.05% (v/v) trypsin–EDTA (Invitrogen). The trypsinization was blocked by 
Dulbecco’s modified Eagle medium (DMEM) (Invitrogen) supplemented with 5% fetal 
bovine serum (FBS) (Invitrogen). After trypsinization, cells were centrifuged at 900 rpm 
for 3 min then resuspended in 1 mL cell-growth medium. 
4.3.2 Primer design and selection of gene target 
Thirteen genes were chosen for RT-qPCR expression level analysis. 18S rRNA, 
28S rRNA, ACTB, and GAPDH were selected as reference genes because they are highly 
expressed housekeeping genes in mammalian cells. The 28S rRNA gene is a reliable 
internal control for comparative transcription analyses under hypoxic conditions (Zhong 
and Simons 1999). HSP70 and HSC70 genes were chosen because HSP70 mRNA 
undergoes dramatic changes under stress conditions, whereas HSC70 does not and can be 
used as a matched reference gene (Mayer and Bukau 2005). HIF1α (Zhong, Agani et al. 
1998), VEGFA (Yoshiji, Gomez et al. 1996), PRKAA1 (Mu, Brozinick et al. 2001), p300 
(Arany, Huang et al. 1996), MT3 (Wang, Wood et al. 2008), Angptl4 (Murata, Yudo et al. 
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2009) and PTGES (Lee, Natsuizaka et al. 2010) are involved in hypoxia response 
signaling pathways. Gene sequences were retrieved from GenBank. qPCR primers were 
designed using the Primer-BLAST, Primer 3 or PrimerExpress V2.0 software packages, 
or retrieved directly from PrimerBank (http://pga.mgh.harvard.edu/primerbank/). For 
each gene, multiple primer pairs were designed on the basis of their coding regions with 
amplification product lengths between 100 and 700 bp and annealing temperatures 
mostly between 60 and 65 °C. The amplification efficiencies of the primers were 
evaluated at bulk-cell and single-cell levels. Optimized primer oligos for single-cell 
analysis of the target genes were obtained from Fisher Scientific (Pittsburgh, PA, USA). 
The selected genes and their corresponding primers are listed in Table 6. 
Table 6 Genes and corresponding primers 
Gene  GenBank Access No. and Description  Sequence  
28S rRNA  
NR_003287.2, Homo sapiens 
RNA, 28S ribosomal 1 
(RN28S1)  
F: CCGCTGCGGTGAGCCTTGAA  
R:  TCTCCGGGATCGGTCGCGTT  
18S rRNA  
NR_003286.2, Homo sapiens 
RNA, 18S ribosomal 1 
(RN18S1)  
F:  CCCGACCCGGGGAGGTAGTG  
R:  GCCGGGTGAGGTTTCCCGTG  
ACTB  NM_001101.3, Homo sapiens actin, beta mRNA (ACTB)  
F:  CATGTACGTTGCTATCCAGGC  
R: CTCCTTAATGTCACGCACGAT  
GAPDH  
NM_002046.3, Homo sapiens 
glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH)  
F: TGTTGCCATCAATGACCCCTT  
R: CTCCACGACGTACTCAGCG  
HIF1A  
NM_001530.3 and 
NM_181054.2, Homo sapiens 
hypoxia inducible factor 1, 
alpha subunit, transcript 
variants 1 and 2 (HIF1A)  
F: CGTTCCTTCGATCAGTTGTGA  





F: GCTACTGCCATCCAATCGAG  
R: TGGTGATGTTGGACTCCTCA  
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4.3.3 Cell staining and fluorescence activated cell sorting 
Cells were stained by incubating in cell medium containing 10 μmol L−1Hoechst 
33342 dye (Invitrogen, Eugene, OR, USA) at 37 °C for 30 min. After staining the cells 
were trypsinized using 0.05% (v/v) trypsin (Invitrogen, Carlsbad, CA, USA) solution and 
NM_001033756, Homo 
sapiens vascular endothelial 
growth factor A (VEGFA) 
transcript variants 1 to 8  
p300  
NM_001429.3, Homo sapiens 
E1A binding protein p300 
(EP300)  
F: GCTTCAGACAAGTCTTGGCAT  
R: GCCTGTGTCATTGGGCTTTTG  
PRKAA1  
NM_006251.5, 
NM_206907.3, Homo sapiens 
protein kinase, AMP-
activated, alpha 1 catalytic 
subunit (PRKAA1), transcript 
variants 1and 2  
F: AACCATGATTGATGATGAAGCCT  
R: GGTGTTTCAGCAACCAAGAATG  
Hsc70  
NM_153201.1, 
NM_006597.3, Homo sapiens 
heat shock 70kDa protein 8 
(HSPA8), transcript variants 1 
and 2  
F: TGTGGCTTCCTTCGTTATTGG  




NM_005345.5, Homo sapiens 
heat shock 70kDa protein 1A 
(HSPA1A), 1B (HSPA1B), 
2(HSPA2)  




NM_139314.1, Homo sapiens 
angiopoietin-like 4 
(ANGPTL4, ANGPTL2) 
F:  ACCTCCCGTTAGCCCCTG 
R:  CATGGTCTAGGTGCTTGTGGTC 
MT3 NM_005954.2, Homo sapiens metallothionein 3 
F: ATGGACCCTGAGACCTGCC 
R: TTGCACACACAGTCCTTGGC 
PTGES  NM_004878.4, Homo sapiens prostaglandin E synthase  
F:  TCAAGATGTACGTGGTGGCC 
R: GAAAGGAGTAGACGAAGCCCAG 
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resuspended in keratinocyte SFM containing 10 μmol L−1 Hoechst 33342. Cells were 
kept on ice before sorting with a BD FACS Aria cell sorter (BD Biosciences, San Jose, 
CA, USA). Cells in G1 phase were used in gene expression assays. 
4.3.4 Hypoxia treatment 
CP-A cells at 80% confluency were incubated in keratinocyte SFM cell-growth 
medium containing 2% (v/v) Oxyrase (Oxyrase, Mansfield, OH, USA) at 37 °C for up to 
30 min (see below). Cells were subsequently trypsinized in 0.05% (v/v) trypsin solution 
containing 2% (v/v) Oxyrase at 37 °C for 9 min. The trypsinization was blocked by 
Dulbecco’s modified Eagle medium (DMEM) (Invitrogen) supplemented with 5% fetal 
bovine serum (FBS) (Invitrogen) containing 2% (v/v) Oxyrase. The oxygen concentration 
was determined by use of an optical sensor (Tian, Shumway et al. 2010) calibrated with a 
Clark electrode. To determine the optimum Oxyrase treatment time, the expression levels 
of selected genes in bulk cells exposed to hypoxia for 10, 20, 30, 60, 180, and 360 min 
were measured. 
4.3.5 Single cell collection 
Single cells were collected using a pick-and-place single-cell manipulation 
robot (Anis, Holl et al. 2010). Single cells were aspirated and dispensed using a 40-μm 
diameter glass capillary micropipette under closed-loop microscopic vision-based 
feedback. After a selected cell was aligned with the micropipette orifice, the cell was 
aspirated by applying a negative pressure to the micropipette capillary, generating a drag 
force on the cell and pulling it into the capillary. The micropipette tip containing an 
aspirated cell was directed into the cap of a 1.5-mL microcentrifuge tube (VWR, West 
Chester, PA, USA) containing 200 μL keratinocyte SFM. The cell was dispensed by 
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applying a positive pressure to the micropipette capillary, generating an ejection force on 
the cell. Fluidic aspiration and dispensing of the cells were accomplished with minimal 
shear force on the cells so as to not cause physical damage to the cell. A total of 36 
hypoxia-treated single cells and 36 control single cells were collected and analyzed. 
4.3.6 RNA isolation and reverse transcription 
Each single cell in the cap of a 1.5-mL microcentrifuge tube was centrifuged at 
4 °C and 17,000 g for 20 min. Medium (160 μL) was taken out and 200 μL RNA lysis 
buffer from the ZR RNA MicroPrep Kit (Zymo Research, Orange, CA, USA) was added 
into the tube. The RNA extraction step was carried out using the ZR RNA MicroPrep Kit 
following the manufacturer’s instructions. A total volume of 6 μL RNA was eluted from 
the column matrix and immediately used in reverse transcription reactions. A total 
volume of 10 μL cDNA synthesis reaction mixture contained the reagents: 2 μL of 5 × 
VILO Reaction Mix (Invitrogen), 1 μL of 10 × SuperScript Enzyme Mix, including 
SuperScript III RT, RNaseOUT Recombinant Ribonuclease Inhibitor, and a proprietary 
“helper” protein (Invitrogen), 6 μL of total RNA from a single cell, and 1 μL of DEPC-
treated water (Ambion, Austin, TX, USA). The tube contents were gently mixed and then 
cDNA synthesis was performed at 25 °C for 10 min, 42 °C for 60 min, followed by 85 °C 
for 5 min to inactivate the reverse-transcriptase. The cDNA obtained was stored at 
−20 °C until further use. 
4.3.7 qPCR 
The Express SYBR GreenER qPCR SuperMix Kit (Invitrogen) was used for 
qPCR analysis. Each qPCR reaction for method development, primer testing, and 
optimization, and the hypoxia response experiment was performed using 5% (1/20th) of 
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the cDNA obtained from a single cell. Reactions were conducted in 0.1-mL MicroAmp 
Fast 8-Tube Strips (Applied Biosystems, Foster City, CA, USA). Hypoxia treatment 
expression assays were conducted in adhesive-sealed, clear 384-well PCR plates 
(BioExpress, Kaysville, UT, USA). DEPC-treated water (30 μL) was added to 10 μL of 
cDNA solution obtained from the reverse transcription step. The total reaction volume 
was 10 μL and comprised the reagents: 5 μL of Express SYBR GreenER qPCR 
SuperMix Universal, 1 μL of each primer (4 μmol L−1), 0.1 μL of ROX reference dye 
(25 μmol L−1), 2 μL of cDNA solution (1/20th of a total of 40 μL cDNA solution obtained 
from a single cell) and 0.9 μL of DEPC-treated water (Ambion). In negative control 
reactions, the 2 μL of cDNA solution was replaced with DEPC-treated water. The 
thermal cycling profile was set up as follows: one cycle at 95 °C for 10 min; 40 cycles at 
95 °C for 15 s, 60 °C for 1 min, and 80 °C for 10 s with signal detection; melt-curve 
analysis at 60 °C for 1 min and the temperature increased in 0.3 °C increments to 95 °C, 
then at 95 °C for 15 s. The method development experiments were run in a StepOne Real 
Time PCR System (Applied Biosystems). The gene expression profiling of hypoxia-
treated cells was run in an Applied Biosystems 7900 Real-Time PCR System. 
In order to push the limit on the number of genes whose expression levels could 
be quantified from a single mammalian cell, qPCR reactions were run on 1/45th of the 
cDNA obtained from individual cells. DEPC-treated water (80 μL) was added to the 
10 μL of cDNA obtained from the reverse transcription step. Each reaction was 
conducted in a 0.1-mL PCR tube (Applied Biosystems). The reaction was set up in a total 
volume of 10 μL and contained the reagents: 5 μL of Express SYBR GreenER qPCR 
SuperMix Universal, 1 μL of each primer (4 μmol L−1), 0.1 μL ROX reference dye 
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(25 μmol L−1), 0.1 μL of Taq DNA Polymerase (5 U μL−1; Fermentas, Glen Burnie, MD, 
USA), 2 μL of cDNA solution (1/45th of a total 90 μL of cDNA solution obtained from a 
single cell), and 1.8 μL of DEPC-treated water. The thermal cycling profile was: 1 cycle 
at 95 °C for 10 min; 50 cycles at 95 °C for 15 s, 60 °C for 1 min, and 80 °C for 10 s with 
signal detection; melt-curve analysis at 60 °C for 1 min and the temperature increased in 
0.3 °C increments to 95 °C then at 95 °C for 15 s. These experiments were run in a 
StepOne Real Time PCR System (Applied Biosystems). Data analysis was carried out 




4.4 Results and discussion 
4.4.1 Two-step RT-qPCR analysis of single mammalian cells 
A procedure was developed for quantifying the expression levels of multiple 
genes in a single mammalian cell using SYBR green-based qPCR. The procedure 
comprises six steps: 
1. fluorescence-activated cell sorting to obtain cells in a particular phase of the 
cell cycle, e.g. G1; 
2. single-cell collection; 
3. RNA extraction; 
4. reverse transcription; 
5. qPCR; 
6. data analysis. 
Adapting technology for RNA isolation and reverse transcription from single 
bacterial cells (Gao, Zhang et al. 2011), a new procedure was conceived, developed, and 
optimized for the isolation, purification, and reverse transcription of the total RNA from a 
single mammalian cell. The ZR RNA MicroPrep kit (Zymo Research) was used, followed 
by cDNA synthesis using the SuperScript VILO cDNA Synthesis Kit (Invitrogen). 
Because of picogram levels of available cDNA templates for qPCR in single-cell 
experiments, the probability of primer dimer formation increases. In this case, 
fluorescence signal originating from double-stranded primer dimers confounds 
quantification of the target gene amplification product. To eliminate such interference, 
primer pairs whose amplification product lengths are between 100 bp and 700 bp were 
designed. Therefore, amplification products can be distinguished from primer dimers, 
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which are typically less than 100 bp, in both melt-curve analysis and agarose gel 
electrophoresis. Also, the qPCR thermal cycling program was modified to enable a 
signal-detection step (80 °C for 10 s) after the annealing/amplification step (60 °C for 
1 min). The melting temperatures of primer dimers are usually less than 75 °C, whereas 
those of the target gene amplification products are more than 80 °C. Thus, when the 
fluorescence signal is detected at 80 °C, only the target gene amplification products will 
remain intact and the double-stranded primer dimers will dissociate. A total volume of 
10 μL SYBR GreenER qPCR reagent kit was used for each qPCR reaction (as described 
in Section 4.3.7 qPCR). The total amount of cDNA obtained from a single CP-A cell was 
divided into twenty equal portions and each portion was used for one qPCR reaction. 
Three technical replicates were run for each pair of primers to assess the sample-handling 
error. cDNA obtained from a bulk cell sample was diluted to a level corresponding to the 
amount of cDNA from 10 cells and used as the positive control. One negative control 
reaction was run for each pair of primers, in which cDNA was replaced with DEPC-
treated water. Experiments were conducted in a StepOne Real Time PCR System 
(Applied Biosystems). After qPCR, the contents of each PCR reaction were subjected to 
agarose gel electrophoresis and sequence analysis. 
For method-validation purposes, qPCR analyses were conducted of highly 
expressed genes (18S rRNA, 28S rRNA, ACTB, and GAPDH genes) in single cells. To 
increase primer binding specificity, several iterations of primer optimization were 
conducted. So far, 13 pairs of primers targeting 13 different genes (Table 6) have been 
validated. Specifically, 28S rRNA is a reliable internal control for comparative 
transcription analyses under hypoxic conditions (Zhong and Simons 1999). Therefore, 
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28S rRNA was used as an internal reference for comparing gene expression levels within 
one cell and among multiple single cells. The choice of Hsp70 and Hsc70 genes is based 
on the fact that Hsp70 expression levels change significantly in response to stress 
whereas Hsc70 is a constitutively expressed cognate gene whose levels remain constant. 
Thus, Hsc70 can be used as a reference gene (Mayer and Bukau 2005) for Hsp70. HIF1α 
(Zhong, Agani et al. 1998), VEGFA (Yoshiji, Gomez et al. 1996), PRKAA1 (Mu, 
Brozinick et al. 2001), p300 (Arany, Huang et al. 1996), MT3 (Wang, Wood et al. 2008), 
Angptl4 (Murata, Yudo et al. 2009), and PTGES (Lee, Natsuizaka et al. 2010) were 
chosen because of their roles in hypoxia response-signaling pathways.  
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Figure 4-1 Amplification plots of gene transcripts using validated primers 
1/20th of the total cDNA obtained from a single CP-A cell was used for each 
qPCR reaction shown. This includes three technical replicates and the no-
template controls (NTC). Each panel shows real-time amplification signal 
curves obtained from a single cell. 
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Using these primers, the expression levels of genes of interest were quantified by 
RT-qPCR using 1/20th of the cDNA obtained from a single CP-A cell. Representative 
amplification plots for the 13 genes are shown in Figure 4-1. The Cq ratio of 28S rRNA to 
18S rRNA has been found to be typically approximately 1 in mammalian cells (Fleige and 
Pfaffl 2006). The results here showed that the Cq values for 28S rRNA and 18S rRNA are 
19.73 and 20.71, respectively, indicating that the method yields intact mRNA and is 
reproducible and quantitative. The Cq values of 28S and 18S rRNAs are approximately 
10 cycles lower than those of ACTB and GAPDH mRNAs. This is consistent with the 
fact that rRNA concentrations are 100 to 1000 times higher than mRNAs in cells, as 
found in bulk cell studies. Reactions with Cq values lower than 37 and standard 
deviations of technical replicates smaller than 1% were regarded as successful. In most 
reactions, no-template negative controls (NTC) were not detected (Figure 4-1). In some 
reactions residual NTC signals, most likely emanating from primer dimers, were detected 
at cycle numbers significantly higher than the product (at least 3 or 4 cycle difference). 
The spurious NTC signals were clearly distinguishable from those of the amplification 
products (cDNA) because of distinctly higher Cq values (Figure 4-1) and different 
melting peak temperatures (Figure 4-2). The amplification products from the reactions 
containing cDNA showed clear bands of the correct sizes in agarose gel electrophoresis 
(data not shown). The gel bands containing products of the right size were cut, and the 
product was purified for sequencing. Sequences were confirmed using BLAST 





Figure 4-2 Melt curves of gene transcripts using validated primers 
Each panel represents derivative reporter values of real-time fluorescence 
signals in melt curve analysis. 
 104 
4.4.2 Detection of up to ten genes from a single mammalian cell 
A method was developed which uses SYBR green-based RT-qPCR for detecting 
expression levels of up to ten different genes (18S rRNA, 28S rRNA, ACTB, Angptl4, 
GAPDH, HIF1A, HSC70, MT3, PTGES, and VEGFA) in a single CP-A cell. These genes 
span a broad range of copy numbers in cells. A population of CP-A cells was exposed to 
hypoxia, and randomly selected, single cells were collected by use of a single-cell 
manipulation workstation. After RNA extraction and reverse transcription, cDNA 
template obtained from a single CP-A cell was divided into 45 equal portions of 2-μL 
volume each. This dilution enabled up to 45 qPCR reactions to be performed on the 
cDNA obtained from a single cell, enabling triplicate analyses of multiple genes from the 
same cell. Each portion of the template was added to an SYBR GreenER qPCR reagent 
mixture, resulting in a total reaction volume of 10 μL. For each gene one RT-qPCR NTC 
was run in parallel. To increase the amplification level, 0.1 μL of Taq DNA Polymerase 
(Fermentas) was added to each reaction mixture. As in the previous experiments, 
reactions for each of the genes were run in triplicate. To achieve sufficient amplification 
levels of low-abundance transcripts, the thermal cycling profile was modified by 
extending the amplification cycle number to 50. The reactions were run utilizing the 
StepOne Real Time PCR instrument. 
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Using this method, the transcription levels of up to ten genes with Cq values lower 
than 50 can be simultaneously quantified (Figure 4-3). The standard deviations of the 
qPCR Cq value of eight genes (18S rRNA, 28S rRNA, ACTB, GAPDH, Angptl4, MT3, 
PTGES and HSC70) were less than 1 (3%) among the technical replicates (Figure 4-3).  
Figure 4-3 Quantification of expression levels of ten genes in a single, 
hypoxia-treated CP-A cell 
1/45th of the total cDNA obtained from a single CP-A cell was used for each 
qPCR reaction. Each box includes quantification cycle (Cq) values from three 
technical replicates for one gene. Average Cq values and standard deviations 
among three technical replicates are summarized in the table. 
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As expected, larger variations between the technical replicates was observed for 
low-abundance transcripts, for example HIF1A and VEGFA (3.4 (7%) and 1.3 (4%), 
respectively). It is most likely that this is because of picogram levels of available cDNA 
templates, which makes the amplification events at the beginning less probable and 
introduces more noise in Cq values. No amplification signal was detected for the NTC 
reactions of HIF1A, VEGFA, and HSC70, and for NTC reactions of 18S rRNA, 28S rRNA, 
Figure 4-4 Gel electrophoresis analysis of RT-qPCR amplification products 
of 10 genes from a single CP-A cell 
2.5 µL of the qPCR products were loaded on a 2% agarose gel. The bands in 
the frame indicate the correct amplification product. In several cases the 
correctness of the PCR products was confirmed by sequencing the contents 
of the corresponding bands. 
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ACTB, GAPDH, Angptl4, MT3, and PTGES amplification signals were observed after a 
large number of cycles. However, the melting temperatures (Tm value) were 0.4–10.3 °C 
different from the Tm values of the corresponding products in cDNA sample reactions. 
Therefore, amplification products resulting from unavoidable minute contamination 
and/or random, non-specific amplification can be identified by their 
characteristic Tm values. Both length and sequence of the amplification products were 
confirmed by agarose gel electrophoresis (Figure 4-4) and sequencing. 
The Cq values for 28S and 18S rRNAs are approximately 10 cycles lower than 
those of the housekeeping genes ACTB and GAPDH (100–1000 times higher in copy 
number), and 7–17 cycles lower than those of the genes of interest (100–100,000 times 
higher in copy number). 
4.4.3 Gene expression under hypoxia 
One of the research objectives was to understand epithelial cells’ responses to 
hypoxic stress. To address the role of intercellular gene expression heterogeneity under 
different physiological conditions, gene expression levels in CP-A cells in response to 
hypoxia were studied. Oxyrase, an oxygen-scavenging enzyme system, was used to 
produce hypoxic conditions in cell growth medium. Oxygen concentration in the cell 
medium was reduced to <0.01 ppm within 20 min after Oxyrase addition (Figure 4-5).  
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To determine the time course of changes in gene expression, bulk cell samples 
(~104 cells per sample) were analyzed at 0, 10, 30, 60, 180, and 360 min after adding 
Oxyrase to the cell medium, and the expression levels were measured of six genes 
(Angptl4, PTGES, MT3, PRKAA1, VEGFA, and GAPDH) known to be involved in 
hypoxia response, using 28S rRNA as the internal control. A 1:1000 dilution of the total 
synthesized cDNA was used for RT-qPCR. The results showed that mRNA levels of 
Angptl4, PRKKA1, and MT3 increased and that of GAPDH decreased in response to the 
Oxyrase treatment, whereas mRNA levels of VEGFA and PTGES were not significantly 
affected (Figure 4-6). 
Figure 4-5 Oxygen depletion in the cell medium 
Time course of the oxygen concentration in the cultivation medium before 
and after addition of 2.0% (v/v) Oxyrase. Arrows indicate the time points of 
gene expression profiling experiments. Oxyrase was added at time zero. 
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The absence of significant changes in the expression levels of VEGFA and 
PTGES genes in bulk cell samples may be cell type-specific or a result of the relatively 



































































































Figure 4-6 qPCR results of long time Oxyrase treatment 
Bulk CP-A cell samples were used to determine the treatment time when the 
largest changes in gene expression levels occur. Expression levels of seven 
genes, 28s rRNA, MT3, VEGFA, PRKAA1, Angptl4, PTEGS, and GAPDH, 
were measured using qPCR at bulk cell levels as a function of time at 0, 10, 
30, 60, 180, and 360 minutes after addition of Oxyrase. The gene expression 
levels were indicated as fold-changes normalized against 28s rRNA. The 
fold-changes of gene expression were calculated as 2-Δ(ΔCq), where ΔCq = 
Cq, target - Cq, 28s, and Δ(ΔCq) = Cq, stimulated - ΔCq, control. 
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sensitive to hypoxia, with 3 and 7-fold increases in expression level after 10 and 30 min 
treatments, respectively. At least twofold increases in transcription levels were observed 
for two other hypoxia-response genes, Angptl4 and VEGFA, in response to 30-min 
Oxyrase treatment. On the basis of the higher expression observed in bulk cell 
experiments after 30 min treatment with Oxyrase, this treatment time was chosen for 
single-cell analysis. 
A total of 72 single CP-A cells were collected, 36 grown under normal 
physiological conditions (controls) and 36 exposed to hypoxia for 30 min, the expression 
levels of seven selected genes in each cell were measured. To limit cell-to-cell variability 
that may result from differences in cell cycle phase, cells in G1 phase sorted by means of 
fluorescence-activated cell sorting were used. In addition to six genes (PTGES (Lee, 
Natsuizaka et al. 2010), Angptl4 (Cazes, Galaup et al. 2006, Galaup, Cazes et al. 2006, 
Gentil, Le Jan et al. 2006, Gustavsson, Mallard et al. 2007, Murata, Yudo et al. 2009), 
MT3 (Wang, Wood et al. 2008), GAPDH (Liu, Cox et al. 1995, Iyer, Kotch et al. 1998, 
Foldager, Munir et al. 2009), PRKAA1 (Mu, Brozinick et al. 2001), and VEGFA (Liu, 
Cox et al. 1995, Yoshiji, Gomez et al. 1996, Hu, Fan et al. 2009)) known to be involved 
in the hypoxia response signaling pathway in various bulk cell-based studies,  the highly-
expressed 28S rRNA was included as the reference gene. The number of cells with all 
seven target genes detected was higher in hypoxia-treated cells. For example, PTGES 
transcripts were detected in all 36 hypoxia-treated cells and in 27 control cells (Figure 
4-7A). This can be attributed to higher mRNA copy numbers of these genes in cells 
exposed to hypoxia than in control cells. The 28S rRNA gene was detected in all 72 cells, 
with small cell-to-cell variations (standard deviations of C q < ±0.5). 
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The differences between ΔCq values (ΔCq = Cq, target gene − Cq, 28s (Golding, 
Paulsson et al. 2005)) of the target genes as measured under normoxic and hypoxic 
Figure 4-7 Single-cell gene-expression profiling in control and hypoxia-
treated CP-A cells 
(A) Histograms of gene expression levels in control (green bars) and 
hypoxia-treated (30 min, hatched bars) single CP-A cells in G1. (B) Box 
plots of single-cell gene-expression levels and p-values associated with 
differences between in untreated controls and hypoxia-treated CP-A cells. 
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conditions were highly variable among cells, indicating significant cell-to-cell 
heterogeneity in the cell population. Distribution histograms of gene expression levels in 
control and hypoxia-treated CP-A cells indicate significant cell-to-cell heterogeneity in 
all six studied genes (Figure 4-7A). PTGES and Angptl4 genes showed the largest 
differences in ΔCq values between control and hypoxia-treated cells. The ΔCq values for 
these genes were lower in the treated cells, indicating up-regulation of PTGES and 
Angptl4 in response to hypoxia. Statistical analysis of gene expression levels in hypoxia-
treated vs. control single cells confirmed a significant reduction of ΔCq values for PTGES 
(p < 0.0005) and Angptl4 (p < 0.005) genes, whereas changes in ΔCq for the other four 
genes were not statistically significant (Figure 4-7B). In some early bulk cell studies, 
expression levels of several of the target genes used in this study, for example the MT3 
gene encoding a metal-binding protein metallothionein 3 and the PTGES gene encoding a 
prostaglandin E synthase, were dramatically increased under hypoxia (Wang, Wood et al. 
2008). The hypoxia treatment times used in the studies were 24 h (Lee, Natsuizaka et al. 
2010), much longer than those used in this study (0.5 h) and, therefore, the findings are 
not directly comparable. 
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Interestingly, it was found that the gene-expression patterns obtained from bulk-
cell (Figure 4-8) and single-cell samples (Figure 4-7) differed in terms of response to 
hypoxia. Only two genes, Angptl4 and VEGFA, showed the same trend in both bulk and 
single-cell analyses: Angptl4 was up-regulated and VEGFA did not change significantly 
in response to hypoxia treatment. Whereas no significant changes at the single-cell level 
Figure 4-8 Gene expression levels of bulk cell samples under normoxic and 
hypoxic conditions 
Results from three different experiments are shown. Green bars represent 
control cells that were not exposed to hypoxia. Light blue bars and red 
bars depict gene expression levels from cells exposed to hypoxia for 10 and 
30 min, respectively. The changes of gene expression were calculated as 
2−Δ(ΔCq ) , where ΔCq = Cq, target − Cq, 28s, and Δ(ΔCq) = ΔCq, stimulated − ΔCq, 
control. Asterisks indicate statistical significance at p < 0.05 on the basis of 
ANOVA t-test analysis. 
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were observed for MT3 and PTGES, both genes were significantly up-regulated in bulk-
cell samples, consistent with other bulk-cell studies (Arany, Huang et al. 1996, Lee, 
Natsuizaka et al. 2010). GAPDH was not significantly changed in single cells but 
significantly down-regulated in bulk cells whereas PTGES was significantly up-regulated 
in single cells whereas no significant change was observed in bulk cells. Recent studies 
on mRNA levels in individual cells suggest that cell-to-cell alterations in gene expression 
levels seem to be a result of variations at the bulk mRNA stability and/or translational 
level (Golding, Paulsson et al. 2005, Siegal-Gaskins and Crosson 2008, Le and Cheng 
2009, Valencia-Burton, Shah et al. 2009, Lidstrom and Konopka 2010). A recent study 
showed that single-cell gene expression has a log-normal distribution, reflecting true 
biological variability (Stahlberg and Bengtsson 2010). This finding indicates that average 
gene expression levels quantified in a population of cells may be substantially different 
from expression levels measured in individual cells from the same population (Bengtsson, 
Hemberg et al. 2008). This result also emphasizes the importance of developing and 
applying microfluidics-based instrumentation for high-throughput single-cell gene 




In summary, a qPCR-based method was developed and applied for single-cell 
gene expression analysis, enabling measurement of multiple gene targets in a single 
mammalian cell. The method is based on separate RNA isolation, cDNA synthesis, and 
qPCR steps. Using this method, gene transcription levels were quantified in control and 
hypoxia-treated cells at both bulk and single-cell levels. The results show that 
quantitative analysis of gene expression of multiple genes can be achieved in single cells 
with good reproducibility and specificity. In addition, significant gene-expression 
heterogeneity was observed among the sorted cell population. 
The procedure can be further improved by performing absolute mRNA abundance 
determination in single cells, using a gene sequence cloned into a plasmid as a reference 
to calculate absolute mRNA copy numbers. ACTB mRNA transcribed in vitro using T7 
RNA Polymerase can be used to validate the efficiency and reliability of the reverse 
transcription step of the procedure. Given the compatibility of this method with most 
commercially available RT-qPCR instrumentation and its relatively low cost, it should be 
amenable to many applications focused on gene expression analysis in single cells, for 
example high-throughput, chip-based techniques (Kelly and Woolley 2005), which will 
provide further insights into the cellular mechanisms involved in physiological and 
pathological processes at the single-cell level. 
  
 116 
4.6 Acknowledgments  
This work was supported by a grant from the NIH National Human Genome 
Research Institute, Centers of Excellence in Genomic Sciences (Grant Number 5 P50 
HG002360 to Deirdre Meldrum). I thank Patti Senechal-Willis for the assistance with cell 
culture. I thank Tong Fu for help with fluorescence-activated cell sorting. 
 117 
CHAPTER 5  
WHOLE TRANSCRIPTOME AND METABOLIC PROFILING OF 
INTERCELLULAR INTERACTIONS BETWEEN NORMAL AND PRE-
MALIGNANT ESOPHAGEAL CELLS  
5.1 Abstract  
Intercellular communications are critical to the growth and function of 
multicellular organisms. The interplay between aberrant cells and their microenvironment 
can drive pathogenesis and progression of many diseases including cancer. Solid tumors 
are organ-like structures with complex and dynamic interactions among different clones. 
Understanding the role of cell-cell communications in the tumor microenvironment could 
lead to new cancer biosignatures and more effective prognostic, diagnostic and 
management strategies of the disease.  This study is about the effects of intercellular 
interactions between normal and late-dysplastic Barrett’s esophagus cells on gene 
transcription levels and metabolic functions. It was investigated how homotypic and 
heterotypic intercellular interactions affect gene expression changes using next-
generation sequencing. Analysis of next-generation sequencing results identified 
differentially expressed genes. These genes were enriched in cellular movement and other 
cancer-related pathways. Heterotypic interactions suppressed downstream genes of TGFβ 
and EGF pathways in late-dysplastic cells, compared with homotypic interactions. Gene 
transcription changes were correlated with cellular proliferation and motility phenotypes 




Cell-cell interactions are essential for growth and function of multicellular 
organisms. Aberrant intercellular communication plays a key role in carcinogenesis and 
tumor progression. More and more evidence has shown that a tumor is not merely a 
collection of homogenous cancer cells undergoing transformation by themselves 
(Hanahan and Weinberg 2011). Tumor genesis and progression is an ecological process 
involving dynamic interplays between malignant and non-malignant cells (Barcellos-Hoff, 
Lyden et al. 2013). Tumor cells are affected by reciprocal interaction between the 
parenchymal and stromal cells in two ways: physically through direct contact or 
intervening extracellular matrix, or biologically through soluble ligands. The 
communication and signaling create a context that promotes tumor growth and helps it 
acquire hallmark traits of cancer (Hanahan and Weinberg 2011).  
Esophageal adenocarcinoma is a highly lethal cancer type (Spechler 2013). It 
arises from metaplasia and dysplasia of the esophageal epithelium (Barrett's esophagus) 
(Shaheen, Crosby et al. 2000). Recent studies and clinical practices have identified and 
used dysplasia and genomic markers for predicting the risk of developing 
adenocarcinoma (Jin, Cheng et al. 2009). However, how the transformation of 
metaplasia-dysplasia-adenocarcinoma occurs still remains to be clarified. 
Neoplastic cells in Barrett’s esophagus collect genetic and epigenetic alterations 
as they undergo evolution by natural selection. This process is influenced by their 
surrounding cells and other factors in the environment. Acid and bile luminal refluxate 
can induce double-stranded DNA breaks or promote oxidative DNA damage (Clemons, 
McColl et al. 2007). Inflammatory cell infiltrate can generate reactive oxygen species 
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(Naya, Pereboom et al. 1997), which might contribute to DNA damage in neoplastic cells. 
Reactive oxygen species might induce growth factors, survival factors or Fas ligand 
secretions (Younes, Schwartz et al. 1999). Inflammatory cell infiltrate can also produce 
cytokines, such as transforming growth factor β (TGFβ), interleukin one β (IL-1β), 
interferon γ (IFNγ), IL-6 (Zhang, Zhang et al. 2011) and tumor necrosis factor α (TNFα) 
(Tselepis, Perry et al. 2002). In the stromal compartment of Barrett’s esophagus, gene 
expression profiles are distinctive among different stages of progression (Lao-Sirieix and 
Fitzgerald 2010). Thrombospondin-1 (TSP1) is overexpressed in stroma from Barrett’s 
esophagus biopsy samples. TSP1 can activate TGFβ, which either controls proliferation 
or promotes epithelial-mesenchymal transition in Barrett’s esophagus and esophageal 
adenocarcinoma (Rees, Onwuegbusi et al. 2006). Furthermore, co-culture of squamous 
carcinoma and Barrett’s carcinoma cells produces more pro-inflammatory cytokines 
compared with cells cultured individually (Fitzgerald, Abdalla et al. 2002). The current 
results suggest that cell-cell interactions in the tumor microenvironment can change 
epithelial cell behavior in Barrett’s esophagus. More systematic research is required to 
elucidate the molecular components contributing to esophageal adenocarcinoma 
development and enhance understanding of this dynamic process. 
Presented here is a study on gene expression and metabolic phenotype profiling of 
heterotypic cell-cell interactions between normal and late-dysplastic Barrett’s esophagus 
cells. It investigated how homotypic and heterotypic intercellular interactions affect gene 
expression changes using next-generation sequencing. Using gene ontology and pathway 
enrichment analysis, a set of genes related to cellular movement and other cancer-related 
pathways is identified. Heterotypic interactions suppressed downstream genes of TGF-β 
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and EGF pathways in late-dysplastic cells. It was also found that heterotypic interactions 
between normal and dysplastic cells inhibited cellular proliferation and changed motility 
in both dysplastic and normal cells. Normal cells are found to inhibit the growth of 
dysplastic cells via TGF-β mediated growth factor pathways. The fractions of normal to 
dysplastic cells can be used as risk stratification markers for Barrett’s esophagus and 
esophageal adeonocarcinoma. TGF-β, EGF and their downstream genes can become 
potential biosignatures for early diagnosis, early detection and risk prediction in pre-




5.3.1 Cell lines  
One normal cell line, EPC-2 (Harada, Nakagawa et al. 2003), and one cell line 
derived from an esophageal region of high-grade dysplasia in Barrett’s esophagus, CP-D 
(Palanca-Wessels, Barrett et al. 1998), were used for cell-cell interaction studies. Cells 
were cultured using Gibco keratinocyte serum-free cell growth medium (Invitrogen, 
Carlsbad, CA, USA), supplemented with hEGF (Peprotech, Rocky Hill, NJ, USA) at 2.5 
μg/500 mL, BPE (bovine pituitary extract) at 25 mg/500 mL and penicillin–streptomycin 
solution (Invitrogen, Carlsbad, CA, USA) at 100 units/100 μg/mL. Cells were grown at 
37 °C in a humidified atmosphere containing 5% CO2.  
CP-D and EPC-2 cell lines were tagged with TurboGFP and TagFP635, 
respectively, to distinguish different cell types using fluorescence microscopy and 
fluorescence activated cell sorting. For lentiviral infection of both cell lines, 1.3 x 104 
CP-D cells and 1.6 x 104 EPC-2 cells were seeded into individual wells of a Costar® 96-
well-plate (Corning, Corning Life Sciences, Corning, NY, USA) containing 100 μL of 
Gibco Keratinocyte serum-free medium. After 24 hours of incubation, the cell culture 
reached about 80% confluency. 100 μL of Keratinocyte serum-free medium containing 8 
mg/mL of hexadimethrine bromide was added to each well. Lentiviral MISSION® 
pLKO.1-puro-UbC-TurboGFP™ Positive Control Transduction Particles (Sigma-Aldrich, 
St Louis, MO, USA), containing a gene encoding TurboGFP under the control of the 
UbC promoter, were added to the well of CP-D cells at a multiplicity of infection of 2. 
Lentiviral MISSION® pLKO.1-puro-UbC-TagFP635™ Positive Control Transduction 
Particles (Sigma-Aldrich, St Louis, MO, USA), containing a gene encoding TagFP635 
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under the control of the UbC promoter, were added to the well of EPC-2 cells at a 
multiplicity of infection of 2 as well. The plate was gently stirred and centrifuged at 1000 
rpm, 37° C for 30 minutes. After 18-20 hours, the medium containing lentiviral particles 
was replaced with 120 μL of Keratinocyte serum-free medium in each well. Four days 
after infection, the cells were imaged using a Nikon C1si (Nikon Inc., Melville, NY, USA) 
confocal microscope to inspect the expression of cytosolic TurboGFP in CP-D cells and 
TagFP635 in EPC-2 cells.  
After the culture was expanded into 75 cm2 flasks (Corning, Corning, NY), a 
puromycin kill curve experiment was performed to determine the minimum concentration 
of puromycin to cause 0% viability ration in puromycin treated cells. 1.0 μg/mL and 0.5 
μg/mL of puromycin were found to effectively kill the CP-D and EPC-2 cells, 
respectively, in which TurboGFP or TagFP635 was not successfully expressed after 96 
hours. CP-D and EPC-2 cells were grown in keratinocyte serum-free medium containing 
puromycin (1.0 μg/mL for CP-D cells and 0.5 μg/mL for EPC-2 cells) for five passages, 
and then grown in normal keratinocyte serum-free medium. The expression of cytosolic 
TurboGFP or TagFP635 was retained in CP-D and EPC-2 cells, respectively, when 
checked under a Nikon C1si confocal microscope. 
5.3.2 Fluorescence assisted cell sorting of co-culture and mono-culture of normal 
and neoplastic cells 
For CP-D and EPC-2 mono-cultures, 2 × 106 cells of each type were seeded into a 
75 cm2 flask. For CP-D and EPC-2 cells co-culture, 1 × 106 CP-D and 1 × 106 EPC-2 
cells suspension were mixed and seeded into a 75 cm2 flask. After 24 hours, cells were 
treated with 0.05% (v/v) trypsin–EDTA (Invitrogen, Carlsbad, CA, USA). The 
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trypsinization was blocked by Dulbecco’s modified Eagle medium (DMEM) (Invitrogen, 
Carlsbad, CA, USA) supplemented with 5% fetal bovine serum (FBS) (Invitrogen, 
Carlsbad, CA, USA). After trypsinization, cells were centrifuged at 900 rpm for 3 min 
then re-suspended in 300 µL of PBS (Gibco, Carlsbad, CA, USA) and kept on ice. CP-D 
and EPC-2 cells were sorted out from co-culture on a BD FACS Aria (BD Biosciences, 
San Jose, CA, USA), using a 488 nm laser to excite TurboGFP in CP-D cells and FP635 
in EPC-2 cells. Manual compensation was performed to correct for spectral cross-over of 
fluorescent proteins. Mono-cultured CP-D and EPC-2 cells were also sorted using the 
same TurboGFP or FP635 gates and regions.  
5.3.3 RNA extraction 
Total RNA was extracted from the sorted cells using RNeasy mini kit (Qiagen, 
Valencia, CA, USA) according to the manufacturer’s protocol. The silica-gel membrane 
and the spin-column technology removed the majority of the DNA. After proprietary 
buffer RW1 treatment, residual DNA in the RNA samples was digested on the column 
using RNase-free DNase set (Qiagen, Valencia, CA, USA) for 15 min at 20–30°C to 
remove DNA more completely. The RNase-free DNase set consists of 10 μL of DNase 1 
stock solution in 70 μL of proprietary buffer RDD. RNA was eluted by adding 30 μL of 
RNase-free water into the silica-gel membrane and stored at -80°C. 
5.3.4 Whole transcriptome amplification 
The quantity and purity of RNA obtained from FACS sorted cells was measured 
using spectrophotometry on a Nanodrop instrument (Agilent Technologies, Santa Clara, 
CA, USA). The concentration of RNA was adjusted to 10 ng/μL. 50 ng of RNA was 
amplified using Nugen Ovation RNA-Seq V2 kits (Nugen Technologies, San Carlos, CA, 
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USA) per manufacturers’ instruction on an Apollo 324 Library Preparation System 
(IntegenX, Pleasanton, CA, USA). Briefly, the RNA was reverse transcribed to the first-
strand cDNA by using a combination of random hexamers and poly-T oligomer. The 
RNA template was fragmented by RNA-dependent DNA polymerase and double-
stranded DNA was generated by the same polymerase. The dsDNA was amplified 
linearly using a single primer isothermal amplification (SPIA) process:  RNase H 
degraded RNA in RNA in the DNA/RNA heteroduplex; the SPIA primer bound to the 
cDNA; the polymerase synthesized new cDNA strand replacing the RNA; random 
hexamers amplified the second-strand cDNA linearly. This technology covered non-
coding RNA and non-polyadenylated RNA besides mRNA and reduced the conversion of 
ribosomal RNA to cDNA (Kurn, Chen et al. 2005). 
Amplified DNA was measured by a Nanodrop instrument for quality control 
purposes. cDNA was sheared to about 250 bp using a Covaris S2 instrument (Covaris, 
Woburn, MA, USA) and checked again using a Nanodrop instrument. 
5.3.5 Library preparation and Illumina sequencing 
Illumina sequencing libraries were prepared on an Apollo 324 Library Preparation 
System using the PrepX™ ILM DNA Library Preparation kit (IntegenX, Pleasanton, CA, 
USA) with four different barcoded adapters for multiplexing. The adapter-ligated 
libraries were amplified by 10 cycles of PCR using a KAPA HiFi Library Amplification 
Kit (Kapa Biosystems, Woburn, MA, USA). PCR amplified libraries were qualified using 
high sensitivity DNA assay on an Agilent Bioanalyzer 2100 (Agilent Technologies, Santa 
Clara, CA, USA) and quantified using a KAPA Library Quantification Kit - 
Illumina/Universal (Kapa Biosystems, Woburn, MA, USA). 
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Clusters were generated using the cBot platform (Illumina, San Diego, CA, USA). 
Four samples were multiplexed per lane with two lane replicates. Single-end sequencing 
with 50 base reads was performed on an Illumina HiSeq 2000 (Illumina, San Diego, CA, 
USA) following the manufacturer’s guidelines. 
5.3.6 Next-generation sequencing alignment 
The sequenced reads were parsed based on the index to allow analysis of the data 
on the individual sample basis. Raw reads were analyzed using the GeneSifter® Analysis 
Edition pipeline (PerkinElmer, Inc., Seattle, WA, USA), a cloud-based software 
architecture. After quality assessment, raw reads were aligned to the Homo sapiens 
genome reference build 37.2 (GRCh37.p2) using Burrows-Wheeler Aligner (Li and 
Durbin 2009) with Genome Analysis Toolkit (McKenna, Hanna et al. 2010) for variant 
calling.  
5.3.7 Differential gene expression 
Three methods were used for identifying differential gene/transcript expressions: 
In the GeneSifter pairwise analysis pipeline, the raw read count was normalized 
by total mapped million reads (RPM) and reported as log2 values. Welch’s t-test (does 
not require equal variance between two groups) was run on the log transformed RPM 
between two conditions to test whether transcript levels were changed due to intracellular 
interactions. A Benjamini–Hochberg correction was performed for multiple testing 
adjustments. Genes were considered as differentially expressed when logarithmic ratio of 
fold change ≥ 2 and false discovery rate (FDR) < 0.05. 
DESeq (Anders and Huber 2010) of R/Bioconductor (Gentleman, Carey et al. 
2004), an analysis based on the negative binomial distribution, was also used for 
 126 
differential expression analysis. The count values from different samples were 
normalized to the library size factors so that they were on a common scale. Genes with 
logarithmic ratio of fold change ≥ 2 and FDR < 0.05 (Benjamini-Hochberg correction) 
were declared significant. 
EdgeR package (Robinson, McCarthy et al. 2010) of R/Bioconductor (Gentleman, 
Carey et al. 2004), another testing based on negative binomial model, was used for 
differential analysis as well. The raw count data was normalized using trimmed mean of 
M-values (TMM) between each pair of samples as the scale factors. After the inter-
library dispersions were estimated, an exact test (Robinson and Smyth 2008) was 
performed to identify differentially expressed genes. Genes with logarithmic ratio of fold 
change ≥ 2 and FDR < 0.05 (Benjamini-Hochberg correction) were identified as 
significant. 
Venn diagrams showing the overlaps of gene candidates from four different 
statistical tests were drawn using Venn Diagram Plotter (PNNL; http://omics.pnl.gov). 
5.3.8 Functional annotations and pathway enrichment 
Functional and pathway analysis of statistically significant gene expression 
changes (candidate genes) were performed using Ingenuity Pathway Analysis (Qiagen, 
Redwood City, CA, USA). Fisher's Exact Test was used to calculate p-values, which 
determined the probability of biological functions/pathways enriched in the candidate 
genes was due to the random effects. A Benjamini–Hochberg correction was performed 
for multiple testing corrections. Functions or pathways with p-values (Fisher’s Exact Test) 
less than 0.05 were considered to be significantly relevant. The activation Z-score was 
calculated by using information about the direction of gene regulation (Kramer, Green et 
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al. 2014). Comparison analysis of pathway enrichment from different statistical tests was 
also carried out using the Ingenuity Pathway Analysis.  
5.3.9 RT-qPCR validation  
Quantitative real-time PCR was used to validate changes in gene expression. 
Primers for each of the target sequences were selected from PrimerBank (Wang and Seed 
2003) or designed using the Primer-BLAST tool (www.ncbi.nlm.nih.gov/tools/primer-
blast/ ). Multiple primer pairs were designed and evaluated at the bulk cell RNA level. 
Optimized primer oligos were obtained from Integrated DNA Technologies (Integrated 
DNA Technologies, Coralville, IA, USA).  
RNA extracted from FACS sorted co-culture and mono-culture cells was used for 
reverse transcription and qPCR. A total volume of 20 μL of the cDNA synthesis mixture 
contained the following reagents: 4 μL of 5 × VILO Reaction Mix (Invitrogen, Carlsbad, 
CA, USA), 2 μL of 10 × SuperScript Enzyme Mix (Invitrogen, Carlsbad, CA, USA), 
including SuperScript III RT, RNaseOUT Recombinant Ribonuclease Inhibitor, and a 
proprietary “helper” protein (Invitrogen, Carlsbad, CA, USA), and 14 μL of total RNA. 
The contents in each tube were gently mixed and spun down, and the cDNA synthesis 
was performed in following thermal steps: (a) 25 °C for 10 min, (b) 42 °C for 60 min, 
and (c) 85 °C for 5 min to inactivate the reverse-transcriptase. The cDNA obtained from 
these reactions was stored at -20 °C until further use.  
Prior to qPCR, cDNA obtained from each single cell was diluted 500 times by 
adding DEPC-treated water (Ambion, Austin, TX, USA). The qPCR runs were conducted 
using the following reagent mixtures: 5 µL of EXPRESS SYBR GreenER qPCR 
SuperMix Universal (Invitrogen, Carlsbad, CA, USA), 1 µL of each primer (4 µM), 0.1 
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µL of ROX Reference Dye (25 µM) (Invitrogen, Carlsbad, CA, USA), 2 µL of diluted 
cDNA, and 0.9 µL of DEPC-treated water (Ambion, Austin, TX, USA). For negative 
controls, 2 µL of DEPC-treated water was used instead of cDNA. The thermal cycling 
profile was set up as follows: one cycle at 95 °C for 10 min; 40 cycles consisting of 95 °C 
for 15 s, 60 °C for 1 min, and 80 °C for 10 s with signal detection; melt-curve analysis at 
60 °C for 1 min and the temperature increased in 0.3 °C increments to 95 °C, then at 
95 °C for 15 s. The experiments were run on a StepOne Real Time PCR System (Applied 
Biosystems, Carlsbad, CA, USA). Data analysis was carried out using the StepOne 
software (Applied Biosystems, Carlsbad, CA, USA). 28S were used to normalize samples 
for comparison. 
5.3.10 Time lapse fluorescent microscopy 
For CP-D and EPC-2 cells co-culture, 3.75 × 104 CP-D and 3.75 × 104 EPC-2 
cells suspension were mixed and seeded into individual wells of a Costar® 24-well-plate 
(Corning Life Sciences, Corning, NY, USA). For CP-D and EPC-2 mono-culture, 7.5 × 
104 cells of each type were seeded into individual wells in a Costar® 24-well-plate. After 
24 hours of growth, cells were stained with nucleus stain Hoechst 33342 (Life 
Technologies, Carlsbad, CA, USA) at 1 µg/mL at 37 °C for 15 min. Time lapse images 
were taken every 5 minutes for 1 hour using a Nikon Eclipse TE2000-E microscope 
(Nikon Inc., Melville, NY, USA). The microscope was equipped with a 20 × phase 
contrast objective (Nikon Inc., Melville, NY, USA)  and a cooled CCD camera 
(CoolSNAP HQ, Photometrics, Tucson, AZ, USA), controlled by NIS-Elements imaging 
software (Nikon Inc., Melville, NY, USA). 
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5.3.11 Image analysis 
Images were analyzed using custom-written MATLAB (MathWorks Inc., Natick, 
MA, USA) code and a Fiji TrackMate plugin (Schindelin, Arganda-Carreras et al. 2012). 
5.3.12 Statistical analysis 
Nonparametric Mann-Whitney test and Kruskal-Wallis test were performed to 




5.4 Results and discussion 
5.4.1 RNA-Seq analysis of the transcriptome in esophageal epithelial normal and 
dysplastic cells 
Over several decades, genetic models of the neoplastic progression in Barrett’s 
esophagus and esophageal adenocarcinoma have been discovered and proposed (Barrett, 
Sanchez et al. 1999, Morales, Souza et al. 2002, Maley, Galipeau et al. 2006, Merlo, 
Pepper et al. 2006), including evolution of neoplastic cell lineages (Barrett, Sanchez et al. 
1999), epigenetically regulated alterations of HOXB genes (di Pietro, Lao-Sirieix et al. 
2012), susceptibility loci (Levine, Ek et al. 2013), and recurrent driver events (Dulak, 
Stojanov et al. 2013). During pre-malignant progression, neoplasms are heterogeneous 
and consist of interactions between normal and neoplastic cells (Anderson, Weaver et al. 
2006, Merlo, Kosoff et al. 2011, Greaves and Maley 2012). In this thesis it was 
hypothesized that heterotypic interactions in the tumor microenvironment can down-
regulate gene transcription, slow down cellular proliferation in dysplastic cells, and thus 
inhibit neoplastic progression. 
Figure 5-1 Workflow of transcriptome analysis of cell-cell interactions 
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To test this hypothesis, a co-culture system containing high-grade dysplastic cells 
(CP-D) and esophageal epithelial squamous cells (EPC-2) was constructed. In order to 
distinguish different cell types in the co-culture, CP-D cells were transfected with 
lentiviral-TurboGFP to stably express cytosolic TurboGFP; EPC-2 cells were transfected 
with lentiviral-FP635 to stably express cytosolic FP635. After co-culturing CP-D and 
EPC-2 cells for 24 hours, fluorescent activated cell sorting (FACS) was used to separate 
two cell types and performed whole transcriptome sequencing, using mono-cultured CP-
D and EPC-2 cells as controls (Figure 5-1). Each condition—co-cultured CP-D cells, 
mono-cultured CP-D cells, co-cultured EPC-2 cells and mono-cultured EPC-2 cells—
contained three biological replicates. Four samples were multiplexed per lane with two 
lane replicates on an Illumina HiSeq 2000 sequencer. The raw reads were aligned to the 
Homo sapiens genome reference build 37.2 (GRCh37.p2) using Burrows-Wheeler 
Aligner (Li and Durbin 2009) with Genome Analysis Toolkit (McKenna, Hanna et al. 
2010) for variant calling. From approximately 100 million single-end 50-bp sequencing 
reads, a median of 72 million mapped reads per sample were recovered. The majority of 
mapped reads are annotated gene features (exon-intron regions) and rRNA or snRNA, 
followed by intergenic regions.  
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Three methods were applied to identify differentially expressed genes: DESeq 
(Anders and Huber 2010), EdgeR (Robinson and Smyth 2008, Robinson, McCarthy et al. 
2010) and welch’s t-test (Dudoit, Yang et al. 2002). For multiple testing corrections, 
Benjamini–Hochberg correction (Hochberg and Benjamini 1990) was performed to 
obtain the false discovery rate (FDR). The pairwise comparisons included three pairs: (1) 
co-cultured CP-D vs. mono-cultured CP-D, (2) co-cultured EPC-2 vs. mono-cultured 
EPC-2, and (3) mono-cultured EPC-2 vs. mono-cultured CP-D. A threshold of 
Figure 5-2 Number of differentially expressed genes 
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Benjamini-Hochberg correction at FDR < 0.05 and another cutoff of logarithmic 
transformed fold change values (log2FC) at 2 were set. Identified by all three methods at 
FDR < 0.05, the numbers of differentially expressed genes with log2FC = 2 cutoff were 
much lower than those without log2FC = 2 cutoff (Figure 5-2). EdgeR found the highest 
number of differentially expressed genes, while DESeq returned relatively few. The 
number of differentially expressed genes determined by all three methods showed the 
same trend in different pairwise comparison groups: more differentially expressed genes 
were found in the co-cultured CP-D vs. mono-cultured CP-D group than the co-cultured 
EPC-2 vs. mono-cultured EPC-2 group; the mono-cultured EPC-2 vs. mono-cultured CP-
D group had the highest number among all three (Figure 5-2). This indicated that gene 
expression profiles in CP-D cells changed more due to heterotypic interactions than those 
in EPC-2 cells. The gene expression difference between CP-D and EPC-2 cells was the 
largest. 
The differentially expressed genes in three pairwise groups determined by 
different tests with FDR < 0.05 and log2FC ≥2 (Figure 5-3) were also compared. All three 
methods were concordant with each other, showing a number of overlapping genes in the 
co-cultured CP-D vs. mono-cultured CP-D group and the mono-cultured EPC-2 vs. 
mono-cultured CP-D groups. Particularly, a large portion of genes with differential 
expression found by DESeq were also identified by EdgeR. Both EdgeR and welch’s t-
test found unique differentially expressed genes in the co-cultured CP-D and mono-
cultured CP-D group, which were not shared by other methods. Previous evaluations 
showed that DESeq was often conservative, while EdgeR was too liberal and yields 
potential false positives (Soneson and Delorenzi 2013). In order to retain the ability to 
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detect the truly differentially expressed genes, the primary step of functional enrichment 
included all the differentially expressed genes found by three methods. However, to 
control false discovery rates, further functional annotations focused mainly on the genes 
identified by DESeq.  
Figure 5-3 Venn diagrams of differentially expressed genes 
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5.4.2 Function enrichment of differentially expressed genes in heterotypic 
interactions 
To discover pathways related to transcriptome alterations, Ingenuity Pathway 
analysis (IPA) was performed to identify functional categories associated with 
differentially expressed genes. The list of differentially expressed genes identified 
independently by DESeq, EdgeR and welch’s t-test was used for IPA core analysis.  
In the co-cultured CP-D vs. mono-cultured CP-D group, 67 significant bio-
function terms in genes were found by DESeq, 74 in genes by EdgeR, and 70 in genes by 
welch’s t-test (Fisher's Exact Test and Benjamini-Hochberg correction, FDR < 0.05). 
Among the significant bio-functions enriched from genes found by all three methods, 
cellular movement ranked among the top 5 functions in –log(FDR) (Figure 5-4). Most of 
Figure 5-4 Top 5 functions enriched in the co-CPD vs. mono-CPD group 
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the other bio-function terms and pathways were also closely related to neoplasia and 
tumorigenesis, such as tissue morphology, cancer, lipid metabolism and molecular 
transport. How those functions are regulated in co-cultured CP-D cells in the DESeq 
identified genes (threshold: activation z-score = 2, Fisher’s Exact Test, Figure 5-5) was 
investigated. Interestingly, most of the bio-functions were suppressed in co-cultured CP-
D. The biggest category of down-regulated features was cellular movement, which 
included a panel of movement related functions, such as invasion and migration. Other 
cellular movement associated functions—organization of cytoplasm, organization of 
cytoskeleton and microtubule dynamics—were also inhibited in co-cultured CP-D cells. 
Co-culturing with EPC-2 cells decreased cancer related functions (metastasis, neoplasia 
and cell production) as well. 
In the co-cultured EPC-2 vs. mono-cultured EPC-2 group, only a few 
differentially expressed genes (1 by DESeq, 20 by EdgeR and 2 by welch’s t-test) were 
found (Figure 5-2, Figure 5-3B). Most of the enriched functional categories were not 
significantly changed (threshold: activation z-score = 2, p = 0.05, Fisher’s Exact Test).  
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The transcriptomes in CP-D and EPC-2 cells when they were in mono-culture 
were compared. A total of 209 significant bio-function terms in genes was determined by 
DESeq, 69 by EdgeR, and 67 by welch’s t-test (Fisher's Exact Test and Benjamini-
Figure 5-5 Functional annotations in the co-CPD vs. mono-CPD group 
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Hochberg correction, FDR < 0.05). Cellular movement, cancer, cellular development, cell 
growth and proliferation, as well as cell death and survival ranked as top 5 significant 
functions (Figure 5-6). Most of them were involved in neoplasia and tumorigenesis, 
which emphasized that the transcriptional difference is due to the cell type difference. 
The majority of significantly altered functions were activated rather than inhibited 
(threshold: activation z-score = 2, Fisher’s Exact Test, Figure 5-7). Functions involved in 
cancer, cellular functions and maintenance, cellular development, tissue development, 
tissue morphology and cellular movement were more active in CP-D cells than in EPC-2 
cells, all of which may participate in neoplastic progression.  Morphology of cells was 
less active in CP-D cells, reflecting the changes in cellular shape and size (cytology) as 
well as cell cohesion (architecture) and polarity in the CP-D cells. 
Figure 5-6 Top 5 functions enriched in the mono-CPD vs. mono-EPC2 group 
 139 
5.4.3 Upstream regulator analysis reveals TGFβ and EGF signaling networks are 
inhibited in co-cultured CP-D cells 
To examine the upstream molecules that trigger the transcriptional changes, the 
upstream regulators and their networks were analyzed. Ingenuity Pathway Analysis was 
used to predict the status of upstream molecules and their biological roles in heterotypic 
interactions. 
A total of 40 upstream regulators activated or inhibited (threshold: activation z-
score = 2, p < 0.05, Fisher’s Exact Test) with expression level (log ratio) changes were 
found. These regulators include growth factors, cytokines, transmembrane receptors, 
Figure 5-7 Functional annotations in the mono-CPD vs. mono-EPC2 group 
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transcription regulators, enzymes, kinases, ion channel, ligand-dependent nuclear 
receptors, peptidase and other signal transducers (Figure 5-8). The regulators were sorted 
based on their enrichment p-value within each category and identified regulators of 
pivotal importance in heterotypic interactions.  
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Growth factors TGFβ1 (transforming growth factor β) and TGFβ2 (transforming 
growth factor β2) were predicted to be down-regulated in co-cultured CP-D cells. They 
appeared in the upstream of 19 regulators and affected the expression of 70 genes in their 
Figure 5-8 Upstream regulator analysis in the co-CPD vs. mono-CPD group 
Log ratio: Log ratio of gene expressions in each regulator. Downstream genes: 
downstream genes in the data-set. Regulators in network: downstream regulators 
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mechanistic network. Among 37 genes which were targeted by TGFβ1 and TGFβ2 in the 
dataset (Figure 5-9), 32 genes were involved in epithelial neoplasia (p = 3.08E11) and 28 
involved in cellular movement (p = 2.24E-17, both p-values calculated by Fisher’s Exact 
Test). TGFβ has dual effects in neoplasia and later stages tumor progression.  It is 
involved in many aspects of the communications between cancer cells and non-neoplastic 
cells in the tumor microenvironment (Ungefroren, Sebens et al. 2011). As an early tumor 
suppressor, TGFβ inhibits proliferation and induces apoptosis. During esophageal 
adenocarcinoma progression, TGFβ loses its anti-proliferative function; instead, it 
mediates epithelial-to-mesenchymal transition by several mechanisms and promotes 
esophageal carcinogenesis (Jankowski, Harrison et al. 2000, Rees, Onwuegbusi et al. 
2006). Intriguingly, DOCK2, a target gene of TGFβ1, is down-regulated in co-cultured 
CP-D cells with single nucleotide variants in one intron region. The splice-site mutant 
human DOCK2 gene has been identified as a recurrent drive event in esophageal 
adenocarcinoma in an exome and whole-genome sequencing study of esophageal 
adenocarcinoma. Mutant DOCK2 family members can enhance cellular motility and 
invasion (Dulak, Stojanov et al. 2013). These results suggest that heterotypic interaction 
can affect neoplastic progression by changing cellular motility via TGFβ-mediated 
networks. 
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It was also observed that EGF (epidermal growth factor) was predicted to be 
down-regulated in co-cultured CP-D cells. It affected 57 genes in its mechanistic network 
and acted in the upstream of 10 transcription regulators as well as 7 other regulators 
(Figure 5-9). All of these regulators in the network were involved in apoptosis (p = 
1.50E-15), proliferation (p = 1.95E-14), differentiation (p = 7.32E-14) and migration (p = 
9.65E-14, all p-values calculated by Fisher’s Exact Test). Downstream of EGF, a panel 
of genes was down-regulated, including Erb and TP53. Increased expression of EGF 
Figure 5-9 Differentially expressed genes in the networks 
(A) TGFB1 and TGFB2 network, (B) EGF mechanistic network shows the 
upstream regulators regulated by EGF. 
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receptors has been implicated in Barrett’s esophagus progression (Jankowski 1993, 
Jankowski, Wright et al. 1999, Pande, Iyer et al. 2008). Abnormal Erb family of tyrosine-
kinase receptors (Miller, Moy et al. 2003) and TP53 (Neshat, Sanchez et al. 1994) 
signaling have been previously implicated in the evolution of Barrett’s metaplasia-
dysplasia-adenocarcinoma. Therefore, inhibited EGF signaling networks indicated that 
EGF can potentially slow down the neoplastic progression in CP-D cells. 
Taken together, the inhibition of growth factors and their downstream 
transcription factors affected cellular motility and proliferation. Given that dysplastic 
cells have relaxed proliferation controls (Jankowski, Wright et al. 1999) and esophageal 
adenocarcinoma is an early invasive cancer (Dulak, Stojanov et al. 2013), heterotypic 
interactions may down-regulate growth factor signaling and contribute to these 
phenotypes. 
5.4.4 Co-culture of CP-D and EPC-2 cells changed the proliferation and motility of 
both cell lines 
To further investigate whether cell motility and proliferation were affected by 
heterotypic interactions, fluorescence microscopy was performed to count cell numbers 
and track cell movements. CP-D and EPC-2 co-culture at a 1:1 ratio, CP-D mono-culture 
and EPC-2 mono-culture in a Costar® 12-well-plate (Corning, Corning Life Sciences, 
Corning, NY, USA) were seeded with the same density in four replicates. After growing 
the cells for 24 hours, the first replicate group (four wells) of cells was stained with 
Hoechst 33342 (Invitrogen, Carlsbad, CA, USA) and they were imaged (Figure 5-10) 
using time-lapse fluorescence microscopy. After 48, 72 and 96 hours, the second, third 
and fourth groups of cells were stained with Hoechst and visualized. 
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After counting the cells (Figure 5-11) it was found that the proliferation of CP-D 
cells was slowed down in the co-culture groups compared with the mono-culture groups.  
Interestingly, the proliferation of EPC-2 cells in co-culture was also slower than mono-
culture, although relevant gene expression did not change significantly according to the 
RNA-Seq analysis. This suggests that heterotypic interaction suppressed the proliferation 
of both dysplastic and normal cell lines. 
Figure 5-10 Fluorescence microscopy of Hoechst 33342 stained cells 
 (A) mono-CPD cells, (B) mono-EPC2 cells, (C) co-culture of CPD and EPC2 
cells. Scale bar: 50 μm. 
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Cell motility was analyzed by comparing the speed, displacement and 
directionality ratio (Euclidean distance/displacement) of co-culture and mono-culture CP-
D and EPC-2 cells, respectively. After 24 hours, co-culture CP-D cells traveled 
significantly further than mono-culture CP-D cells during the one-hour recording (p = 
5E-6, Mann-Whitney test, α = 0.05, Figure 5-12A). They also moved in a significantly 
more directional manner than mono-culture CP-D cells (p = 5E-7, Mann-Whitney test, α 
= 0.05, Figure 5-12C).  
On the contrary, EPC-2 cells moved significantly slower in co-culture than in 
mono-culture (p = 2E-4, Mann-Whitney test, α = 0.05, Figure 5-12A). The displacement 
of EPC-2 cells in co-culture was significantly shorter compared with mono-culture (p = 
2E-2, Mann-Whitney test, α = 0.05, Figure 5-12B). Therefore, heterotypic interactions 
altered the motility of both cell lines in several ways: increased the displacement and 























Figure 5-11 Proliferation of CP-D and EPC-2 cells in mono-culture and co-
culture 
N = 3. Slopes (k) are shown after the line. 
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directionality of CP-D cells, slowed down the speed of EPC-2 cells and decreased the 
displacement of EPC-2 cells.   
Figure 5-12 Migration of CP-D and EPC-2 cells in mono-culture and co-culture 
Violin plots of migration speed (A), displacement (B) and directionality ratio 
(C). Black dot: mean value, grey dot: individual data point. 
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5.5 Conclusion 
In this study, the effects of intercellular interactions between normal and late-
dysplastic Barrett’s esophagus cells on transcriptome and phenotypic levels were 
examined. It was investigated how homotypic and heterotypic intercellular interactions 
alter gene expressions using next-generation sequencing. Bioinformatic analysis of the 
next-generation sequencing results identified differentially expressed genes in high-grade 
dysplastic cells as a result of heterotypic and homotypic interactions. These genes were 
enriched in cellular movement and other cancer-related pathways. Heterotypic 
interactions suppressed downstream genes of TGFβ and EGF pathways in late-dysplastic 
cells. Taken the results of proliferation and motility studies together, the inhibition of 
EGF signaling networks seem to slow down the proliferation in co-cultured CP-D cells. 
TGFβ signaling networks may be undergoing the transition from anti-proliferation to 
promoting motility. Normal cells seem to inhibit the growth of dysplastic cells via growth 
factor signaling pathways. The fraction of normal to dysplastic cells can be used as the 
risk stratification marker for pre-malignant progression in Barrett’s esophagus. TGFβ, 
EGF and their downstream genes have great potential to become biomarkers for early 
diagnosis and early treatment of esophageal adenocarcinoma. 
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CHAPTER 6  
ALTERATIONS IN GENE EXPRESSION LEVELS AND METABOLIC 
PHENOTYPE IN RESPONSE TO HYPOXIC SELECTION IN PRE-
MALIGNANT BARRETT’S ESOPHAGUS CELLS 
6.1 Abstract 
Hypoxia acts as important selective pressure in the clonal evolution of Barrett’s 
esophagus neoplastic progression. It can trigger metabolic reprogramming, one of the 
emerging hallmarks of cancer. Metabolic phenotype measurements indicated that 
Barrett’s esophagus cells undergo a series of changes under hypoxic conditions. However, 
the mechanisms underlying these changes remain less clear. This study provides a 
comparison of the alterations on transcriptome and metabolic phenotype in hypoxia-
adapted cells and age-matched normoxic control cell lines in Barrett’s esophagus. Gene 
expression differences between hypoxia and control cell lines revealed alterations in the 
metabolic processes, such as glycolysis and oxidative phosphorylation related genes. 
Differential gene expression analysis uncovered drastic differences between one pair of 
hypoxia-adapted high-grade dysplastic cells and age-matched control cells. It was 
discovered that a dynamic evolutionary process of cells adapt to hypoxia. Compared with 
CPA and CPD cells, dysplastic CPB and CPC cells are at transitional states and make lots 
of gene expression changes to adapt to hypoxia. These findings open new ways for 
designing diagnosis and treatment strategies for Barrett’s esophagus and adenocarcinoma. 
Physicians will need to tackle the functional plasticity of hypoxia adapted dysplastic cells 
when designing metabolic targets for treatment. Also, hypoxia adaptation can be used as 
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early diagnosis, treatment and risk stratification biosignatures in pre-malignant 
progression of Barrett’s esophagus.  
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6.2 Introduction 
Hypoxia, the lack of oxygen supply, is a risk factor for cancer. It arises as cells 
grow far away from the vasculature and live in a local hypoxic environment. Acute 
oxygen level changes between hypoxia and re-oxygeneration can generate reactive 
oxygen species. Such hypoxic conditions constitute a selective pressure for cellular 
growth and proliferation. To survive and thrive under hypoxia, cells need to reprogram 
their gene expression and phenotypic profiles (Harris 2002) in various aspects: 
angiogenesis (Oh, Takagi et al. 1999), metabolism (Vannucci, Seaman et al. 1996, 
Brugarolas, Lei et al. 2004, Kim, Tchernyshyov et al. 2006), proliferation (Zundel, 
Schindler et al. 2000, Lal, Peters et al. 2001), apoptosis or necrosis (Bruick 2000, Velde, 
Cizeau et al. 2000, Sowter, Ratcliffe et al. 2001, Suzuki, Tomida et al. 2001), genetic 
instability (Bristow and Hill 2008) and migration (Imai, Horiuchi et al. 2003, 
Pennacchietti, Michieli et al. 2003, Semenza 2003). 
The acid-bile reflux in Barrett’s esophagus damages esophageal squamous 
epithelial cells and may cause deep ulceration. This generates a periodic hypoxic 
environment for the esophageal epithelial cells (Suchorolski, Paulson et al. 2013). A 
panel of metabolic related or hypoxia response genes, Glut-1 (Younes, Ertan et al. 1997), 
pyruvate kinase isoform M2 (PKM2) (Koss, Harrison et al. 2004), VEGF (Couvelard, 
Paraf et al. 2000)and erythropoietin (EPO) (Griffiths, Pritchard et al. 2007) have been 
reported to be up-regulated in Barrett’s esophagus tissue. A series of metabolic changes 
are also observed along the sequence of pre-malignant progression. Barrett's metaplastic 
cells generate ATP through normal mitochondrial oxidative phosphorylation. In the 
intermediate stages of Barrett’s dysplastic cells, mitochondria are still active, electron 
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transport chain remains functional, but the cells boost up glycolysis in response to the 
substrate (Suchorolski, Paulson et al. 2013). However, the transcriptome and metabolic 
profile changes in Barrett’s esophagus cells adapted to hypoxia are less clear. 
In this study, eight hypoxia-adapted (HCPA, HCPB, HCPC, and HCPD) and their 
age-matched normoxic controls (CCPA, CCPB, CCPC, and CCPD) esophageal epithelial 
cell lines were used. These cell lines represent a sequence of pre-malignant progression in 
Barrett’s esophagus from metaplasia to high-grade dysplasia. Whole transcriptome 
analysis of hypoxia-adapted cells and age-matched normoxic control cell lines after acute 
hypoxia treatment showed gene expression differences among the eight cell lines. Gene 
expressions differences between hypoxia and control cell lines indicated alterations in the 
metabolic process. Differential gene expression analysis revealed a drastic difference 
between HCPC and CCPC cells.  The interplay between TGFβ and hypoxia induced 
responses were suppressed in HCPC cells. It was also found that, in contrast to hypoxia 
and control CPA, CPB and CPC cells, mitochondrial membrane potentials in HCPD cells 
were higher than CCPD cells. A better understanding of the resistance to the hypoxia 




6.3.1 Cell lines 
Barrett’s Esophageal cell lines were derived from premalignant Barrett’s 
esophagus tissue (Palanca-Wessels, Barrett et al. 1998), representing early (CP-A) and 
late (CP-B, CP-C and CP-D) stages in neoplastic progression. 
Hypoxia-resistant Barrett’s esophagus cells were selected following this 
procedure: cells were incubated under hypoxic conditions (<1% O2) for 18 hours to reach 
10% surviving rate. The surviving cells were cultured under normoxic conditions (22% 
O2) and returned to the hypoxic condition after expansion. The cells underwent six 
rounds of selection and the surviving population was designated as hypoxia-selected cells 
(HCPA, HCPB, HCPC and HCPD).  Their age-matched control cells are named as CCPA, 
CCPB, CCPC and CCPD. 
Cells were cultured using Gibco keratinocyte cell growth medium (Invitrogen, 
Carlsbad, CA, USA), supplemented with hEGF (Peprotech, Rocky Hill, NJ, USA) at 2.5 
μg/500 mL, BPE (bovine pituitary extract) at 25 mg/500 mL, 5% fetal bovine serum 
(FBS) (Invitrogen, Carlsbad, CA, USA) and penicillin–streptomycin solution (Invitrogen, 
Carlsbad, CA, USA) at 100 units/100 μg/mL. Cells were maintained at 37 °C in a 
humidified atmosphere containing 5% CO2. 
6.3.2 Acute hypoxia treatment 
Cells cultured in 75 cm2 flasks (Corning, Corning, NY) at 80% confluency were 
placed into a 37 °C incubator supplied with 5% CO2 and 1% O2. After 2 hours of 
incubation, cells were immediately lysed using 600 μL of Buffer RLT in an RNeasy mini 
kit (Qiagen, Valencia, CA, USA) according to the manufacture’s protocol.  
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6.3.3 RNA extraction 
Total RNA was extracted from the sorted cells using RNeasy mini kit per 
manufacture’s recommendation. DNA was removed by the silica-gel membrane, the spin-
column technology and DNase treatment. RNase-free DNase set (Qiagen, Valencia, CA, 
USA), which consists of 10 μL of DNase 1 stock solution in 70 μL of proprietary buffer 
RDD, was used to remove residual DNA for 15 min at 20–30 °C. RNA was eluted by 
adding 30 μL of RNase-free water into the silica-gel membrane and stored at -80 °C. 
6.3.4 Whole transcriptome amplification 
The whole transcriptome of the hypoxia-selected and age-matched normoxic 
control cells was amplified using Nugen Ovation RNA-Seq V2 kits (Nugen Technologies, 
San Carlos, CA, USA) per manufacturers’ instructions on an Apollo 324 Library 
Preparation System (IntegenX, Pleasanton, CA, USA) as previously described in 5.3.4 
Whole transcriptome amplification (Kurn, Chen et al. 2005). 
6.3.5 Library preparation and Illumina sequencing 
Illumina sequencing libraries were prepared on an Apollo 324 Library Preparation 
System using the PrepX™ ILM DNA Library Preparation kit (IntegenX, Pleasanton, CA, 
USA) with five different barcoded adapters for multiplexing. The adapter-ligated libraries 
were amplified by 10 cycles of PCR using KAPA HiFi Library Amplification Kits (Kapa 
Biosystems, Woburn, MA, USA). Amplified libraries were qualified using high 
sensitivity DNA assay on an Agilent Bioanalyzer 2100 (Agilent Technologies, Santa 
Clara, CA, USA) and quantified using a KAPA Library Quantification Kit - 
Illumina/Universal (Kapa Biosystems, Woburn, MA, USA). 
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Clusters were generated using the cBot platform (Illumina, San Diego, CA, USA). 
Five samples were multiplexed per lane with two lane replicates. Single-end sequencing 
with 50 base reads was performed on an Illumina HiSeq 2000 (Illumina, San Diego, CA, 
USA) following the manufacturer’s guidelines. 
6.3.6 Next-generation sequencing alignment 
The sequenced reads were parsed and analyzed using the GeneSifter® Analysis 
Edition pipeline (PerkinElmer, Inc., Seattle, WA, USA) as previously described in 5.3.6 
Next-generation sequencing alignment. After quality assessment, raw reads were aligned 
to the Homo sapiens genome reference build 37.2 (GRCh37.p2) using Burrows-Wheeler 
Aligner (Li and Homer 2010) with Genome Analysis Toolkit (McKenna, Hanna et al. 
2010) for variant calling. 
6.3.7 Multiple condition gene expression comparison 
In the GeneSifter project analysis pipeline, the raw read count was normalized by 
total mapped million reads (RPM) and reported as log2 values. A nonparametric Kruskal-
Wallis test was run on the log transformed RPM between eight conditions to test whether 
transcript levels were significantly different. A Benjamini–Hochberg correction was 
performed for multiple testing corrections. Genes were considered as differentially 
expressed when the false discovery rate (FDR) was < 0.05. 
A database for Annotation, Visualization, and Integrated Discovery 
(http://david.abcc.ncifcrf.gov) (Huang, Sherman et al. 2007) was used for functional 
classification and annotation of candidate genes in the glycolysis and oxidative 
phosphorylation pathways. 
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6.3.8 Differential gene expression 
Differential gene expression was identified using three independent methods as 
previously described in Section 5.3.7 Differential gene expression. 
Venn diagrams showing the overlaps of gene candidates from four different 
statistical tests were drawn using the Venn Diagram Plotter (PNNL; http://omics.pnl.gov). 
6.3.9 Functional annotations and pathway enrichment 
Functional and pathway analysis of differentially expressed genes were performed 
using the Ingenuity Pathway Analysis (Qiagen, Redwood City, CA, USA). Fisher's Exact 
Test was used to calculate p-values, which determined the probability of biological 
functions/pathways enriched in the candidate genes was due to random effects. A 
Benjamini–Hochberg correction was performed for multiple testing corrections. The 
activation Z-score was calculated by using information about the direction of gene 
regulation (Kramer, Green et al. 2014). Functions or pathways with p-values (Fisher’s 
Exact Test) less than 0.05 were considered to be significantly relevant.  
6.3.10 Mitochondrial membrane potential measurement using flow cytometry 
Mitochondrial membrane potential was quantified with flow cytometry analysis 
using the potentiometric dye JC-1. Cells cultured in 25 cm2 flasks (Corning, Corning, NY) 
at 80% confluency were incubated in Keratinocyte serum-free medium without serum 
containing JC-1 (100 ng/mL) for 15 min. Cells were washed twice with PBS, trypsinized 
and re-suspended in 300 μL of Keratinocyte serum-free medium. 
Flow cytometry was performed using a Becton Dickinson FACS Calibur flow 
cytometer (Becton Dickinson, Franklin Lakes, NJ, USA). FL1 and FL2 corresponds to 
the 530/30 BP and 585/42 BP emission filters respectively. JC-1 fluorescence intensity 
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signals of 10,000 events (cells) were collected in each condition. The flow cytometry data 
was analyzed using custom-written MATLAB (MathWorks Inc., Natick, MA, USA) code. 
6.3.11 Statistical analysis 
Nonparametric Mann-Whitney test and Kruskal-Wallis tests were performed to 
determine the significance of differences. A p-value less than 0.05 was considered to be 
statistically significant.   
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6.4 Results and discussion 
6.4.1 Mitochondrial membrane potential measurement of hypoxia-adapted and 
age-matched control cells 
Mitochondrial membrane potential is an important parameter of mitochondrial 
function. It is generated and maintained by mitochondrial electron transport chain, mainly 
by oxidative phosphorylation. The collapse of mitochondrial membrane potential is an 
early event in apoptosis. High mitochondrial membrane potential is correlated with active 
oxidative phosphorylation. Several human cancers have high mitochondrial membrane 
potential and are resistant to apoptotic cell death (Vander Heiden, Chandel et al. 1997). 
JC-1 is a widely-used fluorescent probe for measuring mitochondrial membrane potential 
(Cossarizza, Baccaranicontri et al. 1993). Flow cytometry analysis of JC-1 stained cells 
revealed marked differences between hypoxia-adapted and age-matched control cells 
(Figure 6-1). Normalized against CCPA cells, the relative mitochondrial membrane 
potentials were significantly lower in hypoxia-adapted cells than control cells (CPA, CPB, 
and CPC); while it was significantly higher in hypoxia-adapted HCPD cells than control 
CCPD cells. This suggests that at later stages of progression, hypoxia adapted CPD cells 
have higher energy needs for proliferation, so they boost up their energy production. 
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Mitochondrial heterogeneity within and between different types of cells has been 
reported before (Huang, Fowler et al. 2004, Wang, Shi et al. 2013). The descriptive 
statistics (Table 7) showed that the kurtosis values were comparable within the same 
hypoxia and control pairs (HCPA and CCPA, HCPB and CCPB, HCPC and CCPC). 
They were higher in HCPC and CCPC cells than the other two pairs, indicating higher 
heterogeneity in HCPC and CCPC cells. However, the hypoxia-adaptation did not 
significantly alter the heterogeneity. The kurtosis value in HCPD cells was the highest 
among all eight cell lines, suggesting a highly heterogeneous population in hypoxia-
adapted CPD cells. The skewness values were negative and comparable in both hypoxia 
and control pairs of CPA and CPB cells. HCPC and HCPD cells have positive skewness 
values; while CCPC and CCPD cells have negative values. The skewness value of HCPD 
Figure 6-1 Violin plot of mitochondrial membrane potentials 
The grey boxes inside the violin plot are the box plot of mitochondrial 
membrane potential distributions. Mann-Whitney test, *p < 0.05. 
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cells was the highest, indicating that extremely high mitochondrial membrane potentials 
appeared in only a few cells. Taken together, HCPA, HCPB and HCPC cells, 
mitochondrial membrane potentials were lower than their age-matched controls, whereas 
membrane potentials in HCPD cells were higher than their controls. Hypoxia selection 
pressure may increase the heterogeneity in both CPC and CPD cells, evidenced by higher 
kurtosis values in HCPC and HCPC cells compared with their age-matched controls.  
Table 7 Descriptive statistics of mitochondrial membrane potentials in eight cell lines at 
the single cell level 
Cell Type N total Mean S.D. Kurtosis Skewness 
CCPA 9952 1.21 0.20 15.50 -3.12 
HCPA 9965 1.16 0.19 15.71 -3.11 
CCPB 8973 0.95 0.27 4.78 -2.16 
HCPB 8652 0.90 0.27 4.49 -2.20 
CCPC 9314 1.32 0.12 36.73 -4.19 
HCPC 9853 1.06 0.19 33.21 0.55 
CCPD 9859 1.17 0.21 15.68 -3.48 
HCPD 8786 1.20 0.50 5849.36 69.04 
 
6.4.2 RNA-Seq of hypoxia-adapted and age-matched control cells 
In pre-malignant progression of esophageal adenocarcinoma, deep ulceration 
generates a periodic hypoxic environment for the esophageal epithelial cells (Suchorolski, 
Paulson et al. 2013). Esophageal cells may change their genotypes and phenotypes in 
response to hypoxia selection pressure. However, very few studies have been reported on 
transcriptome and metabolic changes in Barrett’s esophagus cells under hypoxia selection. 
 162 
To investigate how Barrett’s esophagus cells adapt to selective pressure generated 
via acute repetitive hypoxia insult, hypoxia-adapted and age-matched normoxic control 
Barrett’s esophagus cell lines were generated as described in Section 6.3.1 Cell lines. The 
cells underwent six rounds of selection and the surviving population was designated as 
hypoxia-selected cells (HCPA, HCPB, HCPC and HCPD). Their age-matched control 
cells are named as CCPA, CCPB, CCPC and CCPD. All eight cell lines were treated with 
acute hypoxia (1% O2) for 2 hours in three biological replicates. The total RNA from 
each sample was extracted and subjected to RNA-Seq analysis. Five samples were 
multiplexed per lane with two lane replicates on an Illumina HiSeq 2000 sequencer. The 
raw reads were aligned to the Homo sapiens genome reference build 37.2 (GRCh37.p2) 
using Burrows-Wheeler Aligner (Li and Durbin 2009) with Genome Analysis Toolkit 
(McKenna, Hanna et al. 2010) for variant calling. From approximately 40 million single-
end 50-bp sequencing reads, a median of 35 million mapped reads per sample were 
recovered. Most of the mapped reads fell within annotated gene regions (exon-intron), 
rRNA or snRNA, and intergenic regions.  
6.4.3 Comparisons among hypoxia-adapted and control Barrett’s esophagus cell 
lines 
First, gene expressions among all eight hypoxia-adapted and control Barrett’s 
esophagus cell lines (CCPA, CCPB, CCPC, CCPD, HCPA, HCPB, HCPC, and HCPD) 
were compared. A non-parametric Kruskal-Wallis test was performed on reads per 
million (RPM) of each gene. For multiple testing corrections, a Benjamini–Hochberg 
correction (Hochberg and Benjamini 1990) was applied to obtain the false discovery rate 
(FDR). After the FDR < 0.05 cutoff, it was found that the expressions of 21723 genes 
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were different among these eight cell lines. Sample cluster analysis (Figure 6-2) showed 
that the difference between the hypoxia and control pairs is bigger than that within the 
pairs. Also, the differences between HCPB and CCPB cells, HCPC and CCPC cells are 
bigger than the differences between hypoxia-adapted and control pairs in CPA and CPD 
cell lines. 
Gene ontology analysis of these genes elucidated that metabolism, cellular 
signaling, transport and cell cycle related functions were different among these cell lines. 
Using CCPA cells as a control, most of the enriched metabolism-related functions were 
activated (Figure 6-3, threshold: z-score = 4). This indicated that metabolic 
reprogramming may be taking place during the pre-malignant progression in response to 
hypoxia selection pressure. 
Figure 6-2 Sample cluster of differentially expressed genes 
Distance: correlation; linkage: complete 
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Figure 6-3 Gene ontology analysis of statistically significant genes 
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To gain further insights into the alterations in metabolism, these statistically 
significant genes were sorted based on their functions. Hierarchical clustering of genes 
and cell lines (Figure 6-4) clearly demonstrated that the expression levels of most genes 
in the glycolysis/gluconeogenesis pathway were higher in late-stage dysplastic cells 
(CCPB, HCPB, CCPC, HCPC, CCPD, and HCPD) than in metaplastic cells (CCPA and 
HCPA). The expressions of these genes in hypoxia-adapted cells were generally higher 
than age-matched control cells. The difference between hypoxia-adapted and age-
matched control CPC cells was the largest.  
Intriguingly, the last ten genes in the cluster showed a different pattern from the 
other genes (Figure 6-5): the expressions in hypoxia-adapted cells were higher than 
control cells in the pairs of CPA, CPB and CPC cells; while the expressions in hypoxia-
Figure 6-4 Hierarchical clustering of statistically significant genes in the 
glycolysis/gluconeogenesis pathway 
Distance: correlation; linkage: complete 
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adapted HCPD cells were lower than control CCPD cells. Several alcohol 
dehydrogenases are among these genes. High expression levels of class I (Triano, Slusher 
et al. 2003) and II (Crabb, Matsumoto et al. 2004) alcohol dehydrogenase are associated 
with reduced risk of breast and esophageal cancer. This made for an interesting remark 
on the role of alcohol dehydrogenases in hypoxia-adaptation in esophageal cells.  
Hierarchical clustering of genes involved in oxidative phosphorylation (Figure 
6-5) indicated that expression levels of most genes were also higher in late-stage 
dysplastic cells than in metaplastic cells. In addition, their expressions in hypoxia-
adapted cells were generally higher than in age-matched controls in the pairs of CPB, 
CPC and CPD cells. The last few genes in the cluster also manifested a different pattern, 
including cytochrome c oxidase subunit IV isoform 2 (COX4I2). In contrast, cytochrome 
c oxidase subunit IV isoform 1 (COX4I1) is in the upper part of the cluster. In hypoxic 
human cells, hypoxia-inducible factor 1 (HIF-1) can transactivate the COX4I2 gene and 
mediate the degradation of COX4I1 (Fukuda, Zhang et al. 2007). The COX subunit 
switching mechanism keeps homeostasis by maintaining optimal efficiency of 
mitochondrial respiration under hypoxia. The results suggested that as metaplastic 
(HCPA) and high-grade dysplastic (HCPB and HCPC) cells adapt to hypoxia, COX4I2 is 
induced and acts as a physiological response in these cells. However, this was not 
observed in HCPD cells. 
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Figure 6-5 Statistically significant genes in the glycolysis/gluconeogenesis 
pathway 
Red star: genes in row 1-51 of the cluster. Blue star: genes in row 52-60 of the 
cluster. 
 168 
6.4.4 Differential gene expression analysis 
Three methods were applied to identify differentially expressed genes: DESeq 
(Anders and Huber 2010), EdgeR (Robinson and Smyth 2008, Robinson, McCarthy et al. 
2010) and welch’s t-test (Dudoit, Yang et al. 2002). For multiple testing corrections, the 
Benjamini–Hochberg correction (Hochberg and Benjamini 1990) was performed to 
obtain the false discovery rate (FDR). The pairwise comparisons of hypoxia-adapted and 
age-matched control cells included four pairs: (1) HCPA vs.  CCPA, (2) HCPB vs. CCPB, 
(3) HCPC vs. CCPC, and (4) HCPD vs. CCPD. The threshold of the Benjamini-
Hochberg correction was set to FDR < 0.05 and a cutoff of logarithmic transformed fold 
change values (log2FC) was set at 2. With a FDR threshold at 0.05, the number of 
Figure 6-6 Hierarchical clustering of statistically significant genes in the 
oxidative phosphorylation pathway 
Distance: correlation; linkage: complete 
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statistically significant genes after log2FC = 2 cutoff was much lower than that without 
log2FC = 2 cutoff (Figure 6-6).  
EdgeR found the largest number of differentially expressed genes, followed by 
welch’s t-test, and DESeq found the smallest number of genes. The number of 
differentially expressed genes determined by all three methods showed that the HCPC vs. 
CCPC group has the largest number, followed by the HCPB vs. CCPB and HCPD vs. 
CCPD groups; the HCPA vs. CCPA group has very few genes identified as differentially 
expressed.  
Figure 6-7 Number of statistically significant genes found by three differential 
gene expression tests 
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The differentially expressed genes in three pairwise groups determined by DESeq, 
EdgeR and welch’s t-test with FDR < 0.05 and log2FC ≥ 2 (Figure 6-7) were also 
compared. In all the groups except for HCPA vs. CCPA, a large portion of genes with 
differential expression found by DESeq were also identified by EdgeR. Previous 
evaluations showed that DESeq was often conservative, while EdgeR was too liberal and 
yields potential false positives (Soneson and Delorenzi 2013). To control false discovery 
rates, further functional annotations emphasized mainly the genes identified by DESeq.  
Figure 6-8 Venn diagrams of differentially expressed genes identified by three 
statistical methods 
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6.4.5 Function enrichment and upstream analysis of differentially expressed genes 
between hypoxia-adapted and age-matched control cell lines 
Gene expressions are significantly changed by hypoxia-adaptation in the pair of 
HCPC and CCPC cells based on the number of genes identified by statistical tests. To 
discover biological relevance of the transcriptome alterations, Ingenuity Pathway analysis 
(IPA) was performed on the list of differentially expressed genes identified independently 
by DESeq. 
Seventy-two 72 significant bio-function terms enriched were in genes found by 
DESeq (Fisher's Exact Test and Benjamini-Hochberg correction, FDR < 0.05, activation 
z-score = 2, Figure 6-8 and Figure 6-9). Interestingly, most of these bio-functions were 
suppressed in HCPC cells. A majority of them are related to the vascular system: 
development of the vascular system, neovascularization, remodeling of blood vessel, 
activation of pericytes, and so forth. Other functional categories, including cellular 
movement, cell death and survival and cell cycle, are also down-regulated.  
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Figure 6-9 Vascular system related functions enriched in differentially expressed 
genes in the HCPC vs. CCPC group 
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To examine the upstream molecules that trigger the transcriptional changes, 
Ingenuity Pathway Analysis was used to predict the status of upstream regulators in 
comparing hypoxia-adapted and age-matched control cells. 
Sixty-four upstream regulators were found to be activated or inhibited (threshold: 
activation z-score = 2, p < 0.05, Fisher’s Exact Test) with expression level (log ratio) 
changes. These regulators include growth factors, cytokines, G-protein coupled receptors, 
transcription regulators, transmembrane receptors, enzymes, kinases, and other signal 
transducers (Figure 6-10 and Figure 6-11). The regulators were sorted based on their 
Figure 6-10 Other functions enriched in differentially expressed genes in the 
HCPC vs. CCPC group 
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enrichment p-value within each category and important regulators in adaptation to 
hypoxia selection pressure were identified. 
 
Figure 6-11 Upstream regulator analysis of differentially expressed genes (part 1) 
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The expression levels of several growth factors and transcription regulators are 
different between HCPC and CCPC cells: TGFβ1 (transforming growth factor β), TGFβ2 
(transforming growth factor β2), SMAD family, HIF-1α and SP1. Noticeably, SMAD2 
and SMAD3 were down-regulated, while SMAD7 is activated in HCPC cells. Low oxygen 
Figure 6-12 Upstream regulator analysis of differentially expressed genes (part 2) 
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levels can induce a cooperative interaction in which the TGFβ pathway interplays with 
promoter (SP1) and enhancer (HIF-1α) regions through SMAD3 and enhances the 
transcription of genes associated with angiogenesis (Sánchez-Elsner, Ramı́rez et al. 2004, 
Basu, Hubchak et al. 2011). Under normoxic conditions, SMAD7 inhibits the 
transforming growth factor-beta-activated signaling pathway and prevents carcinoma cell 
invasion. Hypoxia can convert SMAD7 to a promoter of cancer invasion and progression 
(Heikkinen, Nummela et al. 2010). Given that the expressions of TGFβ, SP1, HIF-1α, 
SMAD2 and SMAD3 are inhibited, the crosstalk and functional consequences of these 
genes are suppressed in HCPC cells. These results suggested that hypoxia-adapted HCPC 
cells are more resistant to short-term acute hypoxia compared with their age-matched 
control CCPC cells. 
  
Figure 6-13 TGF-β mediated hypoxia response is suppressed in HCPC cells 
Adapted from Sánchez-Elsner  et al. 2004. Green: inhibition; red: activation. 
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6.5 Conclusion 
Whole transcriptome profiles and mitochondrial functions have revealed changes 
due to hypoxia-selection in pre-malignant Barrett’s esophagus. Under normal conditions, 
mitochondrial membrane potentials are lower in HCPA, HCPB and HCPC cells 
compared with CCPA, CCPB and CCPC cells. However, HCPD cells have higher 
mitochondrial membrane potential and a higher heterogeneity than CCPD cells. This is 
probably because high grade dysplastic cells have higher energy needs for proliferation 
and other cellular processes. Under hypoxic conditions, transcriptome profiling using 
RNA-Seq showed that more differentially expressed genes are found between the HCPB 
vs CCPB group and the HCPC vs CCPC group. The TGFβ mediated hypoxia response 
network is less active in HCPC than CCPC cells. Metabolism and signal transduction 
related genes are also differentially expressed among all eight cell lines. Taken all these 
together, hypoxia adaptation makes cells more resistant to acute hypoxia by changing 
their metabolism and hypoxia-response signaling pathways. 
From these results, an evolutionary process can be proposed (Figure 6-14): as the 
hypoxic selection pressure is applied to these cells, CPA, metaplastic cells, change their 
phenotypes in adaptation to hypoxia. However, when they are treated by another short-
term acute hypoxia, CPA cells did not retain these changes and the adaptation was 
reversed back. CPB and CPC are the dysplastic cells at transitional states of progression. 
They made a lot of transcriptional changes and retained accumulative effects of hypoxia 
adaptation in this process of pre-malignant progression. CPD cells are at the latest stage 
of esophageal adenocarcinoma. They probably have already gone through several rounds 
of hypoxia selection. Therefore, hypoxia-adaptation did not change too much on CPD 
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cells. Compared with CPA and CPD cells, dysplastic CPB and CPC cells are at a 
transitional state and made lots of gene expression changes to adapt to hypoxia. This 
model suggested that hypoxia adaptation can be used as a risk stratification marker in 
Barrett’s esophagus. Also, because of the functional plasticity in dysplastic cells, 
physicians need to target multiple metabolic pathways such as oxidative phosphorylation 
and glycolysis to treat premalignant conditions and cancer. 
  
Figure 6-14 The proposed evolutionary process of Barrett’s esophagus cells 
adapted to the hypoxic selection pressure 
(A) Before acute hypoxia treatment. (B) After acute hypoxia treatment. 
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CHAPTER 7  
CONCLUSION AND FUTURE WORK  
7.1 Conclusion  
The major findings and contributions of my dissertation include: 
(i) Developed and optimized a new method for retrieving single adherent 
cells of different types with minimal perturbation from growth cultures. The method 
combines mechanical (shear flow) and biochemical (enzymatic digestion) treatments and 
is relatively simple to use and replicate by other research groups in the field. Analyzed 
expression levels of stress-related genes in individual cells to a range of different 
combinations of shear flow and enzymatic digestion. Identified optimal conditions of 
shear force and trypsinization time for retrieving single cells with minimal perturbation. 
The study encompasses two important aspects that are broadly applicable in the field of 
single-cell analysis: (a) a new method for single-cell harvesting of different types of cells 
from growth cultures and co-cultures with minimal perturbation; (b) a detailed study of 
the cell response to a range of mechanical and biochemical stress levels in individual 
cells. This study will be of interest to a broad cell biology research community and 
especially to the researchers working in the field of single-cell analysis. 
(ii) Developed a single cell RT-qPCR method for analyzing expression levels 
of multiple genes in individual mammalian cells with high sensitivity and reproducibility. 
It allows for reliable detection of up to ten genes of interest in a single cell with multiple 
technical replicates. Using this method, hypoxia response genes in 36 single cells 
exposed to hypoxia and 36 grown under normal physiological conditions were analyzed. 
This method can also detect cell-to-cell differences of gene expression levels in single 
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cells under hypoxia treatment. The compatibility of the method with most of 
commercially available RT-qPCR instrumentation and its relatively low cost makes it 
amenable to many applications focused on gene expression analysis in single cells, such 
as high throughput, chip-based techniques, which will enable further insights into cellular 
mechanisms involved in disease genesis and progression at the single-cell level.  
(iii) Characterized the transcriptome wide gene expression changes due to cell-
cell interactions in neoplastic progression of Barrett’s esophagus. The results indicated 
that co-culturing of dysplastic cells and normal esophageal epithelial cells significantly 
changed the expression of hundreds of genes in dysplastic cells. These genes are related 
to cellular movement, tissue morphology and cancer functions. Identified upstream 
regulators of differentially expressed genes. Signaling networks regulated by TGFβ and 
EGF were significantly inhibited in dysplastic cells by heterotypic interactions. 
Functional validations showed that proliferation and cellular motility are also changed in 
co-culture of dysplastic and normal cells. The results suggest that heterotypic interactions 
in Barrett’s esophagus are complicated and dynamic processes involve myriads of 
transcriptional and phenotypic changes. This study provides deep insights into the role of 
cell-cell interactions and the tumor microenvironment in the neoplastic progression of 
Barrett’s esophagus. The transcriptional changes due to the presence of cell-cell 
interactions will shed light on esophageal adenocarcinoma progression, and are likely to 
reveal the mechanisms of neoplastic progressions in cancer as a general disease. 
(iv) Analyzed whole-transcriptome profiles and mitochondrial functions in 
pre-malignant Barrett’s esophagus cell lines adapted to hypoxia. Using RNA-Seq and 
differential gene expression analysis, observed that gene expression differences between 
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hypoxia and control cell lines are related to alterations in metabolic processes. The gene 
expression differences were larger in the HCPB vs. CCPB group and the HCPC vs. 
CCPC group than in the HCPA vs. CCPA group and the HCPD vs. CCPD group. From 
upstream analysis, discovered that the interplay between TGFβ and hypoxia induced 
responses were suppressed in hypoxia-adapted high grade dysplastic HCPC cells 
compared with CCPC cells. Mitochondrial membrane potentials in hypoxia-selected and 
age-matched control cell lines are significantly different: potentials are lower in hypoxia-
selected HCPA, HCPB and HCPC cells than their age-matched controls; potentials are 
higher in hypoxia-selected HCPD cells than the age-matched control. Results from this 
study will lead to a greater understanding of mitochondrial functions in neoplasia and 
tumor progression. It will also help clinicians develop better adjuvant therapeutic 
strategies targeting cancer metabolism.  
With these results, one paper was published, one manuscript was submitted and 
two more manuscripts are in preparation for publication. All of them are listed below. 
1. Zeng, J.*, Wang, J.*, Gao, W., Mohammadreza, A., Kelbauskas, L., 
Zhang, W., Johnson, R. H., and Meldrum, D. R. (2011). Quantitative single-cell gene 
expression measurements of multiple genes in response to hypoxia treatment. Analytical 
and Bioanalytical Chemistry 401, 3-13. (*Co-first authorship) PMID:21614642. 
Published in a special, accelerated section, “Paper in Forefront.” 
2. Zeng, J., Mohammadreza, A., Gao, W., Merza, S., Smith D., Kelbauskas, 
L., and Meldrum, D. R. A minimally invasive method for retrieving single adherent cells 
of different types from cultures. Under review. 
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3. Whole transcriptome and metabolic profiling of intercellular interactions 
between normal and pre-malignant esophageal cells. In preparation. 
4. Alterations in gene expression levels and metabolic phenotype in response 
to hypoxic selection in pre-malignant Barrett’s esophagus cells. In preparation. 
7.2 Future work 
In this dissertation research, single cell harvesting and RT-qPCR methods were 
developed for implementing multi-parameter single-cell analysis and correlating 
genotype to phenotype in various diseases. The transcriptome-wide differential gene 
expression analysis of cell-cell interactions and hypoxia responses in Barrett’s esophagus 
cells allows novel inquiries into neoplastic progression.  
However, more work will be required in the future to apply these single-cell 
technologies in an integrated framework to link genotype to phenotype in neoplastic 
progression. First, the throughput of single-cell harvesting needs to be increased. 
Currently it takes about 1 min to retrieve a single cell from a microwell. A micro-pipette 
array can be designed and tested for collecting single cell or single cell lysate, which may 
enable high-throughput harvesting of single cells from an ultra-high density micro-well 
array. Second, the single cell RT-qPCR method should be combined with Fluidigm’s 
BioMark platform. Even though the single cell RT-qPCR method developed here can 
detect up to ten genes without pre-amplification, a larger number of genes is still desired. 
It will be helpful if an interface or pipeline can be built in the future, bridging the 
extraction-reverse-transcription step of the RT-qPCR method developed here and 
Fluidigm BioMark’s 96 cells × 96 genes assays. Third, a 3D culture system of 
intercellular communications in the tumor microenvironment should be created. Cell-cell 
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interactions in Barrett’s esophagus experiments were performed in 2D cell culture. This 
model is still far away from the native state of the cells. Creating a 3D culture system and 
further an organotypic model for cell-cell interactions in the tumor microenvironment 
will allow further inquiries into pre-malignant progression. Fourth, there is a need to 
track cell-cell interactions for longer periods of time. The process of cell-cell interactions 
is dynamic. RNA-Seq analysis after 24 hours of co-culturing dysplastic and normal cells 
only took a snapshot of the ever-changing microenvironment. The landscape of the 
transcriptome might be drastically different after longer culture times, when both cell 
lines have adapted to the environment. Therefore, time series experiments on a multi-
dimensional co-culture system holds the potential to uncover more events and underlying 
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